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Abstract 
 
 
New heterocyclic bioactive fluorescent compounds: spectroscopic studies of DNA 
interactions and encapsulation in nanoliposomes 
 
Spectroscopic studies (absorption and steady-state fluorescence) of potential 
antitumoral heteroaryl and heteroannulated indoles, benzothienopyran-1-ones, 
methyl 3-amino-6-heteroarylthieno[3,2-b]pyridine-2-carboxylates, tetracyclic 
thieno[3,2-b]pyridine derivatives and benzothienoquinolines, synthesized in our 
research group, were performed in solvent of different polarities. Generally, all the 
compounds presented a solvent sensitive emission with significant red-shifts in polar 
solvents, pointing out for their potential use as solvatochromic probes.  
The antitumoral potential of some of the compounds was evaluated by the growth 
inhibition of human tumor cell lines in collaboration with the Faculty of Pharmacy of 
the University of Porto. 
The spectroscopic properties of the compounds were also evaluated when 
incorporated in liposomes of neat lipids and lipid mixtures of different formulations, 
including, Egg-PC (egg yolk phosphatidylcholine), DPPC (dipalmitoyl 
phosphatidylcholine), DPPG (dipalmitoyl phosphatidylglycerol), DMPG (dimyristoyl 
phosphatidylglycerol), DOPE (dioleoyl phosphatidylethanolamine), DSPE-PEG 
(Distearoyl phosphatidylethanolamine-polyethylene glycol), DODAB 
(Dioctadecyldimethylammonium bromide) and cholesterol.  
Fluorescence steady-state anisotropy measurements allowed monitoring the location 
and behaviour of the compounds in the liposomes. In most cases, they showed to be 
located mainly in the hydrophobic region of the lipid bilayers, experiencing differences 
in fluidity between the rigid gel and the liquid-crystalline phases. These studies of the 
antitumoral compounds encapsulation were made having in mind future drug delivery 
applications. 
The mean size, size-distribution and zeta-potential of the liposomes incorporating the 
most promising antitumoral compounds, were determined by DLS (Dynamic Light 
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Scattering). Almost all the liposomes with the incorporated compounds have shown  
diameters under 165nm and, with some formulations like DPPC:DMPG:DSPE-PEG 
(1:1:0.1), small diameters (below 100nm), low polydispersity and reasonable negative 
zeta-potential values were obtained for two of the methyl 3-amino-6-
heteroarylthieno[3,2-b]pyridine-2-carboxylates studied. 
In order to evaluate the interaction with nucleic acids, the binding modes of the 
tetracyclic planar fluorescent thieno[3,2-b]pyridine derivatives and of the 
benzothienoquinolines to salmon sperm DNA and/or to synthetic double-stranded (ds) 
heteropolynucleotides  were studied using spectroscopic methods which allowed the 
determination of intrinsic binding constants (Ki) and binding site sizes (n). Fluorescence 
quenching experiments with iodide ion were also performed in order to distinguish 
between the different binding modes of the compounds to the nucleic acids studied, 
since intercalated molecules are less accessible to anionic quenchers due to 
electrostatic repulsion with negatively charged nucleic acids. All the compounds 
interact with DNA and polynucleotides either by intercalation or groove binding. The 
latter seems to be the main type of interaction of these compounds with nucleic acids.   
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Resumo 
 
 
Novos compostos heterocíclicos bioativos fluorescentes: estudos espetroscópicos de 
interação com DNA e incorporação em nanolipossomas. 
 
Foram realizados estudos espetroscópicos (absorção e fluorescência em estado 
estacionário) de heteroarilindoles e indoles heteroanelados, benzotienopiran-1-onas, 
3-amino-6-heteroariltieno[3,2-b]piridina-2-carboxilatos de metilo, derivados 
tetracíclicos de tieno[3,2-b]piridinas e benzotienoquinolinas com potencial 
antitumoral, sintetizados no nosso grupo de investigação, em solventes de diferentes 
polaridades. 
De um modo geral, todos os compostos apresentaram uma emissão sensível ao 
solvente com significativos desvios para vermelho em meios polares, indicando a sua 
potencial utilização como sondas solvatocrómicas. 
O potencial antitumoral de alguns dos compostos foi avaliado através da inibição do 
crescimento de linhas celulares tumorais humanas em colaboração com a Faculdade 
de Farmácia da Universidade do Porto. 
As propriedades espetroscópicas foram também avaliadas para os compostos 
incorporados em lipossomas de lípidos puros e misturas lipídicas de diferentes 
formulações, incluindo, Egg-PC (fosfatidilcolina do ovo), DPPC 
(dipalmitoilfosfatidilcolina), DPPG (dipalmitoilfosfatidilglicerol), DMPG 
(dimiristoilfosfatidilglicerol), DOPE (dioleoilfosfatidiletanolamina), DSPE-PEG (Distearoil 
fosfatidiletanolamina-polietilenoglicol), DODAB (Brometo de 
dioctadecildimetilamónio) e colesterol.  
Medidas de anisotropia de fluorescência em estado estacionário permitiram 
monitorizar a localização dos compostos nos lipossomas. Na maioria dos casos, os 
compostos mostraram estar localizados maioritariamente na região hidrofóbica da 
bicamada lipídica, sentindo diferenças de fluidez entre a fase-gel e a fase líquido-
cristalina dos lípidos. Estes estudos de encapsulação dos compostos antitumorais 
foram realizados tendo em vista aplicações futuras de libertação de fármacos. 
xii 
 
O tamanho médio, distribuição de tamanhos e potencial-zeta dos lipossomas 
incorporando os compostos antitumorais mais promissores foram avaliados através de 
medidas de DLS (Difusão de Luz Dinâmica). A maioria dos lipossomas mostrou possuir 
diâmetros menores que 165nm e, algumas formulações como DPPC:DMPG:DSPE-PEG 
(1:1:0.1), exibiram tamanhos menores que 100nm e baixa polidispersividade. Valores 
de potencial-zeta razoavelmente negativos foram obtidos para dois dos 3-amino-6-
heteroariltieno[3,2-b]piridina-2-carboxilatos de metilo estudados. 
Para avaliar a interação com os ácidos nucleicos, os modos de ligação dos derivados 
tetracíclicos fluorescentes planares  de tieno[3,2-b]piridinas e de benzotienoquinolinas  
ao DNA de esperma de salmão e heteropolinucleótidos sintéticos de cadeia dupla, 
foram estudados usando métodos espetroscópicos que permitiram a determinação 
das constantes de ligação (Ki) e tamanho dos sítios de ligação (n). 
Medidas de inibição de fluorescência pelo ião iodeto foram também realizadas para 
distinguir entre os diferentes modos de ligação dos compostos aos ácidos nucleicos 
estudados, uma vez que as moléculas intercaladas estão menos acessíveis a inibidores 
aniónicos devido às repulsões eletrostáticas com os ácidos nucleicos carregados 
negativamente. Todos os compostos interatuam com o DNA e polinucleótidos ou por 
intercalação, ou por ligação nos sulcos (grooves). Este modo de ligação parece ser o 
tipo de interação predominante dos compostos com os ácidos nucleicos. 
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Thesis outline 
 
 
 The present dissertation is divided into six chapters and a description of each 
chapter is outlined. 
 
Chapters 1, 2, 3 and 4 represent an introduction to the work presented. In 
chapter 1, the synthesis of the compounds studied is presented and discussed. In 
chapters 2 and 3 are based on a literature review of recent years, in the areas of the 
interaction with DNA and encapsulation in nanoliposomes of biologically active 
compounds. Chapter 4 is dedicated to theoretical concepts of molecular fluorescence 
spectroscopy. The organization of these four chapters is as follows:  
Chapter 1 - New potential antitumoral fluorescent heterocyclic compounds 
 
Chapter 2 - Compounds/DNA interaction 
 
 Chapter 3 - Compounds encapsulation in nanoliposomes 
 
 Chapter 4 - Molecular Fluorescence Spectroscopy 
 
 Chapter 5 comprises a compilation of articles published in international 
scientific journals and a manuscript to be submitted for publication, in the scope of this 
thesis. Each article/manuscript is presented as a sub-chapter. The organization of this 
chapter is as follows: 
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1. Introduction 
The therapy of tumors is being currently achieved by surgical intervention, radiation 
treatment and chemotherapy. The drawbacks of this latter are mainly due to the 
toxicity of the drugs, which is usually not limited to the cancer cells, and to the 
acquired resistance of the cancer cells to some of the most widely used drugs, which 
reduces the long-term efficacy of the therapy. For these reasons, there is a strongly 
need in the oncology field for new compounds endowed with antitumour activity. 
Thus, the chemistry and biological study of heterocyclic and/or heteroaromatic 
compounds has been an interesting field for a long time in medicinal chemistry, 
namely in anti-cancer chemistry1,2. One way to avoid the toxicity and to decrease the 
therapeutic dose of the antitumoral compounds is to encapsulate them in 
liposomes3,4. The study of the antitumoral mechanism of action of the compounds is 
also an important issue for cancer treatment. 
For some years now, our research group has been interested in the synthesis of 
heterocyclic antitumoral compounds, using several synthetic methodologies and 
different starting materials. 
In this work, several classes of compounds synthesized in our research group were 
studied due to their fluorescence properties and their potential antitumoral activity: 
heteroaryl and heteroannulated indoles, benzothienopyranones, heteroaryl and 
tetracyclic thienopyridine derivatives and benzothienoquinolines. These compounds 
were shown to be fluorescent in several solvents with different polarity and this 
important feature allowed us to study their location when encapsulated in liposomes 
of different lipid composition, and DNA interactions of some of them (including 
intercalation and groove binding) using natural double-stranded (ds) salmon sperm 
DNA and/or synthetic ds-polynucleotides. 
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2. Heteroaryl and heteroannulated indoles 
A number of heterocyclic derivatives containing nitrogen atom serve as a unique and 
versatile scaffolds for experimental drug design. Indole along with their several 
derivatives finds a prominent place in synthetic organic chemistry, as they found to be 
potent pharmacophores. Indole derivatives have displayed versatile pharmacological 
properties such as anti-inflammatory, anticancer, antidiabetic, antimalarial, 
antibacterial, antifungal, anticonvulsant and cardiovascular activities. Notably, the 
indolic amino acid tryptophan is the precursor of the neurotransmitter serotonin (5-
hydroxytriptamine) (Figure 1.1.). In addition, the indole ring is present in various 
marine or terrestrial natural compounds, which have useful biological properties. The 
name indole is deriving from the words indigo and oleum, since indole was first 
isolated by treatment of the indigo dye with oleum. Indole is an aromatic heterocyclic 
organic compound, having a bicyclic structure, consisting of a six-membered benzene 
ring fused to a five-membered nitrogen containing pyrrole ring, i.e., indole is a 
benzopyrrole (Figure 1.1)5. 
 
Figure 1.1. Indole, L-Tryptophan and Serotonin structures. 
 
Several recent reviews6-8 represent some synthesized indole derivatives and their 
pharmacological profiles, namely anticancer, which may contribute in future to 
synthesize various analogs and to develop new pharmacologically less toxic medicines.  
Furthermore, many planar heteroaromatic derivatives have shown anti-proliferative 
activity in vitro and some of them are important anticancer drugs2. 
Keeping these observations in mind and the interest of our research group in the 
synthesis of new biologically active heterocycles, namelly antitumoral compounds, it 
was planned to synthesize several fluorescent planar indole derivatives including 
heteroannulated ones. 
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Thus, in an earlier work9,10, ,-diaryldehydroamino acids 1 and 2 were obtained by 
palladium-catalyzed Suzuki (C-C) cross-couplings11 of the methyl ester of N-(t-
butoxycarbonyl)-,-dibromodehydroalanine with dibenzothien-4-yl and dibenzofur-4-
yl boronic acids and were cyclized to new tetracyclic heteroaromatic compounds, the 
methyl 1-(dibenzothien-4-yl)-3H-benzothieno[2,3-e]indole-2-carboxylate 3, and the 
methyl 1-(dibenzofuro-4-yl)-3H-benzofuro[2,3-e]indole-2-carboxylate 4 in high yields, 
by a novel metal assisted (palladium (II) and copper) C-N intramolecular cyclization 
developped by us12-15 (Scheme 1.1).  
 
 
Scheme 1.1. Synthesis of the bis-Suzuki coupling products 1 and 2, and their intramolecular C-N 
cyclization
9,10
 to the tetracyclic compounds 3 and 4. 
 
The general catalytic cycle for the Suzuki (C-C) cross coupling involves three steps: 
oxidative addition, transmetallation and reductive elimination (Scheme 1.2)11. 
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Scheme 1.2. General catalytic cycle of the Suzuki cross-coupling reaction for formation of Ar-Ar’. 
 
The first step is the oxidative addition of an organic (aryl, heteroaryl or vinyl) halide to 
the Pd(0), occurring the formation of an organopalladium (II) halide. Then, the halide 
ion of the palladium (II) complex can be removed by the metal of the base, yielding an 
organopalladium alkoxide or hydroxide (more reactive than the organopalladium 
halide as the Pd-O bond is more polar than the Pd-X bond). In the electrophilic 
transmetallation step, the boron organometallic compound reacts with the palladium 
complex (Ar-Pd(II)-Y), giving rise to the diorganometallic complex (Ar-Pd(II)-Ar’). For 
that, the boronic acid must be activated by the base converting in a boron tetravalent 
compound. Finally, the reductive elimination of Pd(0) occurs and the C-C bond (Ar-Ar’) 
is formed.  
The mechanism for the intramolecular C–N cyclization of the Suzuki cross-coupling 
products proposed by our research group involves the formation of a palladacycle. 
After extrusion of Pd(0), the pyrrole ring is formed, and  it is thought that Cu(OAc)2 
reoxidizes it to Pd(II), avoiding the use of a stoichiometric  amount of Pd(OAc)2. As 
acetic acid is formed, the Boc group is removed12 (Scheme 1.3).  
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Scheme 1.3. Intramolecular C–N cyclization of the Suzuki cross-coupling products 1 and 2, to the 
compounds 3 and 4 (adapted from ref.12). 
 
Compounds 3 and 4 were prepared as potential new DNA targets and their absorption 
and fluorescence properties in different solvents and in the presence of natural 
double-stranded (ds) salmon sperm DNA were studied. The results in several solvents 
showed that either compound 3 or compound 4 can be used as fluorescence solvent 
sensitive probes. Spectroscopic studies of the interaction of both compounds with 
dsDNA allowed the determination of the binding constant (Ki) values and binding site 
sizes (n). Fluorescence quenching experiments using iodide ion allowed the 
determination of the accessibilities to the quencher, showing that intercalation is the 
preferred mode of binding of these molecules to DNA, compound 3 being the most 
intercalative showing also the highest affinity to DNA.  
Following the same strategy in a posterior work1, we synthesized the -
heteroaryldehydrophenylalanines 5 and 6 (E and Z) by Suzuki (C-C) cross-couplings of 
the methyl ester of N-(t-butoxycarbonyl)-(E or Z)--bromodehydrophenylalanine16 with 
dibenzothien-4-yl and dibenzofur-4-yl boronic acids, in excellent yields maintaining the 
stereochemistry of the starting material.  The intramolecular metal-assisted (Pd/Cu) C-
N cyclization of the Suzuki coupling products 5-E, 5-Z, 6-E and 6-Z gave, in all cases,  
two new heterocyclic compounds, the 3-(dibenzothien-4-yl)indole 7 and the 
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phenylbenzothienoindole 8 or the 3-(dibenzofur-4-yl)indole 9 and the 
phenylbenzofuroindole 10 in different ratios depending on the starting stereoisomer. 
These compounds result either from direct cyclisation or cyclization after isomerization 
of the Suzuki coupling products and were separated by column cromatography 
(Scheme 1.4, Table 1.1).  
 
Scheme 1.4. Synthesis of heteroaryl and heteroannulated indoles 7-10 from the pure stereoisomers 
Suzuki cross-coupling products1 5-E, 5-Z, 6-E and 6-Z. 
 
 
Table 1.1. Heteroaryl and heteroannulated indoles 7-10 prepared via scheme 1.4. 
Starting material Cyclized products 
 (ratios, yields) 
Time and temperature 
5-E 7/8  (3:1, 41%/14%) 3h30min, 130ºC + 3h30min, 160ºC 
5-E 7/8  (1.5:1, 37%/26%) 5h, 130ºC + 2h, 160ºC 
5-Z 7/8  (2:1, 20%/10%) 12h, 160ºC 
6-E 9/10  (6:1, 30%/5%) 5h, 160ºC 
6-Z 9/10  (5:1, 49%/10%) 3h, 160ºC 
 
Compounds 7, 8 and 9 were evaluated in colaboration with other research group of 
the Faculty of Pharmacy of the University of Porto, for their capacity to inhibit the in 
vitro growth of three human tumor cell lines, MCF-7 (breast adenocarcinoma, 1.5105 
cells/mL), NCI-H460 (non-small cell lung cancer, 0.75105 cells/mL), and SF-268 (CNS 
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cancer, 1.5105 cells/mL) after a continuous exposure of 48h. Compound 7 showed to 
be the most potent presenting GI50 (50% of cell growth inhibition) values of 11, 13 and 
17 μM, respectively, whereas compound 9 exhibited only a low inhibitory effect 
against the tumor cell lines tested with GI50 values of 27, 18 and 35 μM, respectively. 
Compound 8 presented a weak growth inhibitory effect (GI50 values of 73, 40 and 50 
μM, respectively). Comparing the activities of the heteroarylindoles 7 and 9, the 
oxygen isostere 9 presented a weaker growth inhibitory effect, although the results in 
NCI-H460 cell line are comparable1.  
Due to these results, the fluorescence properties in several solvents and in lipid 
membranes of these three indole derivatives were studied in the present work 
(Chapter 5.1). 
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3. Benzothienopyranones 
In the last years, several lactones have shown to be potent anticancer agents17-20. 
Additionally, promising pharmacological activities of 3-substituted isocoumarins21-23 
and 4-alkynyl substituted 2-pyrones24 (Figure 1.2) and the fact that thiophene moiety is 
common in manybioactive agents and drugs25 lead our research group to synthesize 
new potential antitumoral benzothienopyranones26.  
 
Figure 1.2. General structures of 2-pyrones and isocoumarins. 
 
Thus, several 3-arylbenzothieno[2,3-c]pyran-1-ones, including compounds 11a and 11b 
were prepared  in our research group, through a tandem one-pot procedure of 
Sonogashira coupling followed by a regioselective 6-endo-dig intramolecular 
lactonization from the commercial 3-bromobenzo[b]thiophene-2-carboxylic acid and 
different arylacetylenes (Scheme 1.5)26. 
As the product yields of the one-pot procedure were not high, Sonogashira couplings27 
of the methyl 3-bromobenzo[b]thiophene-2-carboxylate28 with several arylacetylenes 
were performed. The Sonogashira coupling products were obtained in good yield, 
using conditions similar to those of the one-pot procedure, but 1.5 equiv. of the 
arylacetylene were needed to completely consume the brominated compound. Several 
compounds, including compound 11d were obtained by a 6-endo-dig cyclization of  
methyl 3-(arylethynyl)benzo[b]thiophene-2-carboxylates, using TFA (trifluoroacetic 
acid) as a Brönsted acid at room temperature (Scheme 1.5).  
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Scheme 1.5. Synthesis of the 3-arylbenzothieno[2,3-c]pyran-1-ones 11a–d. 
 
The copper-cocatalyzed Sonogashira reaction is believed to take place through two 
independent catalytic cycles (Pd-cycle and Cu-cycle) as shown in Scheme 1.6, where a 
tertiary amine is represented as base. The generally accepted catalytic cycle for the 
palladium catalysis (the Pd-cycle) is based on a usually fast oxidative addition of R1-X 
(R1 = aryl, heteroaryl, vinyl; X = I, Br, Cl, OTf) to the real catalyst generated from the 
initial palladium complex. The next step in the Pd-cycle would connect with the cycle 
of the copper cocatalyst (the Cu-cycle). Thus, a usually rate-determining 
transmetallation from the copper acetylide formed in the Cu-cycle would generate a 
R1Pd(-CCR2)L2 species, which gives the final coupled alkyne after reductive 
elimination with regeneration of the catalyst. In the Cu-cycle, the base is supposed to 
abstract the acetylenic proton of the terminal alkyne, thus forming a copper acetylide 
in the presence of the copper(I) salt. It should be pointed out that the generally 
employed amines are usually not basic enough to deprotonate the alkyne in order to 
generate the anionic nucleophile that should form the copper acetylide. Therefore, a 
-alkyne-Cu complex as shown in Scheme 1.6 could be involved in the cycle, thus 
making the alkyne proton more acidic for easier abstraction. These copper acetylides 
could also be involved in the formation of the initial Pd(0)L2 catalytic species by 
reaction with the starting palladium(II) complexes, thus forming Pd-(-CCR2)2L2, which 
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after reductive elimination would afford active Pd(0)L2 and some amounts of a 
diacetylene byproduct. 
 
Scheme 1.6. General catalytic cycle of the copper-cocatalyzed Sonogashira reaction
27
. 
 
A plausible mechanism for the intramolecular cyclization of the Sonogashira products 
using TFA is polarization of the triple bond of the 3-(arylethynyl)benzo[b]thiophene-2-
carboxylates with H+ enhancing the electrophilicity of the alkyne (Scheme 1.7). 
 
Scheme 1.7. Proposed intramolecular cyclization of the Sonogashira products using TFA. 
 
The effect of the cyclized products (tricyclic lactones) on the in vitro growth of three 
tumor cell lines, namely MCF-7 (1.5105 cells/mL), SF-268 (1.5105 cells/mL) and NCI-
H460 (0.75105 cells/mL), was evaluated after exposure of 48h. The compounds have 
shown ability to inhibit the growth of all the cell lines tested, with GI50 values in the 
M range, and it was possible to establish some structure–activity relationships, 
namely related to the presence and position of substituents (OMe or F) in the phenyl 
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ring, compound 11a (ortho-fluorinated compound) showing clearly the best results, 
with quite low GI50 values (19, 12 and 15 M, respectively) for the three tumor cell 
lines mentioned above26. 
As the lactone compound with an ortho-fluorinated phenyl ring relative to the C–C 
bond showed the highest antitumoral activity, it was decided in this work, to perform 
fluorescence studies in solution and in liposomes of compounds with a fluor atom (11a 
and 11d) and with a methoxy group in the same positions, for comparison (11b and 
11c). The latter was synthesized in the present work by the same methodology used 
for the synthesis of compounds 11a-b (scheme 1.5). Fluorescence (steady-state) 
anisotropy measurements were also performed in order to obtain further information 
about the location of these compounds in liposomes (Chapter 5.2).  
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4. Thienopyridines 
Among pyridine derivatives, its fused analogs, namely thienopyridines, are often of 
much greater interest from the standpoint of biological activity than the corresponding 
constituent monocyclic compounds29. Six isomeric thienopyridine structures 
characterized by different annelation modes are known (Figure 1.3): thieno[2,3-
b]pyridine (A), thieno[3,2-b]pyridine (B), thieno[2,3-c]pyridine (C), thieno[3,2-
c]pyridine (D), thieno[3,4-b]pyridine (E), and thieno[3,4-c]pyridine (F). 
 
 
Figure 1.3. Isomeric thienopyridine structures
29
. 
 
The diversity of biological activities of the thieno[3,2-b]pyridine system lead our 
research group to synthesize several methyl 3-amino-6-(hetero)arylthieno[3,2-
b]pyridine-2-carboxylates30 by Suzuki-Miyaura cross-coupling of the methyl 3-amino-6-
bromothieno[3,2-b]pyridine-2-carboxylate31 with several (hetero)arylboronated 
pinacolboranes32 (for example, in the synthesis of 12b and 12c) or potassium 
trifluoroborates33 (for example in the synthesis of 12a), in high yields. These boron 
compounds are easier to handle than the boronic acids due to their insensitivity to air 
and moisture. Furthermore the corresponding boronic acids did not react with the 
methyl 3-amino-6-bromothieno[3,2-b]pyridine-2-carboxylate under the conditions 
used. Some of the compounds prepared are presented in scheme 1.8. 
 
 
Scheme 1.8. Some of the methyl 3-amino-6-heteroarylthieno[3,2-b]pyridine-2-carboxylates synthesized 
by our research group by Suzuki-Miyaura cross-coupling
30
.  
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According to the fact that neither the 2-thienyl pinacolborane ester nor the 
corresponding potassium trifluoroborate salt are commercially available, the  methyl 
6-(thiophen-2-yl)thieno[3,2-b]pyridine-2-carboxylate 12d was synthesized by a one-pot 
palladium-catalyzed two steps, borylation with pinacolborane followed by Suzuki 
coupling (BSC) with the methyl 3-amino-6-bromothieno[3,2-b]pyridine-2-carboxylate 
(Scheme 1.9). Due to the electron-rich character of the thiophene ring, compound 12d 
was only obtained using tri-t-butylphosphonium tetrafluoroborate34 as the ligand, in 
70% yield. To our knowledge it was the first time that this ligand was used in a BSC 
reaction. 
 
 
Scheme 1.9. Synthesis of compound 12d by a BSC reaction
30
. 
 
The C-B catalytic cycle begins with the (Het)Ar-X oxidative addition to the Pd(0) 
catalyst,  yielding an arylpalladium(II) species [(Het)Ar-Pd(II)-X]. Then the X atom of the 
[(Het)Ar-Pd(II)-X] complex is removed by the boron anion, forming the intermediate  
[(Het)Ar-Pd(II)-B(OR)2]. A reductive elimination of Pd(0) regenerates the catalyst and 
originates the heteroarylboronated compound. The use of Et3N in the coupling is very 
effective, preventing the formation of Ar-H, and facilitating the formation of the C-B 
bond (Scheme 1.10)35. 
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Scheme 1.10. Catalytic cycle proposed for the boronation C-B using pinacolborane and Et3N
35
. 
 
The advantages of these BSC sequencies are the use of two halogenated reagents and 
to perform an in situ borylation, yielding a C-B bond, without isolating the boronated 
intermediate, followed by a Suzuki-Miyaura cross-coupling (C-C) when the other halide 
reagent and the other base are added. 
The growth inhibitory effect of the coupling products was evaluated against three 
human tumor cell lines MCF-7(1.5105 cells/mL), A375-C5 (melanoma, 0.75105 
cells/mL), and NCI-H460 (0.75105 cells/mL), after 48 h of continuous exposure. From 
the results it was possible to establish some structure-activity relationships. The most 
active compound was 12c (the 2,2’-bithiophene derivative) with selectivity against 
MCF-7 and NCI-H460 cell lines presenting very low GI50 values (1 and 0.7 M, 
respectively). For this reason, compound 12c was selected to be further studied 
regarding its influence on the cell cycle distribution of the NCI-H460 cells and it was 
shown that this compound induce a cell cycle arrest in the G0/G1 phases. 
Due to these results, the spectroscopic properties in solvents of different polarity and 
in nanoliposomes  of compound 12c, as well as of the other thiophene derivatives 12a 
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and 12d and of the furan derivative 12b for comparison (although for the latter, the 
results in the cell lines were not good), were studied in the present work (Chapter 5.4).  
Our research group has also synthesized fused thienopyridines with pyrimidones. Thus, 
the tetracyclic compound 13a and 13b were synthesized by a tandem C–N coupling of 
the methyl 3-amino-thieno[3,2-b]pyridine-2-carboxylate or of the methyl 3-amino-6-
[2-(4-methoxyphenyl)ethynyl]thieno[3,2-b]pyridine-2-carboxylate with 2-
bromopyridine followed by intramolecular cyclization involving the nucleophilic attack 
of the pyridine nitrogen on the carbonyl of the ester group with loss of MeOH31 
(Scheme 1.11). This type of reaction was already performed by us in the 
benzo[b]thiophene series36. 
 
Scheme 1.11. Synthesis
31
 of the tetracyclic thienopyrimidine derivatives 13. 
 
The methyl 3-amino-6-[2-(4-methoxyphenyl)ethynyl]thieno[3,2-b]pyridine-2-
carboxylate was prepared by a Sonogashira coupling of the methyl 3-amino-6-
bromothieno[3,2-b]pyridine with the 4-methoxyphenylacetylene31,36. 
The interactions with DNA and nanosized liposomes of the fluorescent planar 
tetracyclic compounds 13a and 13b as potential new antitumorals were studied in the 
present work (Chapter 5.3). 
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5. Benzothienoquinolines 
Benzothieno[3,2-b]quinoline 1437 and benzothieno[2,3-c]quinoline 1538 are known for 
their anti-plasmodic and anti-infectious activities, acting mainly through intercalation 
between DNA base pairs when used in their salt form. These compounds were earlier 
synthesized by separated reactions and in several steps37,38, but our research group 
recently was able to obtain the two compounds in a one pot procedure. Thus, the 
reaction of the commercial available 3-bromobenzo[b]thiophene-2-carbaldehyde with 
2-aminophenylpinacolborane under Suzuki coupling conditions using a 
stereochemically hindered ligand, 2-(cyclohexylphosphane)biphenyl39, gave 
compounds 14 and 15 which were separated by column chromatography (Scheme 
1.12). 
 
Scheme 1.12. One pot synthesis of benzothieno[3,2-b]quinoline 14 and benzothieno[2,3-c]quinoline 15. 
 
The obtainment of the benzothieno[3,2-b]quinoline 14 was unexpected using these 
reaction conditions. It seems that it is the result of a Pd-catalyzed C-N coupling 
followed by an intramolecular cyclization that may perhaps occur by nucleophilic 
attack of the activated ortho position of the diarylamine intermediate on the carbonyl 
of the aldehyde, after deboronation. In the synthesis of the expected compound 15 a 
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Suzuki cross-coupling and a nucleophilic attack of the amino group on the aldehyde 
occurred.  
Despite these compounds have already been synthesized by others in several steps we 
were able to prepare them in a one pot procedure which is very advantageous to 
economize reagents and time. 
In this work, the interaction of the synthesized benzothienoquinolines 14 and 15 with 
natural double-stranded salmon sperm DNA and with synthetic ds-
polyheteronucleotides was investigated by fluorescence emission measurements. 
These studies are important due to the biological relevance of both compounds as 
potential antitumorals (Chapter 5.5).  
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1. Deoxyribonucleic acid (DNA) 
DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all 
other organisms. DNA contains the instructions needed for an organism to develop, 
survive and reproduce. To carry out these functions, DNA sequences must be 
converted into messages that can be used to produce proteins, which are the complex 
molecules that do most of the work in our bodies. 
Most of the DNA is found inside a special area of the cell called the nucleus (nuclear 
DNA). Because the cell is very small, and because organisms have many DNA molecules 
per cell, each DNA molecule must be tightly packaged. This packaged form of the DNA 
is called a chromosome. Each DNA sequence that contains instructions to make a 
protein is known as a gene. The size of a gene may vary greatly, ranging from about 
1,000 bases to 1 million bases in humans. The complete set of nuclear DNA, or 
genome, for a human contains about 3 billion bases and about 20,000 genes on 23 
pairs of chromosomes1.  
The DNA sequences from everyone in the world are more than 99% identical. That 
means that only 1% of our DNA sequence is unique. Single nucleotide polymorphisms 
(SNPs) represent the 1% where we differ from each other. These differences influence 
why some people have a greater risk for cancer, or respond poorly to a particular 
medication2. 
The German biochemist Frederich Miescher first observed DNA in the late 1800s3. But 
the importance of DNA became clear only in 1953 due to the work of James Watson, 
Francis Crick, Maurice Wilkins and Rosalind Franklin. By studying X-ray diffraction 
patterns and building models, the scientists figured out the double helix structure of 
DNA4. The term double helix is used to describe DNA's winding, double-stranded 
chemical structure. This shape - which looks much like a twisted ladder - gives DNA the 
power to pass along biological instructions with great precision (Figure 2.1).  
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Figure 2.1. Double-helix DNA structure (computer model, one strand illustrated with green color and the 
other strand illustrated with red color; the weak colors represent nucleobases).  
 
DNA is a polymer. The monomer units of DNA are nucleotides, and the polymer is 
known as a "polynucleotide". Each nucleotide consists of a 5-carbon (pentose) sugar 
(2-deoxyribose, Figure 2.2), a nitrogen containing base-covalently bonded to the 1’- 
carbon of the deoxyribose (nucleobase or base), and a phosphate group5.  
     
 
 
 
 
 
 
Figure 2.2. 2-Deoxyribose molecule (a) and 2-Deoxyribose residue in DNA (b). 
 
The sugars are joined together by phosphate groups that form phosphodiester bonds. 
The two polynucleotide chains are held together by weak thermodynamic forces 
(hydrogen bonds between the bases), to form a DNA molecule (Figure 2.3)6. 
 
 
Base Phosphate 
group 
Phosphate 
group 
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2’ 3’ 
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Figure 2.3. DNA structure (adapted from ref. 6). 
 
There are two types of nitrogen bases found in nucleotides (Figure 2.4): 
- purines: adenine (A) or guanine (G)  
- pyrimidines: cytosine (C) or thymine (T) 
Figure 2.4. Structure of DNA nucleobases, purines and pyrimidines. 
 
The order, or sequence, of these bases determines what biological instructions are 
contained in a strand of DNA. For example, the sequence ATCGTT might instruct for 
blue eyes, while ATCGCT might instruct for brown.  
In a DNA double helix, each type of nucleobase on a strand binds with just one type of 
nucleobase on the other strand. This is called complementary base pairing. Here, 
purines form hydrogen bonds to pyrimidines, with adenine bonding only to thymine in 
 
Nucleotide 
Phosphate group 
 
 
 
 
 
Base 
Phosphodiester bonds 
Base 
Phosphate-sugar 
Backbone 
Hydrogen bonds 
Sugar 
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two hydrogen bonds, and cytosine bonding only to guanine in three hydrogen bonds. 
This arrangement of two nucleotides binding together across the double helix is called 
a base pair (Figure 2.5)7.  
 
Figure 2.5. Complementary base pairing in DNA
7
. 
 
In the double helix, the direction of the nucleotides in one strand is opposite to their 
direction in the other strand because the phosphodiester bonds occur between the 
third and fifth carbon atoms of adjacent sugar rings. Thus, these asymmetric bonds 
mean that a strand of DNA has a direction and we say that the strands are antiparallel. 
The asymmetric ends of DNA strands are called the 5′ (five prime) and 3′ (three prime) 
ends, with the 5′ end having a terminal phosphate group and the 3′ end a terminal 
hydroxyl group (Figure 2.6)8. 
 
 
 
 
 
 
 
 
 
 
Figure 2.6. Three views of DNA structure: schematic representation (a), atomic model (b), computer 
model (c) (adapted from ref. 8). 
 
3’ 
5’ 
5’ 
3’ 
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As hydrogen bonds are not covalent, they can be broken and rejoined relatively easily. 
The two strands of DNA in a double helix can therefore be pulled apart like a zipper, 
either by a mechanical force or high temperature9. As a result of this complementarity, 
all the information in the double-stranded sequence of a DNA helix is duplicated on 
each strand, which is vital in DNA replication. Indeed, this reversible and specific 
interaction between complementary base pairs is critical for all the functions of DNA in 
living organisms10.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 – Compounds / DNA interaction 
__________________________________________________________________________________________________________  
 
36 
 
2. DNA binding modes 
Many small molecules that bind to DNA are effective pharmaceutical agents, especially 
in cancer chemotherapy. Understanding the DNA binding of such drugs is essential for 
understanding their mode of action and for the development of design principles to 
guide the synthesis of new, improved compounds with enhanced or more selective 
activity11. 
The interaction of the anticancer drugs with DNA occurs mainly by three different 
ways12, 13, 14 (Figure 2.7). The first one is through control of transcription factors and 
polymerases in which drug interacts with proteins that bind to DNA, namely 
topoisomerases15,16. The second is through RNA (Ribonucleic Acid) binding either to the 
DNA double helix to form nucleic acid triple helix structures or to exposed DNA single 
strand forming DNA–RNA hybrids that may interfere with transcriptional activity. The 
third type of interaction involves the covalent/cross-linking or non-covalent binding of 
small aromatic ligand molecules to DNA double helical structures17. 
 
Figure 2.7. Summary of mechanism of action of anticancer drugs
17
. 
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The non-covalent interaction between small molecules and DNA generally follows 
three models12 (Figure 2.8): 
(i) Outside-edge binding: This involves ligand binding (e.g. Na+, Mg2+ or polyamines, 
Section 2.2.1.) to the outside of the helix through non-specific, primarily electrostatic 
interactions with the sugar–phosphate backbone. 
(ii) Intercalation/Bisintercalation: A planar (or near planar) aromatic ring system 
inserts in between two adjacent base pairs, perpendicular to the helical axis (section 
2.2.2). 
(iii) Groove binding: A bound ligand makes direct molecular contacts with functional 
groups on the edges of the bases that protrude into either the major or minor grooves 
(section 2.2.3.). 
Compounds that have the potential to be clinically useful are normally either 
intercalators or groove binders. However, outside-edge, electrostatic interactions are 
also important, not least because the association of positively charged counterions 
with the DNA polyanion has a large effect on DNA conformation and stability12. Thus, 
some antitumoral compounds have shown to be minor groove binders but, although 
they are toxic, nonselective, and sometimes expensive, at the present time DNA 
intercalators are among the most important drugs for treating cancer16.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8. Drug-DNA non-covalent interactions a) schematic representation b) computer model. 
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2.1. Outside-edge binding 
It is an electrostatic interaction with the negatively charged nucleic acid sugar-
phosphate structure (which is generally non-specific)17. The archetypal outside-edge 
binding drugs are the polyamines, spermine and spermidine which play an analogous 
role to histones, in that they may neutralize some of the negative charges on the DNA 
backbone and hence promote DNA packaging (Figure 2.9)12. 
 
Figure 2.9. Structures of two outside-edge electrostatic DNA binding ligands, spermine and spermidine. 
 
2.2. Intercalation/bisintercalation  
Planar organic molecules containing several aromatic condensed rings often bind to 
DNA in an intercalative mode between base pairs18,19. Ligand intercalation is 
associated with favourable enthalpic contributions to free energy arising from the 
formation of noncovalent interactions between the drug and base pairs. These 
noncovalent interactions involve several different forces, such as the hydrophobic 
effect, reduction of coulombic repulsion, Van der Waals interactions, -stacking, and 
hydrogen bonding12. Several acridines (e.g. C-1311), alkaloids (e.g. diplamine), 
anthracyclines (e.g. doxorubicin), anthracenediones (e.g. mitoxantrone), 
arylaminoalcohols (elinafide), coumarins (e.g. 9-methyl-2,3-
dihydrocyclopenta[c]furo[3,2-g]chromen-4(1H)-one), phenanthridines (e.g. ethidium 
bromide), quinolines (e.g. fascaplysin), indoles (e.g. AT2433-B1), and quinoxalines (e.g. 
Triostin A) have shown to be intercalating antitumoral drugs16 (Figure 2.10).  
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Figure 2.10. Several DNA-intercalators which act as antitumoral drugs
16
. 
 
Bisintercalators (e.g. bisacridine, Figure 2.11) are bifunctional molecules that possess 
two planar intercalating aromatic ring systems covalently linked by chains of varying 
length. A good reason for designing and synthesising a bisintercalator is that it should 
have a significantly higher affinity and much slower dissociation kinetics than the 
monointercalator equivalents. The binding constant for a bisintercalator should be 
approximately the square of the monomer binding constant. Since the biological 
activity is often closely correlated with binding affinity, bisintercalators should also 
have enhanced medical application12. 
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Figure 2.11. A flexibly linked bisintercalator formed from two dimethylaminoethylacridine-4-
carboxamide moieties
12
. 
 
The spatial arrangement of DNA before, during, and after replication is essential to a 
high-quality cell-division process. In this way, DNA topology is governed by 
Topoisomerases (Topos)20. Topos can be classified in two main classes: Topo I, which 
breaks only one strand of the DNA21, although both strands are involved in the 
interaction with the enzyme22, and Topo II23, which breaks both strands of the 
duplex24,25. A DNA intercalator has cytotoxic activity when it poisons the Topo by 
stabilizing the ternary, DNA–intercalator–Topo complex in such a way that the 
enzymatic process cannot continue forward or backward. Once the enzyme–DNA 
complexes are poisoned by intercalators, the ternary complex is detected by the cell as 
a damaged portion, which triggers a series of events; one of the more important 
events involves p53 protein, which induces cell apoptosis (programmed cell death) 
(Figure 2.12)26-28.   
 
Figure 2.12. Schematic representation of the mechanism of cytotoxicity of a DNA-Intercalator
16
. 
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Since Topos are ubiquitous in eukaryotic cells, both healthy and damaged cells can be 
affected during treatment with this class of poisons29, although cells that are 
constantly and frequently replicating (i.e., tumor cells) will be affected more than 
healthy cells16. 
 
2.3. Minor and major DNA grooves binding interaction 
The drugs which bind to DNA minor or major grooves are typically composed of several 
aromatic rings such as pyrrole, furan, or benzene that are connected by bonds 
possessing torsional freedom19. Minor groove binding makes intimate contacts with 
the walls of the groove, and as a result of this interaction numerous hydrogen binding 
and electrostatic interactions occur between anticancer drugs and DNA (DNA bases 
and the phosphate backbone).  Major groove binding occurs via the hydrogen bonding 
to the DNA and can form a DNA triple helix.  
A large number of functional groups of the DNA bases are accessible in the wide major 
groove compared to the narrow minor groove. However, many small molecules 
interact with DNA in the minor groove. The major and minor grooves differ in 
electrostatic potential, hydrogen-bonding characteristics, steric effects, and hydration. 
In general, small groove-binding molecules exhibit a preference for the minor groove, 
not least because this site of interaction provides better Van der Waals contacts. 
Distamycin A and mithramycin A are antitumoral compounds which bind to DNA in the 
minor grooves (Figure 2.13)17. 
   
        Distamycin A                 Mithramycin A 
Figure 2.13. Distamycin A and Mithramycin A structures. 
 
Different modes of binding can occur simultaneously with the same antitumoral 
compound30.  For example, mitomycin is a groove binder but also a cross-linker and 
Chapter 2 – Compounds / DNA interaction 
__________________________________________________________________________________________________________  
 
42 
 
daunomycin is able to bind to the minor groove and intercalate between the DNA base 
pairs (Figure 2.14). Note that many minor groove-binding ligands prefer A-T sites 
compared to intercalators, which generally exhibit a G-C preference12. 
 
Figure 2.14. (a) Atomistic structure of daunomycin. Constructed and equilibrated structures of (b) the 
intercalated state and (c) the minor groove-bound state. In both figures, DNA is shown in a 
semitransparent surface representation including ball and stick atom models and residue-based color 
(yellow for C, green for G, red for A and blue for T), whereas daunomycin is represented via a ball and 
stick model with element-based CPK color
30
. 
 
2.4. Thermodynamics of drug-DNA interactions 
A classical equation for the determination of binding parameters (more specifically, 
the association constant) for the non-cooperative binding is the modified form of 
Scatchard plot, proposed by McGhee and von Hippel12: 
 
  
         
      
        
 
   
                                                
 
where r is the binding ratio (defined as the ratio of the concentration of bound drug  
(Cb) over the total concentration of DNA binding sites (S), Cf the concentration of free 
drug, K the equilibrium binding constant for all sites, i.e. any sequence dependence for 
drug binding is ignored, and n the binding site size, i.e. the number of base pairs 
occupied by a bound drug. Cb and Cf can be calculated by 
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where      is the fluorescence intensity of the free compound and     the fluorescence 
intensity of the bound compound at total binding. 
When a complex between DNA and drug is formed, changes in the thermodynamic 
stability and the functional properties of DNA occur17.  Although there is a significant 
free energy cost for the establishment of the intercalation cavity (approximately 4 kcal 
mol-1), favorable contributions (hydrophobic, ionic, hydrogen bonding, and Van der 
Waals) result in association constants of 105 to 1011 M-1. Groove binders are stabilized 
by intermolecular interactions and typically have larger association constants than 
intercalators (approximately 1011 M-1), since a cost in free energy is not required for 
creation of the binding site15. 
 
2.5. Methods to determine the DNA-drug binding modes 
Determination of DNA binding modes of small molecules is crucial for revealing their 
potential genotoxicity. Drug–DNA binding may result in changes in gene expression 
and influence cell proliferation31,32. Thus, understanding drug–DNA binding 
mechanisms is crucial for predicting the consequences of these interactions in the 
human body33. Groove binding typically results in only subtle changes in structure, and 
the DNA remains in the same form. In contrast, intercalation, in which a planar ligand 
moiety is inserted between adjacent base pairs, results in a substantial change in DNA 
structure, and causes lengthening, stiffening, and unwinding of the helix. These 
changes result in a pronounced alteration of the hydrodynamic properties of DNA for 
intercalation, but not for groove binding. Furthermore, for intercalation, the planar 
chromophore is in close contact with the DNA base pairs, and is oriented roughly 
perpendicular to the DNA helix axis. Thus, techniques that can evaluate the orientation 
of the ligand chromophore and its proximity to the DNA bases, can potentially 
distinguish intercalation from groove binding34. 
Many techniques have been applied for investigation of the interaction of DNA with 
small molecules including X-ray diffraction, Nuclear Magnetic Resonance, Mass 
Spectrometry, Footprinting, UV-Visible Spectroscopy, Circular Dichroism Spectroscopy, 
Calorimetry, Gel electrophoresis, Dynamic Viscosity, Single Molecule Force 
Spectroscopy, Docking Studies, FT-IR and Raman Spectroscopy, Molecular Modeling 
Techniques, Equilibrium Dialysis, Electric Linear Dichroism, Surface Plasmon Resonance 
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and Electrochemical Techniques15,16,17,18,33,34. Standard fluorescence methods, such as 
intensity measurements, polarization, and solute quenching studies have also been 
applied. Indeed, many molecules exhibit a large fluorescence enhancement15,33 and an 
increased polarization value34 on binding to DNA. Fluorescence quenching assays allow 
distinguishing between DNA binding modes35 since intercalators are less accessible to 
anionic quenchers than groove binders, due to electrostatic repulsion with the 
negatively charged sugar-phosphate DNA backbone36. 
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1. Nanocarriers for drug delivery 
The last years have seen an explosion of interest for the area of science and 
technology known as “nanotechnology”. Nanotechnologies are defined as 
technologies which include components that have at least one dimension between 1-
100 nm, and display unique characteristics due to being at this scale. Unlike previous 
high-technology waves, nanotechnology covers a diverse field of sciences and 
engineering, crosses boundaries between them and aims to utilize the very 
fundamental characteristics of matter by manipulation and control at the nanoscale in 
order to create new material and devices with functional characteristics different from 
the common materials1. 
Bionanotechnology is one of the most promising areas of nanotechnology and in the 
present it is directly related with the use of biological systems, like cells and cellular 
components, to create functional nanodevices made of organic and inorganic materials 
for biological activity. This is an area in permanent expansion and a lot of studies about 
new fabrication methods and characterization techniques arise constantly. 
Bionanotechnology includes many important areas such as nanomedicine, diagnosis 
and therapy with the development of new drugs. One of the most promising research 
areas of bionanotechnology is the development of systems for controlled drug delivery 
by nanoencapsulation of drugs, to solve several limitations of conventional drug 
delivery systems, such as nonspecific biodistribution and targeting, lack of water 
solubility, poor oral bioavailability, and low therapeutic indices, namely due to 
resistance of the cancer cells2.  
The use of nanocarriers as systems for drug delivery has many advantages when 
compared with other conventional methods, since they can potentially overcome 
solubility, pharmacokinetics, in vivo stability and toxicity problems3-5, more precisely: 
o The biodistribution of cancer drugs is improved as nanoparticles have optimal 
size and surface characteristics which increase their circulation time in the 
bloodstream; 
o The nature and the composition of the vehicles protect and prevent the 
decomposition of the drug; 
o Nanocarriers allow a secure administration of the drug without local 
inflammatory reactions; 
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o More effective therapy and decrease of the number of the doses due to the 
gradual and controlled release of the drug; 
o Nanocarriers can enhance the intracellular concentration of drugs in cancer 
cells while avoiding toxicity in normal cells, by using both passive targeting 
strategies (such as the acidic environment of tumor cells or the enhanced 
permeability and retention effects of tumors due to their leaky vasculature 
and their lack of an effective lymphatic drainage system) and active targeting 
strategies (using ligands or antibodies directed against selected tumor 
targets)2,6,7. 
o When nanocarriers bind to specific receptors and then enter the cell, they are 
usually enveloped by endosomes via receptor-mediated endocytosis, thereby 
bypassing the recognition of P-glycoprotein, one of the main drug resistance 
mechanisms8. 
There are many different submicron-sized (3-200nm) devices being used for drug 
delivery, namely devices made of polymers (polymeric nanoparticles, micelles, or 
dendrimers), viruses (viral nanoparticles), organometallic compounds (carbon 
nanotubes) or lipids (liposomes). Each of these systems has specific peculiarities that 
should be considered in the choice of the delivery system2 (Table 3.1). 
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Table 1. Types of nanocarriers for drug delivery (adapted from ref. 2). 
System Structure Characteristics 
Polymeric nanoparticles 
(polymer-drug conjugates) 
 
Drugs are encapsulated in a 
polymer or conjugated to the 
side chain of a linear polymer 
with a linker (cleavable bond). 
a) Water-soluble, nontoxic, 
biodegradable; 
b) Surface modification 
(pegylation); 
c) Selective accumulation and 
retention in tumor tissue (EPR 
effect); 
d) Specific targeting of cancer 
cells while sparing normal cells-
receptor mediated targeting 
with a ligand. 
Polymeric micelles 
 
Amphiphilic block copolymers 
assemble and form a micelle 
with a hydrophobic core 
(reservoir for hydrophobic 
drugs) and hydrophilic shell 
which stabilizes the core and 
renders the polymer to be 
water-soluble. 
a) Suitable carrier for water-
insoluble drug; 
b) Biocompatible, self-
assembling, biodegradable; 
c) Ease of functional 
modification; 
d) Targeting potential. 
Dendrimers 
 
Radially-emerging 
hyperbranched synthetic 
polymer with regular pattern 
and repeated units. 
a) Biodistribution and pK can 
be tuned; 
b) High structural and 
chemical homogeneity; 
c) Ease of functionalization, 
high ligand density; 
d) Controlled degradation; 
e) Multifunctionality. 
Viral nanoparticles 
 
Protein cages, which are 
multivalent, self-assembled 
structures. 
a) Surface modification by 
mutagenesis or bioconjugation 
– multivalency; 
b) Specific tumor targeting, 
multifunctionality; 
c) Defined geometry and 
remarkable uniformity; 
d) Biological compatibility and 
inert nature. 
Carbon nanotubes 
 
Carbon cylinders composed of 
carbon atoms in a hexagonal 
arrangement. 
a) Water-soluble and 
biocompatible through chemical 
modification (organic 
functionalization); 
b) Multifunctionality. 
Liposomes 
 
Self-assembling closed colloidal 
structures composed of lipid 
bilayers in which an aqueous 
volume is entirely enclosed by a 
membranous lipid bilayer. 
a) Amphiphilic, biocompatible; 
b) Ease of modification; 
c) Targeting potential. 
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However, although nanoparticles offer many advantages as drug carrier systems, there 
are still many limitations to be solved such as poor oral bioavailability, instability in 
circulation, inadequate tissue distribution, and toxicity2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3- Compounds encapsulation in nanoliposomes 
__________________________________________________________________________________________________________ 
57 
 
2.  Liposomes  
2.1. Lipids as structural components of liposomes 
Lipids constitute a group of naturally occurring molecules that include fats, waxes, 
sterols (such as cholesterol), fat-soluble vitamins (such as vitamins A, D, E, and K), 
monoglycerides, diglycerides, triglycerides, phospholipids, and others. The main 
biological functions of lipids include energy storage, signaling, and acting as structural 
components of cell membranes9,10. Lipids have found applications in cosmetic and 
food industries, as well as in nanotechnology, e.g. acting as structural components of 
liposomes11.  
Phospholipids play a central role in the biochemistry of all living cells. These molecules 
constitute the lipid bilayer defining the outer confines of a cell, but also serve as the 
structural entities which confine subcellular components12. Furthermore, 
phospholipids are the widely used structural components of liposomes.  A 
phospholipid is composed of two fatty acid chains, a glycerol unit, a phosphate group 
and a polar molecule (e.g. choline, glycerol, etc). Phospholipids are 
amphipathic/amphiphilic compounds in a way that the phosphate group and polar 
head region of the molecule is hydrophilic, while the fatty acid tail region is 
hydrophobic (Figure 3.1).   
 
Figure 3.1. Typical structure of a phospholipid. 
 
Lipids are characterized by the phase transition temperature (or melting temperature), 
Tm, which is defined as the temperature required to induce a change in the lipid 
physical state from the ordered gel phase, where the hydrocarbon chains are fully 
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extended and closely packed, to the disordered liquid crystalline phase, where the 
hydrocarbon chains are randomly oriented and fluid. There are several factors which 
directly affect the phase transition temperature including hydrocarbon length, 
unsaturation, charge, and headgroup species. As the hydrocarbon length is increased, 
van der Waals interactions become stronger requiring more energy to disrupt the 
ordered packing, thus the phase transition temperature increases. Likewise, 
introducing a cis double bond into the acyl group puts a kink in the chain which 
requires much lower temperatures to induce an ordered packing arrangement. 
Relatively to the electric charge, lipids can be ionic (cationic or anionic) molecules, 
neutral molecules or zwitterionic molecules (both positive and negative charge, in 
different atoms). Table 3.2 shows some lipids structures, as well as their electric charge 
and phase transition temperature. 
 
Table 3.2. Structure, electric charge and phase transition temperature, Tm, of some lipids. 
Structure 
Electric 
charge 
Tm /ºC 
 
Egg-PC 
1,2-diacyl-sn-glycero-3-phosphocholine from egg yolk 
 
Zwitterionic 
Very 
low 
 
DPPC 
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine 
 
Zwitterionic 
41 
(Ref. 13) 
 
DPPG 
1,2-dipalmitoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) 
 
Anionic 
40 
(Ref. 14) 
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DMPG 
1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) 
 
Anionic 
23 
(Ref. 15) 
 
DOPE 
1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine 
 
 
zwitterionic 
Very 
low 
 
DSPE-PEG 
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene 
glycol)-2000] (ammonium salt) 
 
 
Anionic 12.8  
 
DODAB 
dioctadecyldimethylammonium bromide 
 
Cationic 
45 
(Ref. 16) 
 
Cholesterol 
 
Neutral 
Very 
low 
 
2.2. Molecular Self-assembly 
Molecular self-assembly is the process by which molecules adopt a defined 
arrangement without guidance or management from an outside source. When 
phospholipids are suspended in water they tend to self-orient in order to avoid any 
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contact between the non-polar tails and water (energetically unfavorable) and to 
maintain the contact between water and the polar head of the molecules. In this way, 
amphiphilic molecules can form a variety of structures, such as bilayers, micelles or 
liposomes, due to hydrophilic/hydrophobic interactions but also electrostatic and Van 
der Waals interactions (Figure 3.2). 
 
Figure 3.2. Different self-organized structures. 
 
2.3. Different types of liposomes 
Liposomes were discovered in 1965 by Bangham, who found that when phospholipids 
were dispersed in water, vesicular structures of hydrated bilayers with an aqueous 
cavity are form spontaneously17. 
Liposomes are vesicles composed of one or more lipid bilayer membranes. The unique 
ability of liposomes to entrap drugs both in an aqueous and a lipid phase make such 
delivery systems attractive for hydrophilic and hydrophobic drugs18. Because lipids are 
amphipathic in aqueous media, their thermodynamic phase properties and self- 
assembling characteristics evoke entropically driven sequestration of their 
hydrophobic regions into spherical bilayers. Those layers are referred to as lamellae19 
(Figure 3.3). Liposomes can be unilamellar (with only one bilayer surrounding the 
aqueous core) or multilamellar (with several bilayers oriented concentrically around an 
aqueous core)20. 
 
Figure 3.3. Unilamellar liposome structure. 
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According to size and number of lamellae, liposomes are divided into different 
subcategories (table 3.3 and figure 3.4). 
 
Table 3.3. Liposome classification based on structural parameters
20
. 
 
 
 
 
 
 
 
 
Figure 3.4. Schematic representation of different liposomes
21
. 
 
2.4. Liposomes preparation 
In contrast to other surfactant aggregates such as micelles, liposomes do not form 
spontaneously in aqueous media and are therefore not thermodynamically stable 
structures22. Formation of liposomes requires energy. Depending on which type of 
liposome is produced, the required energy input can greatly vary. MLVs form readily 
when bilayer-forming polar lipids are dispersed in aqueous media under mild agitation. 
In order to produce LUVs and SUVs, substantial energy inputs are required that are 
sufficient to disrupt MLV and MVV structures and force the generation of unimodal 
vesicles23. Generally, liposomes are only stable for a defined period of time; i.e. they 
are said to be “kinetically stable” similar to emulsions. Because of this, many of the 
principles of emulsion formation also apply to the formation of liposomes and the 
techniques used to produce emulsions may often be used to produce liposomes24. 
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Liposomes can be obtained by means of several different methods (Scheme 3.1). 
Normally, the entrapped agents are loaded before or during the manufacturing 
procedure (passive loading). However, certain type of compounds with ionizable 
groups, and those which display both lipid and water solubility, can be introduced into 
the liposomes after the formation of intact vesicles (active loading)25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.1. Different methods for liposomes preparation
25
. 
 
The adequate choice of liposome preparation method depends on the following 
parameters26,27:  
1) the physicochemical characteristics of the material to be entrapped and those of the 
liposomal ingredients; 
2) the nature of the medium in which the lipid vesicles are dispersed;  
3) the effective concentration of the entrapped substance and its potential toxicity;  
4) additional processes involved during application/delivery of the vesicles;  
5) optimum size, polydispersity and shelf-life of the vesicles for the intended 
application and  
6) batch-to-batch reproducibility and possibility of large-scale production of safe and 
efficient liposomal products. 
 
Methods of Liposomes preparation 
Passive loading 
techniques 
Active loading 
techniques 
Mechanical dispersion 
methods 
Detergent removal 
methods 
Solvente dispersion 
methods 
 
 Lipid film hydration by 
hand shaking, non-hand 
shaking or freeze drying. 
 Micro-emulsification 
 Sonication 
 French pressure cell 
 Membrane extrusion 
 Dried reconstituted 
vesicles 
 Freeze-thawed liposomes 
 
 Ethanol injection 
 Ether injection 
 Double emulsion 
 Reverse phase 
evaporation vesicles 
 Stable pluri lamellas 
vesicles 
 
 Detergent (Chocolate, 
alkylglycoside, Triton 
X-100) removal from 
mixed micelles by: 
- Dialysis 
- Column 
chromatography 
- Dilution 
- Reconstituted sendai 
virus enveloped 
 
Chapter 3- Compounds encapsulation in nanoliposomes 
__________________________________________________________________________________________________________ 
63 
 
3. Liposomes as drug delivery systems 
Liposomes were suggested as drug carriers in cancer chemotherapy by Gregoriadis et 
al.28 in 1974. Since then, liposomes have been extensively used as carriers for 
pharmaceutical, diagnostic and cosmetic agents, with already a few commercially 
available products29,30. As an example, Doxil® is a liposomal formulation of the 
anthracycline drug doxorubicin used to treat cancer in AIDS-related Kaposi sarcoma 
and multiple myeloma. Its advantages over free doxorubicin are greater efficacy and 
lower cardiotoxicity31. Nevertheless, liposomes still have not attained their full 
potential, and improvements must be made in terms of design, functionality and 
stability to allow the drugs to reach and to be transferred to the target site20 and to 
combat the increasing problem of multidrug resistance (MDR) acquired by cancers31.  
To reach the target site, the liposomes must remain time enough in the circulatory 
system without being disintegrated by high-density lipoproteins (HDLs) in the plasma 
(which were found to remove phospholipid molecules rapidly from the bilayers of 
vesicles) or without being intercepted by the fixed macrophages of the 
reticuloendothelial system (RES)32.  
The selective delivery of drugs into disease sites is generally achieved by extravasation 
into the interstitial space from the bloodstream31 (Figure 3.5). This can be achieved by 
either passive or active targeting3,29. Active targeting requires some kind of ligand to 
bind the liposome surface to the pathological cells and passive targeting uses the 
physical properties of the liposomes together with the microanatomy and the 
microenvironment of the target tissue to obtain selective localization20. For example, 
liposomes can be designed to release their entrapped contents under certain 
controlled pH or temperature conditions18. In solid tumors, the extracellular pH tends 
to be significantly more acidic (6.5) than the pH of the blood at 37 C, which is (7.5); so, 
it is possible to engineer vehicles for drugs with the adequate composition so that the 
delivery occurs in these specific sites. On the other hand, temperature can also be 
exploited, using a delivery system that releases the drug at temperatures above 37 C 
(e.g. using lipids with Tm > 37 C in the liposomes preparation)
20. 
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Figure 3.5. Active and passive targeting of cells for drug targeting using liposomes. At sites of pathology, 
where the endothelium layer is inflamed, mediators such as bradykinin, vascular endothelium growth 
factor, and prostaglandins increase the endothelial permeability. Underlying pathology includes cancer, 
rheumatoid arthritis and infection. Liposomes extravasate through the gaps between cells and enter the 
interstitial fluid. Active targeting is achieved by conjugating ligands to the liposome that bind to a 
specific target cell receptor, leading to internalization or release of the drug. Passive targeting can be 
mediated by internalization or local high-concentration release of the drug
31
.  
 
To effectively deliver drug to the targeted tumor tissue, liposomes must have the 
ability to remain in the bloodstream for a considerable time without being eliminated. 
Conventional liposomes are usually caught in the circulation by the reticuloendothelial 
system, such as the liver and the spleen, depending on their size and 
composition/surface characteristics33. 
 
Size 
The size of nanoliposomes used in a drug delivery system should be large enough to 
prevent their rapid leakage into blood capillaries but small enough to escape capture 
by fixed macrophages that are lodged in the reticuloendothelial system, such as the 
liver and spleen. The size of the sinusoid in the spleen and fenestra of the Kuffer cells 
in the liver varies from 150 to 200 nm34 and the size of gap junction between 
endothelial cells of the leaky tumor vasculature may vary from 100 to 600 nm35. 
Consequently, the size of nanoliposomes should be up to 100 nm to reach tumor 
tissues by passing through these two particular vascular structures2.  
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Composition/surface characteristics 
The phospholipid DMPG have shown to provide the formation of perforations (pores) 
across the lipid membrane in the intermediate phase (between the turbid gel and fluid 
membrane phases). This behavior might be a characteristic of charged membranes in 
general: they could exhibit a ‘‘melting regime’’ (temperature interval where the 
melting process evolves) instead of a unique melting transition. Thus, a high local 
concentration of charged lipids could help the formation/stabilization of transient 
pores across the membrane, which would enable a controlled material transport 
across biological membranes36. Furthermore, the opening of pores across the 
membrane tuned by ionic strength, temperature, and pH, is likely to have biological 
relevance and could be used in applications for controlled release from 
nanocompartments37. 
The addition of cholesterol to the liposomes composition will prevent substance 
release as it will decrease liposome permeability and improve their chemical stability 
(higher membrane rigidity)38,39. Egg-PC (egg yolk phosphatidylcholine) liposomes with 
cholesterol, in (7:3) proportion, are commonly used as models of cell membranes40,41. 
Nanoliposomes should ideally have a hydrophilic surface to escape macrophage 
capture and enhance their life span in the circulatory system42. This can be achieved by 
coating the liposome with the synthetic polymer polyethyleneglycol (PEG)18,43-45. The 
pegylated liposomes are long circulating in blood due to a highly hydrated and 
protected liposome surface, constituted by the hydrophilic polymers that inhibit 
protein adsorption and opsonization of the liposomes. PEG provides the liposomes 
with up to 72 hours half-life in blood20. 
Grafting specific ligands to the liposome surface facilitates the fusion of the liposome 
with target cells by endocytosis, thus releasing material to be delivered18. This can be 
achieved by coupling liposomes to specific antibodies or coating the liposomes with 
ligands targeting proteins expressed on cancer cell membranes or endothelial cells 
lining the newly generated blood vessels in the tumor20. 
In terms of the liposomes charge, cationic liposomes, unlike their anionic and 
electroneutral counterparts, have been shown to target tumor vessels to a significant 
extent over vessels in normal healthy tissues, targeting approximately 25 and 5% of 
vessel areas respectively46 (electrostatic interactions between positively charged 
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liposomes and the negatively charged cell membranes facilitate cell uptake). However, 
cationic liposomes can cause cytotoxicity limiting their safety for clinical use.  
Consequently, interest for drug delivery has turned to neutral and anionic liposomes 
and the latters have shown to have enhanced macrophage internalisation47. 
Additionally, there is a relationship between surface charge and stability. This 
relationship can be evaluated by zeta-potential measurements: in general, particles 
with zeta potentials more positive than +30mV or more negative than -30mV are 
normally considered stable, with no tendency to aggregate, due to the electrostatic 
repulsion between the particles. 
In conclusion, it can be stated that liposomes are just beginning to make an impact in 
chemotherapy owing to the promising effects in the reduction of toxicity and side 
effects of existing therapies and in the increase efficacy by selective targeting of 
tumors. However, the full potential of these emerging technologies has not yet been 
fully realized. The toxicology of nanomaterials in humans still needs to be fully studied 
and evaluated. The studies already performed have been small and limited to short-
term exposure and should focus on long-term exposure in humans, animals and the 
environment. Further, in vivo studies are needed to determine the efficacy of these 
new drug formulations, and the reproducibility of batches of drug formulations also 
needs to be refined31. 
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4. Determination of the size and zeta-potential of the liposomes with incorporated 
compounds 
The fate of intravenously injected liposomes used as drug delivery systems is 
determined by a number of properties, two of the most important being particle size 
and zeta potential. The size is one of the most important physical properties of lipid 
vesicles with incorporated compounds because this parameter has a direct influence in 
many other properties such as reactivity, stability and efficacy of drug delivery. Unless 
the sample to characterize is perfectly monodisperse, i.e. every single particle has 
exactly the same dimensions, it will consist of a statistical distribution of particles of 
different sizes. It is common practice to represent this distribution in the form of a 
frequency distribution curve, or a cumulative (undersize) distribution curve (size 
distribution)48. 
Zeta-potential is another important parameter that affects the stability of the 
liposomes. It represents a measure of the magnitude of the electrostatic or charge 
repulsion or attraction between particles, and its measurement brings detailed insight 
into the causes of dispersion, aggregation or flocculation, and can be applied to 
improve the liposomes formulation. 
The development of a net charge at the particle surface affects the distribution of ions 
in the surrounding interfacial region, resulting in an increased concentration of counter 
ions, ions of opposite charge to that of the particle, close to the surface. Thus, an 
electrical double layer exists around each particle. The liquid layer surrounding the 
particle exists as two parts; an inner region (Stern layer), where the ions are strongly 
bound, and an outer (diffuse) region where they are less firmly associated. Within the 
diffuse layer, there is a notional boundary inside which the ions and particles form a 
stable entity. When a particle moves (e.g. due to gravity), ions within the boundary 
move with it. Those ions beyond the boundary stay with the bulk dispersant. The 
potential at this boundary (surface of hydrodynamic shear) is the zeta potential (Figure 
3.6)49.  
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Figure 3.6. Schematic representation of zeta-potential
49
. 
 
The magnitude of the zeta potential gives an indication of the potential stability of the 
colloidal system. If all the particles in suspension have a large negative or positive zeta 
potential, then they will tend to repel each other and there will be no tendency for the 
particles to come together. However, if the particles have low zeta potential values, 
then there will be no force to prevent the particles coming together and flocculating. 
The general dividing line between stable and unstable suspensions is generally taken at 
either +30 or -30 mV. Particles with zeta potentials more positive than +30 mV or more 
negative than -30 mV are normally considered stable.  
Particles size, size distribution and zeta-potential of particles, typically in the 
submicron region, suspended in a liquid can be evaluated by DLS (Dynamic Light 
Scattering), a non-invasive and well-established technique with many advantages, such 
as50: 
 Accurate, reliable and repeatable particle size analysis in one or two 
minutes. 
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 Measurement in the native environment of the material. 
 Mean size only requires knowledge of the viscosity of the liquid. 
 Simple or no sample preparation, low concentration, turbid samples can be 
measured directly. 
 Simple set up and fully automated measurement. 
 Size measurement of  particles typically in the submicron region down to 
1nm nanometre. 
 Low volume requirement (as little as 2 µL). 
 
The Brownian motion of particles or molecules in suspension causes laser light to be 
scattered at different intensities. Analysis of these intensity fluctuations yields the 
velocity of the Brownian motion (random movement of particles due to the 
bombardment by the solvent molecules that surround them). The larger the particle, 
the slower the Brownian motion will be. Smaller particles are “kicked” further by the 
solvent molecules and move more rapidly (Figure 3.7). 
 
Figure 3.7. Different rates of the Brownian motion of particles according to their size and respective 
size-distribution curves. 
 
 An accurately known temperature is necessary for DLS, because knowledge of the 
viscosity is required (the viscosity of a liquid is related to its temperature). The 
temperature also needs to be stable, otherwise convection currents in the sample will 
cause non-random movements, that will ruin the correct interpretation of size. The 
velocity of the Brownian motion is defined by a property known as the translational 
Chapter 3 – Compounds encapsulation in nanoliposomes 
__________________________________________________________________________________________________________  
 
70 
 
diffusion coefficient, D, and the size of the particles is calculated from this coefficient, 
by using the Stokes-Einstein relationship: 
  
  
    
                                                                         
where k is Boltzmann's constant, T is the absolute temperature,   is the solvent 
viscosity, and R is the molecular radius.  
Note that the diameter that is measured in DLS is a value that refers to how a particle 
diffuses within a fluid, so it is referred to as a hydrodynamic diameter. The diameter 
that is obtained by this technique is the diameter of a sphere that has the same 
translational diffusion coefficient as the particle50.  
If the particles are small compared to the wavelength of the laser used (typically, less 
than d =λ/10, or around 60 nm for a He-Ne laser), then the scattering from a particle 
illuminated by a vertically polarised laser will be essentially isotropic, i.e. equal in all 
directions. The Rayleigh approximation tells us that Ι α d6 and also that Ι α 1/λ4, where 
Ι is the intensity of light scattered, d is the particle diameter and λ is the laser 
wavelength. The d6 term tells us that a 50nm particle will scatter one million times as 
much light as a 5nm particle. Hence, there is a danger that the light from the larger 
particles will swamp the scattered light from the smaller ones. This d6 factor also 
means that it is difficult to measure a mixture of 1000 nm and 10 nm particles with 
DLS, because the contribution to the total light scattered by the small particles will be 
extremely small. The inverse relationship to λ4 means that a higher scattering intensity 
is obtained as the wavelength of the laser used decreases50. 
A conventional dynamic light scattering instrument consists of a laser light source, 
which converges to a focus in the sample using a lens. Light is scattered by the 
particles at all angles and a single detector, traditionally placed at 90° to the laser 
beam, collects the scattered light intensity. The intensity fluctuations of the scattered 
light are converted into electrical pulses, which are fed into a digital correlator. This 
generates the autocorrelation function, from which the particle size is calculated48. 
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1. Introduction 
Spectroscopy is basically related with the absorption, emission or scattering of 
electromagnetic radiation by atoms or molecules. Electromagnetic radiation covers a 
wide wavelength range, from radio waves to -rays. As the name implies, it contains 
both an electric and a magnetic component, which are best illustrated by considering 
plane-polarized (also known as linearly polarized) radiation. Figure 4.1 illustrates one 
photon of such radiation travelling along the x-axis. The electric component of the 
radiation is in the form of an oscillating electric field of magnitude E, and the magnetic 
component is in the form of an oscillating magnetic field of magnitude H. These 
oscillating fields are at right angles to each other. The plane of polarization is 
conventionally taken to be the plane containing the direction of E and that of 
propagation; in Figure 4.1 this is the xy-plane. The reason for this choice is that 
interaction of electromagnetic radiation with matter is more commonly through the 
electric component1. 
 
Figure 4.1. Plane-polarized electromagnetic radiation travelling along the x-axis; Ey is the electric 
component; Hz is the magnetic component
1
. 
 
In vacuum, all electromagnetic radiations travel at the same speed, the speed of light c 
(2.99792458x108 ms-1), and may be characterized by its wavelength, , in air or 
vacuum, or by its wavenumber,  , or frequency, , both conventionally in vacuum, 
where  
     
 
 
 
 
 
                                                               
Figure 4.2 illustrates the extent of the electromagnetic spectrum and the processes 
that may occur in an atom or molecule exposed to radiation. Indications of region 
boundaries, which should not be regarded as clear cut, are given in wavelength (mm, 
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m or nm), frequency (GHz) and wavenumber (cm-1). In addition, in the high-energy 
regions the energy is indicated in electron volts (eV) where 
       1 eV = 1.60218  10-19 J                                   (4.2) 
A molecule may undergo rotational, vibrational, electronic or ionization processes, in 
order of increasing energy (typical ranges are indicated in Figure 4.2). A molecule may 
also scatter light in a Raman process, and the light source for such an experiment is 
usually in the visible or near-ultraviolet region. An atom may undergo only an 
electronic transition or ionization since it has no rotational or vibrational degrees of 
freedom. Nuclear magnetic resonance (NMR) and electron spin resonance (ESR) 
processes involve transitions between nuclear spin and electron spin states, 
respectively, but these spectroscopies need the sample to be located between the 
poles of a magnet. 
 
Figure 4.2. Regions of the electromagnetic spectrum
1
. 
 
When an atom or molecule is exposed to a radiation of frequency , it passes from a 
state m to a state n separated by 
          
  
 
                                                           
where h is the Planck constant (h=6.62606876  10-34Js). This can occur by three 
possible processes1: 
 Induced absorption, where the molecule (or atom) M absorbs a quantity of 
radiation and is excited from state m to state n:  
M + h  M* 
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 Spontaneous emission, in which M* (in state n) spontaneously emits a 
quantum of radiation: 
M*  M + h 
 Induced, or stimulated, emission. This is a different type of emission in which a 
quantum of radiation is required to induce, or stimulate, M* to go from state n 
to state m: 
M* + h  M + 2h 
The populations of the states m and n (respectively, Nm and Nn) are related, at 
equilibrium, through the Boltzmann distribution law: 
  
  
 
  
  
      
  
  
                                                           
where gn and gm are the degrees of degeneracy of the states n and m respectively, T is 
the absolute temperature (K) and k is the Boltzmann constant                                            
(k = 1.3806503   10-23 JK-1). 
Molecular Fluorescence is a spontaneous emission after induced absorption involving 
electronic transitions. The energies needed to change the electron distributions of 
molecules are of the order of several electron volts. Consequently, the photons 
emitted or absorbed when such changes occur lie in the visible and ultraviolet regions 
of the spectrum (Figure 4.2, Table 4.1)2. 
 
Table 4.1. Colour, frequency and energy of infrared, visible and ultraviolet light
2
. 
Colour  / nm  / (1014 Hz) E / kJ mol-1 
Infrared >1000 <3.0 <120 
Red  700 4.3 170 
Yellow 580 5.2 210 
Blue 470 6.4 250 
Ultraviolet <300 >10 >400 
 
Molecular Fluorescence has many applications in physical, chemical, material, 
biological and medical sciences. It was first used as an analytical tool to determine the 
concentrations of several species, but is also the best method for the detection of 
analytes with a very high sensitivity (considerably improved due to the progress in 
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instrumentation) and a powerful tool for the investigation of structures and dynamics 
of matter or living systems at a molecular or supramolecular level. Biological 
membranes are examples in which it is possible to determine some parameters such as 
polarity, fluidity, order, molecular mobility and electrical potential by the use of 
fluorescent probes3. 
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2. Fluorescence as a particular case of Luminescence 
According to The Fluorescent Mineral Society, “Light is a form of energy. To create 
light, another form of energy must be supplied”. Luminescence is "cold light" (vs 
incandescence which is “hot light”) that can be emitted at normal and lower 
temperatures. In luminescence, some energy source kicks an electron out of its lowest 
energy "ground" state into a higher energy "excited" state; then, the electron returns 
the energy in the form of light, so it can fall back to its "ground" state. With few 
exceptions, the excitation energy is always larger than the energy (wavelength, color) 
of the emitted light. 
There are several types of luminescence, each named according to the mode of 
excitation4: 
Chemiluminescence is luminescence where the energy is supplied by chemical 
reactions. The glow-in-the-dark plastic tubes sold in amusement parks are examples of 
chemiluminescence. 
Bioluminescence is luminescence caused by chemical reactions in living things; it is a 
form of chemiluminescence. Fireflies glow by bioluminescence. 
Electroluminescence is luminescence caused by electric current. 
Sonoluminescence  is luminescence caused by a micron size gas bubble which is both 
spatially trapped and oscillated by an acoustic field in such a way that, on each 
compression of the bubble, a small burst of light is emitted. 
Cathodoluminescence is electroluminescence caused by electron beams; this is how 
television pictures were formed on a CRT (Cathode Ray Tube). Other examples of 
electroluminescence are neon lights, the auroras, and lightning flashes. This should not 
be confused for what occurs with the ordinary incandescent electric lights, in which 
the electricity is used to produce heat, and it is the heat that in turn produces light. 
Radioluminescence is luminescence caused by nuclear radiation. Older glow-in-the-
dark clock dials often used a paint with a radioactive material (typically a radium 
compound) and a radioluminescent material.  
Triboluminescence is luminescence triggered by mechanical action or 
electroluminescence excited by electricity generated by mechanical action. Some 
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minerals glow when hit or scratched, e.g. by banging two quartz pebbles together in 
the dark.  
Thermoluminescence is luminescence caused by temperatures above a certain 
threshold. This should not be confused with incandescence, which occurs at higher 
temperatures. In thermoluminescence, heat is not the primary source of the energy, 
only the trigger for the release of energy that originally came from another source.  
Photoluminescence is luminescence where the energy is supplied by electromagnetic 
radiation. The mode of excitation is absorption of a photon which brings the absorbing 
species into an excited state and the photoluminescence is the emission of photons 
accompanying de-excitation process. 
Fluorescence, delayed fluorescence and phosphorescence are particular cases of 
photoluminescence. 
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Figure 4.3. Types of luminescence processes and respective ways of molecules excitation (adapted from 
ref. 3). 
 
Phosphorescence is delayed luminescence or "afterglow" (the term phosphorescence 
comes from the Greek:  = light and  = to bear; therefore, phosphor means 
“which bears light”). Many minerals are phosphorescent. The most famous is the 
Bolognian phosphor discovered by a cobbler of Bologna in 1602 during a walk in the 
Monte Paterno: he picked up some strange heavy stones and, after calcination with 
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coal, he observed that the stones glowed in the dark after exposure to light (the stones 
contained barium sulfate, which, upon reduction by coal, led to barium sulfide, a 
phosphorescent compound). Today, many glow-in-the-dark products, especially toys 
for children, involve substances that receive energy from light, and emit the energy 
again as light later.  
Fluorescence is seen in fluorescent lights, amusement parks and movie special effects, 
the redness of rubies in sunlight, "day-glo" or "neon" colors, and in emission nebulae 
seen with telescopes in the night sky. The first reported observation of fluorescence 
was made by a spanish physician, Nicolas Monardes, in 1565: he observed that an 
infusion of a wood called Lignum Nephriticum exhibits a wonderful blue color. In his 
famous paper “On the change of refrangibility of light” (1852), Stokes5 reinvestigated 
this fact and demonstrated that the phenomenon was an emission of light after 
absorption of light. 
A basic distinction between fluorescence and phosphorescence based on experiment 
was made on the nineteenth century: Fluorescence disappears with the end of 
excitation, whereas phosphorescence persists after the end of excitation. Now, we 
know there are  long-lived fluorescence and short-lived fluorescence and Francis Perrin 
was the first who theoretically distinguished fluorescence and phosphorescence, in 
19296: a molecule emit phosphorescence when it pass, between absorption and 
emission, through an intermediate state and it is not able to reach the fundamental 
state without receiving some energy from the medium. 
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3.  Absorption of UV-Visible light 
3.1. Molecular orbitals and electronic transitions 
A molecular orbital is a mathematical function describing the wave-like behavior of an 
electron in a molecule7. It represents regions in a molecule where an electron is likely 
to be found. Molecular orbitals arise from allowed interactions between atomic 
orbitals (which predict the location of an electron in an atom), which are allowed if the 
symmetries are compatible. Efficiency of atomic orbital interactions is determined 
from the overlap (a measure of how well two orbitals constructively interact with one 
another) between two atomic orbitals, which is significant if the atomic orbitals are 
close in energy. When atomic orbitals interact, the resulting molecular orbital can be 
of three types8: bonding ( or  orbitals), antibonding (* or * orbitals), or 
nonbonding (n orbitals): 
 Bonding molecular orbitals: Constructive (in-phase) interactions between 
atomic orbitals lead to bonding molecular orbitals. These molecular orbitals are 
lower in energy than the atomic orbitals that combine to produce them. They 
can be  orbitals or  orbitals:  orbitals are formed either from two s atomic 
orbitals, or from one s and one p atomic orbital, or from two p atomic orbitals 
having a collinear axis of symmetry;  orbitals are formed from two p orbitals 
which overlap laterally. 
 Antibonding molecular orbitals: Destructive (out-of-phase) interactions 
between atomic orbitals lead to antibonding molecular orbitals. They can be * 
or * molecular orbitals and are higher in energy than the atomic orbitals that 
combine to produce them.  
 Nonbonding molecular orbitals (n orbitals): they are the result of no interaction 
between atomic orbitals because of lack of compatible symmetries. Normally, 
these molecular orbitals are located on heteroatoms such as oxygen or 
nitrogen and have the same energy as the atomic orbitals of these atoms in the 
molecule. 
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A molecule is in an excited state when an electronic transition occurs, i.e. when one 
electron passes from an orbital of the molecule in the ground state to an unoccupied 
orbital by absorption of a photon. Normally,  orbitals are more stable than  orbitals 
and, for molecules with heteroatoms,  orbitals are more stable than n orbitals. The 
lower is the bonding molecular orbital, the higher is the respective antibonding 
molecular orbital. 
 
 
 
 
 
Scheme 4.1. Energy levels of molecular orbitals and possible electronic transitions. 
 
From scheme 4.1, it can be seen that the lowest energy (the longest wavelength) 
transitions are from a non-bonding orbital n to a * antibonding orbital (transition      
n-*). Normally, it corresponds to the near UV and visible region. Hereafter come the 
-* transitions, n-* transitions, -* transitions and finally -* transitions, which 
normally occur below 200nm9: 
 
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Figure 4.4. Types of bonding and antibonding molecular orbitals. 
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En-* < E-* < En-* < E-* < E-* 
Following both the Pauli exclusion principle and Hund’s rule, electrons fill in orbitals of 
increasing energy. Thus, for molecules with heteroatoms, the HOMO (Highest 
Occupied Molecular Orbital) - LUMO (Lower Unoccupied Molecular Orbital) transition 
is a n-* transition.  
In conjugated systems, overlap of the  orbitals allows the electrons to be delocalized 
over the whole system (resonance effect) and not only between pairs of atoms. As 
there is no overlap between  and  orbitals, the  electron system is independent of 
the  bonds and the higher its extent, the lower the energy of the -* transition (i.e., 
the larger the wavelength of the absorption band)3. 
 
3.2. Selection rules for electronic transitions 
There are two principal rules for electronic transitions: 
 Symmetry rule:  some transitions are forbidden for symmetry reasons. This is 
the case, for example, of n-* transitions. However, a symmetry-forbidden 
transition can become weakly allowed when the molecular vibrations cause 
some departure from perfect symmetry (vibronic coupling). The intensity of a 
band indicates if the respective transition is allowed (high probability to occur) 
or forbidden (low probability to occur). Consequently, we can observe such 
bands although with low intensities, in electronic spectra.  
  S=0: transitions between states of different multiplicity are forbidden2.  
The multiplicity of a term is the 2S+1 value. S is the total spin angular momentum 
quantum number. S is a non-negative integer or a half integer and is obtained by 
coupling the individual spin angular momenta by using the Clebsch-Gordan series: 
S = |s1-s2|, |s1-s2|+ , …, s1+s2                                         (4.5)             
As each electron has s= 
 
 
 , S can be 1 or 0 for two electrons. If there are three 
electrons, the third spin must be coupled to each value of S, which results in S = 
 
 
,
 
 
. 
When S=0 (for a closed shell), the electrons are all paired, 2S+1=1, which gives rise 
to a singlet term S (there is only one possible value for MS, the total spin magnetic 
quantum number: MS=0). When there are two unpaired electrons, S=1, thus 
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2S+1=3, which gives rise to a triplet term T (there are three possible values for MS:               
Ms=-1, 0, 1). 
Note: it is important to distinguish S, the total spin angular momentum quantum 
number from S, which designate a singlet term3. 
The ground state is normally a singlet state (denoted S0) because the total spin angular 
momentum quantum number S is equal to 0 and the multiplicity (2S+1) is equal to 1. 
When one electron is promoted to a molecular orbital of higher energy during a n-* 
transition or a -* transition, etc., its spin is in principle unchanged and the 
corresponding excited states are also singlet states (denoted S1, S2, etc…). In this case, 
the electronic transition is called a “singlet-singlet” transition. If the spin of the 
electron is changed during the transition, the reached state is called triplet state 
because the total spin angular momentum quantum number S is 1 and the  multiplicity 
(2S+1) is equal to 3, which leaves three possible values for the total spin magnetic 
quantum number MS, namely -1, 0, 1 (three states of equal energy). In this case, the 
electronic transition is called a “singlet-triplet” transition and is spin-forbidden ( S0). 
Spin-forbidden transitions can be observed, although with very small molar absorption 
coefficients due to spin-orbit coupling, which is the interaction of the spin magnetic 
moment with the magnetic field arising from the orbital angular momentum of the 
electron. As this coupling increases sharply with atomic number (as Z4), such forbidden 
transitions are favored by the presence of heavy atoms. 
Direct formation of a triplet is a very improbable process, since both the orbit and spin 
of the electron would have to change simultaneously. Normally, triplet states are 
lower in energy than singlet states because the electrons have an electronic and 
magnetic part due to the spin correlation effect. If the spins are in the same direction, 
there is a magnetic repulsion and the electrons are farther. This gives a less electronic 
repulsion, thus a lower energy state (Hund’s rule)2. 
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Scheme 4.2. Energy levels of molecular orbitals and distinction between singlet and triplet state using 
formaldehyde as an example (only higher energy orbitals are shown) (adapted from ref. 3). 
 
3.3. The Franck-Condon principle 
To account for the vibrational structure in electronic spectra of molecules, we apply 
the Franck–Condon principle, which is a consequence of the Born-Oppenheimer 
approximation2: according to this approximation, the nuclei of a molecule, being so 
much heavier than the electrons, move very slowly comparatively with the electrons 
and thus may be treated as stationary. Indeed, promotion of an electron to an 
antibonding orbital after excitation takes about 10-15s, while the characteristic times 
for molecular vibrations are about 10-10 – 10-12 s. Thus, the Franck Condon principle 
states that an electronic transition is most likely to occur without change of nuclear 
positions and momenta. In other words, in a vibronic transition, the nuclei have very 
nearly the same position and velocity before and after the transition. Thus, upon 
excitation, the molecule is assumed to be initially in the Franck-Condon state (F)1,10. 
Figure 4.5a) shows potential curves for the lower state (which is the ground state if we 
are considering an absorption process) and the upper state, as a function of the 
nuclear configuration (internuclear distance in the case of diatomic molecules). The 
curves have been drawn so that     
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  . When the lower state is the ground state, 
E 
 
 
* 
* 
n HOMO 
LUMO   
So 
Ground State 
S1 
  n-* 
S2 
  -* 
T1 
  n-* 
T2 
  -* 
 
 
E 
S0 
S1 
S2 
T2 
T1 
Chapter 4 – Molecular Fluorescence Spectroscopy 
__________________________________________________________________________________________________________  
 
94 
 
this is very often the case, since the electron promotion involved is often from a 
bonding orbital to an orbital which is less bonding, or even antibonding. Before the 
absorption, at room temperature, most of the molecules are in the lowest vibrational 
level of the ground state (according to the Boltzmann distribution, see equation 4.4).  
In absorption, from point A of the ground state, the transition will be to point B of the 
upper state. The requirement that the nuclei have the same position before and after 
the transition means that the transition is between points which lie on a vertical line in 
the figure: this means that r remains constant and such a transition is often referred to 
as a vertical transition. The second requirement, that the nuclei have the same velocity 
before and after the transition, means that a transition from A, where the nuclei are 
stationary, must go to B, as this is the classical turning point of a vibration, where the 
nuclei are also stationary. A transition from A to C is highly improbable because, 
although the nuclei are stationary at A and C, there is a large change of r. An A to D 
transition is also unlikely because, although r is unchanged, the nuclei are in motion at 
the point D. 
Figure 4.5b) illustrates the case where   
     
  . Here the most probable transition is 
from A to B with no vibrational energy in the upper state. The transition from A to C 
maintains the value of r but the nuclear velocities are increased due to their having 
kinetic energy equivalent to the distance BC. 
 
Figure 4.5. Illustration of the Franck-Condon principle for (a)   
  >   
   and (b)   
     
  . The vibronic 
transition A–B is the most probable (and so the most intense) in both cases
1
. 
  
In addition to the most probable transition, there are several vibronic transitions 
whose intensities depend on the relative position and shape of the potential energy 
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curves. The width of the bands depends is the result of two factors: homogeneous and 
inhomogeneous broadening. Homogeneous broadening is due to the existence of 
continuous set of vibrational sublevels in each electronic state. Inhomogeneous 
broadening results from the fluctuations of the structure of the solvation shell3 (Figure 
4.6). 
 
Figure 4.6. Potential energy diagrams with vertical transitions and respective absorption spectra; the 
vertical broken lines represent the absorption lines that are observed for a vapor, whereas the solid 
lines represent the expected broadening of the spectra in solution
3
.  
 
3.4. Probability of transitions. The Beer-Lambert law 
The absorbance A() and the Transmittance T() represent the efficiency of light 
absorption by a sample, for a given wavelength  and are defined as: 
                    
        
  
 
                                                                    
    
and                       
     
 
  
                                                                            
     
or                                     
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where I0  and I are the light intensities of the beams before and after passing through 
the sample. 
In many cases, namely in the absence of aggregate formation at high concentrations, 
in the absence of other absorbing species or in the absence of instrument deviations, 
as described hereafter, the absorbance of a solution follows the Beer-Lambert law: 
                                                                           
or                                             I = I0 exp(-2.3Cl)                                                  (4.10) 
where () is the molar absorption coefficient (in L mol-1cm-1) (it expresses the ability 
of a molecule to absorb light in a given solvent at a given wavelength); C is the 
concentration of absorbing species (in mol L-1); l is the path length (thickness of the 
cuvette in cm). 
 
 
 
 
 
 
 
 
As referred above, under certain circumstances, the Beer-Lambert relationship breaks 
down and gives a non-linear relationship. These deviations from the Beer-Lambert law 
can be classified into three categories11: 
1. Real Deviations - These are fundamental deviations due to the limitations of 
the law itself: Beer-Lambert law is capable of describing absorption behavior of 
solutions containing relatively low amounts of solutes dissolved in it (< 10-2 M). 
When the concentration of the analyte in the solution is higher, the analyte 
begins to behave differently due to interactions with the solvent and other 
solute molecules and can form aggregates.  
2. Chemical Deviations - These deviations occur due to chemical phenomenon 
involving the analyte molecules due to association, dissociation and interaction 
 
Figure 4.7. Illustration of the Beer-Lambert law
11
. 
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with the solvent (for example, hydrogen bonding interactions) to produce a 
product with different absorption characteristics. 
3. Instrument Deviations - These are deviations which occur due to the way the 
absorbance measurements are made. They can be due to polychromatic 
radiation, to mismatched cells in reference and sample, to the presence of 
scattered radiation (mainly with samples of macromolecules or other large 
aggregates), or to fluorescence of the sample.  
The optical density resulting from scatter is proportional to 1/4 (Rayleigh 
scattering) and may thus be easily recognized as a background absorption 
which increases rapidly with decreasing wavelengths12. 
If the absorbing species is fluorescent, the emitted light can reach the detector 
but, as the fluorescence is omnidirectional whereas the incident light is 
collimated along an axis, this effect can be minimized by keeping the detector 
distant from the sample and thereby by decreasing the efficiency with which 
the fluorescence emission is collected. 
The maximum value of the molar absorption coefficient, εmax, is an indication of the 
intensity of a transition. However, as absorption bands generally spread over a range 
of wavenumbers, quoting the absorption coefficient at a single wavenumber might not 
give a true indication of the intensity of a transition. The integrated absorption 
coefficient,  , is the integral over the entire band (Figure 4.8), and corresponds to the 
area under the plot of the molar absorption coefficient against wavenumber2: 
                                                                                   
 
 
  
 
 
 
 
 
 
 
 
Figure 4.8. Integrated absorption coefficient of a transition
2
. 
Chapter 4 – Molecular Fluorescence Spectroscopy 
__________________________________________________________________________________________________________  
 
98 
 
If the absorption is due to an electronic transition, then fnm, the oscillator strength, is 
often used to quantify the intensity and is related to the area under the curve by1 
    
 ε    
     
    
 ε     
     
     
                                                   
where 0 is the vacuum permittivity (0 = 8.854187816 10
-12 C2 J1m1), me and e are 
the electron mass and charge, respectively (me = 9.10938188 10
-31 kg and                            
e = -1.602176462 10-19C), c is the speed of light (c = 2.99792458 108 ms-1) and NA is 
the Avogadro’s number (NA = 6.02214199 10
23 mol-1). 
The quantity fnm is dimensionless and represents the ratio of the strength of the 
transition to that of an electric dipole transition between two states of an electron, 
oscillating in three dimensions in a simple harmonic way, and its maximum value is 
usually 1 (completely allowed transition). 
For n* transitions, the values of  are in the order of a few hundreds or less, and 
those of fnm are no greater than 10
-3. For * transitions, the values of  and fnm are 
in principle much higher (except for symmetry-forbidden transitions): fnm is close to 1 
for some compounds, which corresponds to values of  that are of the order3 of 
100000 M-1 cm-1. 
To characterize the displacement of charges during a transition between an initial and 
a final state, a vector quantity called transition moment,   , is introduced (note that 
it is not strictly a dipole moment): in most cases, it can be drawn as a vector in the 
coordinate system defined by the location of the nuclei of the atoms. This concept is 
very important in all experiments carried out with polarized light, because the 
molecules whose absorption transition moments are parallel to the electric vector of a 
linearly polarized incident light are preferentially excited. The probability of excitation 
is proportional to the square of the scalar product of the transition moment and the 
electric vector. This probability is thus maximum when the two vectors are parallel and 
zero when they are perpendicular.  
For * transitions of aromatic hydrocarbons, the absorption transition moments 
are in the plane of the molecule. The direction with respect to the molecular axis 
depends on the electronic state attained on excitation. For example, in naphthalene 
Chapter 4- Molecular Fluorescence Spectroscopy 
__________________________________________________________________________________________________________ 
99 
 
and anthracene, the transition moment is oriented along the short axis for the S0S1 
transition and along the long axis for the S0S2 transition. 
 
Figure 4.9. Naphthalene and anthracene with their absorption transition moments. 
 
The transition moment can be defined by 
       
                                                                     
for interaction with the electric component of the radiation. The quantity  is the 
electric dipole moment operator,  
                                                                             
 
 
where qi and ri are the charge and position vector of the i-th particle (electron or 
nucleus).  
The transition moment can be thought as the oscillating electric dipole moment due to 
the transition. Figure 4.10 shows the  and * molecular orbitals of ethylene and, if an 
electron is promoted from  to * in an electronic transition, there is a corresponding 
non-zero transition moment. This example illustrates the important point that a 
transition moment may be non-zero even though the permanent electric dipole 
moment is zero in both the states m and n1. 
 
Figure 4.10. A  (a) and a * (b) molecular orbital of ethylene. 
 
The square of the magnitude of     is the transition probability, |   |2. It is related to 
selection rules in spectroscopy: it is zero for a forbidden transition and non-zero for an 
allowed transition. The electric dipole moment operator, , has components along the 
cartesian axes: 
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where qi and xi are, respectively, the charge and x-coordinate of the i-th particle, and 
so on. Similarly, the transition moment can be resolved into three components: 
  
      
               
      
               
      
                      
and the transition probability is related to these by 
|   |2  =     
   2 +    
   2 +    
                                                 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4- Molecular Fluorescence Spectroscopy 
__________________________________________________________________________________________________________ 
101 
 
4.  De-excitation processes of excited molecules 
When a molecule has been promoted to an excited state, it does not remain there for 
a long time, and has many ways to return to the ground state. We may classify de-
excitation processes to two broad categories9: 
A. Photophysical deactivation processes, e.g. photoluminescence (normal or 
delayed fluorescence and phosphorescence), vibrational/rotational transitions, 
internal conversion (IC), intersystem crossing (ISC) and quenching (Q).  
B. Photochemical deactivation processes, i.e. de-excitation resulting from excited 
state photochemical reactions, implying bond breaking and formation of new bonds, 
so that the ground state of the molecule is not recovered (photodecomposition, 
photoaddition, photosubstitution, etc.). Some of these processes may lead to 
fluorescent species whose emission can be higher than that of the initial one. 
Photochemical deactivation processes, as well as vibrational/rotational transitions, 
internal conversion (IC), intersystem crossing (ISC) and quenching (Q) are radiationless 
processes (heat emission, i.e., the excess energy is transferred into the vibration, 
rotation, and translation of the surrounding molecules), whereas normal or delayed 
fluorescence and phosphorescence are radiant processes (the molecule discards its 
excitation energy as a photon). 
The time that a molecule spends in the excited state is determined by the inverse of 
the sum of the kinetic constants of all de-excitation processes. Fluorescence competes 
with the other de-excitation pathways and can be observed if its rate constant, kF, is 
higher than that sum. 
The Perrin-Jablonski diagram (scheme 4.3) shows the absorption process as well as the 
different possible de-excitation processes. The radiative processes are represented by 
straight arrows. The non-radiative decays are represented by wavy arrows. Vibrational 
levels are represented for each electronic state. Note that fluorescence and 
phosphorescence always occur from the lowest vibrational level of the excited state 
because if the molecule is on a non-zero vibrational level, it is subjected to collisions 
with the surrounding molecules and gives up energy, until arise the zero vibrational 
level by vibrational relaxation, before emitting fluorescence or phosphorescence. 
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Scheme 4.3. Perrin-Jablonski diagram, illustration of the relative positions of absorption, fluorescence 
and phosphorescence spectra and characteristic times for each transition process (adapted from ref. 3). 
 
Absorption of a photon can bring a molecule to one of the vibrational levels of S1, S2,… 
and the subsequent de-excitation processes may be3,9: 
 
 
 
S1S0 
 
T2 
T1 
Singlet states S0, S1 and S2 Triplet states T1 and T2 
Vibrational 
Energy 
States S2 
S1 
S0 
 
 
BISC 
ISC VR 
VR 
VR VR 
VR 
VR 
VR 
VR 
Q Q 
IC 
IC 
ISC 
ABSORPTION FLUORESCENCE PHOSPHORESCENCE 
S0S2 T1S0 S0S1 S1S0 
Radiative processes (straight arrows): 
Absorption (10-15s) 
 Fluorescence (10-10 – 10-7s) 
 Delayed Fluorescence (after BISC T1S1) 
 Phosphorescence (10-4 – 1s) 
Non-Radiative processes (wavy arrows): 
Intersystem Crossing ISC (10-10 - 10-8s) 
Back Intersystem Crossing BISC 
 Internal Conversion IC (10-11 – 10-9s) 
 Vibrational Relaxation VR (10-12 – 10-10s) 
 Quenching Q 
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 Internal Conversion: 
Internal Conversion is a non-radiative transition between two states of the same spin 
multiplicity that occurs with a time-scale of 10-11 – 10-9 s. When a molecule is excited to 
a singlet state higher than S1, internal conversion leads the molecule to the S1 state. 
Internal conversion from S1 to S0 is also possible, but is less efficient than conversion 
from S2 to S1, because of the much larger energy gap between S1 and S0. Furthermore, 
internal conversion from S1 to S0 competes with other de-excitation processes 
(fluorescence, intersystem crossing to the triplet state, etc.). 
 
 Vibrational Relaxation: 
It is a non-radiative transition between two different vibrational levels of the same 
electronic state. When a molecule is on a non-zero vibrational level of the ground state 
or of the excited state, the excess vibrational energy is transferred to the solvent 
during collisions of the molecule with the surrounding solvent molecules. This process 
is called Vibrational Relaxation and occurs with a time-scale of 10-12 – 10-10 s. 
 
 Intersystem Crossing: 
Intersystem Crossing is a non-radiative transition between two isoenergetic vibrational 
levels belonging to electronic states of different multiplicities. When a molecule is in 
the lowest vibrational level of the S1 state, it can move to the isoenergetic vibrational 
level of the Tn state. Then, internal conversion and vibrational relaxation bring it to the 
lowest vibrational level of the T1 state. This process occurs with a time-scale of 10
-10 – 
10-8 s. Thus, it is fast enough to compete with other pathways of de-excitation.  
Normally, crossing between states of different multiplicity is forbidden (selection rule 
 S=0, see section 3.2.2.), but spin-orbit coupling may be large enough (especially with 
the presence of heavy atoms) to make it possible. The probability of intersystem 
crossing depends on the singlet and triplet states involved. For example, if the 
transition S0S1 is of n* type (symmetry forbidden transition), intersystem 
crossing is often efficient. 
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 Back Intersystem Crossing: 
Back Intersystem Crossing is a reverse Intersystem Crossing T1S1, that can occur 
when the energy difference between S1 and T1 is small and when the lifetime of T1 is 
long enough. Normally, it is followed by delayed fluorescence (fluorescence emission 
with the same spectral distribution as normal fluorescence, but with a much longer 
decay time constant, because the molecule stay in the triplet state before emitting 
from S1).  
 
 Quenching: 
Quenching is any non-radiative intermolecular process responsible for de-excitation of 
molecules which decrease the fluorescence or phosphorescence intensity: energy 
transfer, electron transfer, proton transfer, complex formation and collisional 
quenching. 
In these cases, the fluorescence and/or phosphorescence characteristics (decay time 
and/or fluorescence/phosphorescence quantum yields) of the molecules are affected 
by the presence of a quencher, as a result of competition between the intrinsic de-
excitation and these intermolecular processes. 
 
 Fluorescence: 
Fluorescence is the emission of photons accompanying the S1S0 relaxation. The 
downward electronic transition is vertical (according to the Franck-Condon principle) 
and the fluorescence spectrum has a vibrational structure characteristic of the lower 
electronic state. 
The absorption spectrum arises from 0–0, 0–1, 0–2,… transitions, that occur at 
progressively higher wavenumbers and with intensities governed by the Franck-
Condon principle. The fluorescence spectrum arises from 0–0, 0–1, 0-2,… downward 
transitions that hence occur with decreasing wavenumbers, i.e., the wavelength of a 
fluorescence emission should always be higher than that of absorption. This was 
empirically observed by Stokes before the knowledge of the Perrin-Jablonski diagram 
and, for that reason, this statement is called “Stokes rule”. The vivid oranges and 
greens of fluorescent dyes are an everyday manifestation of this effect: they absorb in 
the ultraviolet and blue, and fluoresce in the visible. The gap (expressed in 
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wavenumbers) between the maximum of the first absorption band and the maximum 
of fluorescence is called “Stokes shift” (Figure 4.11) and can provide useful information 
on the excited states because it is a result of several dynamic processes. These 
processes include energy losses due to dissipation of vibrational energy, redistribution 
of electrons in the surrounding solvent molecules induced by the generally increased 
dipole moment of the excited fluorophore, reorientation of the solvent molecules 
around the excited state dipole, and specific interactions (like hydrogen bonding and 
formation of charge transfer complexes) between the fluorophore and the solvent. 
 
Figure 4.11. Definition of the Stokes shift
3
. 
 
Despite the Stokes rule, in most cases, the absorption spectrum partly overlaps the 
fluorescence spectrum, i.e., a fraction of light is emitted at shorter wavelengths than 
the absorbed light. It can be explained by the fact that at room temperature, a small 
fraction of molecules is in a vibrational level higher than level 0 in the ground state, as 
well as in the excited state. At low temperature, this departure from the Stokes law 
should disappear. 
Normally, the fluorescence spectrum resembles the first absorption band (“mirror 
image” rule) because the differences between the vibrational levels are similar in the 
ground and excited states. 
The 0-0 transitions are usually the same for absorption and fluorescence, but 
sometimes they are not exactly coincident because the solvent may interact differently 
with the solute in the ground and excited states (for instance, the hydrogen bonding 
pattern might differ). Absorption of light occurs in about 10–15 s, a very short time. For 
that reason, the solvent molecules do not have time to rearrange during the transition. 
Thus, absorption spectra are less sensitive to solvent polarity because the molecule is 
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exposed to the same local environment in the ground and excited states. In contrast, 
the emitting fluorophore is exposed to the relaxed environment, which contains 
solvent molecules oriented around the dipole moment of the excited state (Figure 
4.12). The mechanism also suggests that the intensity of the fluorescence ought to 
depend on the ability of the solvent molecules to accept the electronic and vibrational 
quanta. It is indeed found that a solvent composed of molecules with widely spaced 
vibrational levels (such as water) can in some cases accept the large quantum of 
electronic energy and so extinguish, or quench, the fluorescence.  
 
 
 
 
 
 
 
 
 Delayed Fluorescence: 
Delayed Fluorescence is similar to normal fluorescence but with a longer decay time 
constant, because the molecule is subjected to an intersystem crossing from a singlet 
to a triplet state, stay in the triplet state and is subjected to a back intersystem 
crossing from the triplet to the singlet state, before emitting fluorescence.  
 
 Phosphorescence: 
Phosphorescence is the emission of photons accompanying the T1S0 relaxation after 
an intersystem crossing S1T1. Once a molecule is in a triplet state, it continues to 
deposit energy into the surroundings. However, it is now stepping down the triplet’s 
vibrational ladder, and, at the lowest energy level, it is trapped because the triplet 
state is at a lower energy than the corresponding singlet (that is why the 
phosphorescence spectrum is located at higher wavelengths than the fluorescence 
spectrum). The solvent cannot absorb the final, large quantum of electronic excitation 
energy, and the molecule cannot radiate its energy because return to the ground state 
is spin-forbidden. However, the radiative transition is not totally forbidden because the 
Figure 4.12. Shift to higher wavelengths of the fluorescence spectrum relative to the absorption spectrum 
due to interaction with solvent
13
. 
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spin-orbit coupling, that was responsible for the intersystem crossing, also breaks the 
selection rule. The molecules are therefore able to emit weakly, and the emission may 
continue long after the original excited state was formed.  
Phosphorescence competes with non-radiative de-excitation processes from the triplet 
state. In solution, at room temperature, as the transition T1S0 is spin-forbidden, the 
radiative rate constant is very low (103 s-1 or less), and during such a process, the 
numerous collisions with solvent molecules (or oxygen and impurities) favor non-
radiative processes (intersystem crossing, vibrational relaxation and quenching, with 
radiationless rate constants about 109 s-1). On the contrary, at low temperatures 
and/or in a rigid medium (e.g. polymer), the lifetime of the triplet state may be long 
enough to observe phosphorescence. 
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5.  Characteristics of fluorescence emission 
5.1. Fluorescent probes 
Fluorescence is a powerful investigative tool in the study of the structure and dynamics 
of matter or living systems due to its high sensitivity, its specific characteristics 
according to the microenvironment of the emitting molecules (e.g. polarity, hydrogen 
bonds, pH, pressure, viscosity, temperature, quenchers, electric potential and ions) 
and its ability to provide spatial and temporal information. As a consequence, 
fluorescent molecules are very often used as probes for the investigation of matter 
and living systems3. 
Fluorescent probes (also called fluorophores or simply dyes) have been used for nearly 
a century to study cellular processes, due to their exquisite sensitivity and selectivity. 
Their high sensitivity arises in part because, unless a fluorophore is irreversibly 
destroyed in the excited state by photobleaching, the same fluorophore can be 
repeatedly excited and detected. This allows a single fluorophore to generate many 
thousands of detectable photons. Fluorescent probes have also gained in popularity as 
safety and environmental concerns over the use of radioactive probes have grown14. In 
contrast to radioactive tracers or EPR (Electronic Paramagnetic Resonance) probes, 
which are used in relatively few applications, fluorescent probes can be used in the 
study of innumerous systems like polymers, solid surfaces, surfactant solutions, 
biological membranes, vesicles, proteins, nucleic acids or living cells. They can also be 
used in fluoroimmunoassays3. 
There are two principal classes of fluorescent probes9: 
A. Intrinsic probes: occur naturally in the systems under study such as aromatic 
amino acids, neurotransmitters, porphyrins, and green fluorescent protein. 
B. Extrinsic probes: synthetic fluorescent probes that are added to a species to 
produce fluorescence with specific spectral properties. These probes may be 
covalently attached (markers) or non-covalently attached probes3. 
The advantage of markers versus non-covalently attached probes is that, in the first 
type, we know the location of the probe. However, as the synthesis of covalently- 
bound probes is difficult, most of the experiments are carried out with non-covalently 
attached probes. 
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In the choice of a probe, it is important to consider its sensitivity to a particular 
property of its microenvironment (or not, e.g. in fluorescence polarization or in energy 
transfer experiments). 
The main clause criticism to the use of extrinsic probes is the possible perturbation 
induced by the probe itself; hence, attention must be paid to the size and the shape of 
the probe with respect to the probed region12. 
 
5.2. Lifetimes and quantum yields 
The fluorescence lifetimes and quantum yields of fluorescent molecules are frequently 
measured, because they represent the most important characteristics of a 
fluorophore. The lifetime () determines the time available for the fluorophore to 
interact with or diffuse in its environment, and the quantum yield (F) is the number 
of emitted photons relative to the number of absorbed photons.  
The lifetime  of the excited state is defined by the average time the molecule spends 
in the excited state prior to return to the ground state3: 
  
 
  +    
                                                                   
where kR and kNR are the rate constants for radiative (fluorescence) and non-radiative 
(internal conversion and intersystem crossing) decays, respectively. 
The lifetime of a homogeneous population of fluorophores is very often independent 
of the excitation wavelength, because internal conversion and vibrational relaxation 
are always very fast in solution and emission arises from the lowest vibrational level of 
S1 state. 
The lifetime of the molecule in the absence of non-radiative processes is called the 
intrinsic lifetime or radiative lifetime (0), and is given by
3 
   
 
  
                                                                          
The radiative lifetime can be theoretically calculated from the absorption and 
fluorescence spectra, using the Strickler-Berg relation22: 
Chapter 4 – Molecular Fluorescence Spectroscopy 
__________________________________________________________________________________________________________  
 
110 
 
 
  
 
          
  
 
           
   
           
  
ε        
  
               
           
   
           
  
ε        
  
                                   
where n is the refractive index, c is the speed of light,  is the molar absorption 
coefficient, NA is the Avogadro’s number and            is the fluorescence spectrum, 
defined by  
                                                                          
 
 
 
 
  
Thus, quantum yields (and radiative lifetimes) are usually determined by integration of 
the fluorescence spectrum (and subsequent normalization using a standard of known 
fluorescence quantum yield, in order to get rid of the instrumental factor).  
Attention should be paid to the method of integration; from a theoretical point of 
view,               is equivalent to             . However, from a practical point 
of view, because all spectrofluorometers are equipped with grating monochromators, 
calculation of the integral must be made with the wavelength form3. 
The Strickler-Berg equation yields values of  that are often in agreement with the 
experimental ones, but it fails in a number of cases, especially when the interactions 
with the solvent cannot be ignored and when there is a change in the excited-state 
geometry. An important consequence of this equation is that the lower the molar 
absorption coefficient, the longer the radiative lifetime, i.e. the lower the rate of the 
radiative process. 
The fluorescence intensity is defined as the amount of photons emitted per unit time 
and per unit volume of solution, according to3 
A*  A + photon 
The fluorescence intensity, iF, at time t, after excitation by a very short pulse of light at 
time 0, is proportional, at any time, to the instantaneous concentration of molecules 
still excited [A*]; the proportionality factor is the rate constant for radiative de-
excitation, kR : 
iF(t) = kR [A*] = kR       exp   
 
 
                                              
kR 
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iF(t), the -pulse response of the system, decreases according to a single exponential. 
In any practical measurement of fluorescence intensity, the measured quantity is 
proportional to iF, the proportionality factor depending on instrumental conditions. 
The “measured” fluorescence intensity will be denoted IF and its numerical value is 
obtained on an arbitrary scale, depending on the experimental settings. 
The fraction of fluorophores which decay through emission, and hence the 
fluorescence quantum yield, F, is given by
3 
  
  
  +    
       
 
  
                                                 
The quantum yield can be close to the unity if the radiationless decay of deactivation is 
much smaller than the rate of radiative decay, that is kNR  kR, but it is always less 
than unity because of the Stokes losses. 
It is interesting to note that when the fluorescence quantum yield and the excited 
state lifetime of a fluorophore are measured under the same conditions, the non-
radiative and radiative rate constants can be easily calculated by means of the 
following relations: 
   
 
 
                                                                         
               
 
 
                                                                      
Following an external perturbation, the fluorescence quantum yield can remain 
proportional to the excited state lifetime (e.g. in the case of dynamic quenching:  
section 6.2), variation in temperature, etc.). However, such a proportionality may not 
be valid if de-excitation pathways – different from those described above – result from 
interactions with other molecules. A typical case where the fluorescence quantum 
yield is affected without any change in excited-state lifetime is the formation of a 
ground-state complex that is non-fluorescent (static quenching; section 6.3). 
It is well known that atmospheric oxygen quenches fluorescence (and 
phosphorescence) (section 6.1), but its effect on quantum yields and lifetimes strongly 
depends on the nature of the compound and the medium. Oxygen quenching is a 
collisional process and, therefore, is diffusion-controlled. Consequently, compounds of 
long lifetime, such as naphthalene and pyrene, are particularly sensitive to the 
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A + h’ 
A + h           A* 
A 
kA 
kR 
kNR 
 
presence of oxygen. Moreover, oxygen quenching is less efficient in media of high 
viscosity.  
Generally, an increase in temperature results in a decrease in the fluorescence 
quantum yield and lifetime, because the non-radiative processes related to thermal 
agitation (collisions with solvent molecules, intramolecular vibrations and rotations, 
etc.) are more efficient at higher temperatures. Experiments are often in good 
agreement with the empirical linear variation of    
 
  
    versus  
 
 
 . 
 
5.3. Emission and excitation spectra 
Emission and excitation spectra are recorded using a spectrofluorometer. The light 
source is a lamp emitting a constant photon flow, i.e. a constant amount of photons 
per unit time, whatever their energy. Let us denote by N0 the constant amount of 
incident photons entering, during a given time, a unit volume of the sample where the 
fluorophore concentration is [A] (N0 and [A] in mol L
-1). N0 represents the amount of 
absorbed photons per unit volume involved in the excitation process 
 
 
 
 
Scheme 4.4. Absorption and de-excitation processes and respective rate constants. 
 
The rate constant for absorption, kA, is very large (kA  10
15 s-1) comparing with the 
radiative and non-radiative de-excitation rate constants (kR and kNR  10
7 - 1010 s-1). 
Under continuous illumination, the concentration [A*] remains constant, which means 
that A is in a steady state. Measurements under these conditions are then called 
steady-state measurements. 
The rate of change of [A*] is equal to zero: 
     
  
             +       
                                         
kAN0 represents the amount of absorbed photons per unit volume and per unit time. 
It can be rewritten as I0 where I0 represents the intensity of the incident light (in 
moles of photons per liter and per second). 
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The constant concentration [A*] is thus given by 
     
   
  +    
                                                              
The amount of fluorescence photons emitted per unit time and per unit volume, i.e. 
the steady-state fluorescence intensity, is then given by 
       
      
  
  +    
                                                  
This expression shows that the steady-state fluorescence intensity per absorbed 
photon,  
  
   
 , is the fluorescence quantum yield. 
We saw (equation 4.25) that                 
 
 
, where   is the fluorescence 
quantum yield and         represents the fluorescence spectrum (or emission 
spectrum): it represents the probability of the various transitions from the lowest 
vibrational level of S1 to the various vibrational levels of S0. The emission spectrum is 
characteristic of a given compound and may be used in some cases for the 
identification of species, especially when the spectrum exhibits vibronic bands (e.g. in 
the case of aromatic hydrocarbons), but the spectra of most fluorescent probes (in the 
condensed phase) exhibit broad bands. 
In practice, the steady-state fluorescence intensity, IF(em), measured at wavelength 
em, is proportional to         and to the number of photons absorbed at the 
excitation wavelength ex ,  
IF(exem) = k         IA(ex)= k         (I0(ex)-I(ex)) 
 IF(exem) =k         I0(ex)[1- exp(-2.3(ex)C l)]                     (4.33) 
where k is an instrumental factor, (ex) is the molar absorption coefficient of the 
fluorophore at wavelength ex (in L mol-1 cm-1), C is the concentration in mol L
-1, l is 
the optical path in the sample (cm),         is the fluorescence spectrum, and IA(ex) 
is the absorbed intensity, defined as the difference between the intensity of the 
incident light, I0(ex), and the intensity of the transmitted light, I(ex). 
So, measurement of IF as a function of em for a fixed excitation wavelength, ex, 
provides the fluorescence spectrum. As the proportional instrumental factor k is 
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normally unknown, the measured intensity IF has no meaning and is expressed in 
arbitrary units. 
In the case of low concentrations, the following expansion of [1 - exp(-2.3(ex)C l)] 
can be used: 
1- exp(-2,3(ex)C l) = 2.3(ex)C l - 
 
 
(2.3(ex)C l)2+…                    (4.34) 
As the term of higher order become negligible for highly diluted solutions, we obtain 
IF(ex,em)  k         I0(ex)[2.3(ex)C l)] = 2.3k         I0(ex)A(ex)         (4.35) 
where A(ex) represents the absorbance at wavelength ex (according to the Beer-
Lambert law). 
This relation shows that the fluorescence intensity is proportional to concentration 
only for low absorbances: deviations from a linear variation increase with increasing 
absorbance, Table 4.2. Furthermore, when the concentration is high, inner filter effects 
reduce the fluorescence intensity, depending on the observation conditions. In 
particular, the photons emitted at wavelengths corresponding to the overlap of the 
absorption and emission spectra can be reabsorbed. That is the reason why, in 
practice, the fluorescence spectra are recorded for samples of low absorbances (< 0.1), 
i.e. diluted solutions. 
 
Table 4.2. Deviation from linearity in the relation between fluorescence intensity and absorbance
3
. 
Absorbance Deviation (%) 
10-3 0.1 
10-2 1.1 
0.05 5.5 
0.10 10.6 
0.20 19.9 
 
 
The excitation spectra represent the variations in fluorescence intensity as a function 
of the excitation wavelength, ex, for a fixed observation wavelength, em. If we look to 
the last expression, these variations reflect the evolution of the product I0(E)A(E). 
As the wavelength dependence of the incident light, I0(ex), can be compensate, the 
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only term to be taken in account is A(ex). The corrected excitation spectrum is thus 
identical in shape to the absorption spectrum, unless several species (or a species in 
different forms like aggregates, complexes, etc.) are present in the ground state. 
 
5.4. Effects of molecular structure on fluorescence 
 Extent of -electron system 
Most fluorescent compounds are aromatic. Generally speaking, an increase in the 
extent of the -electron system (high degree of conjugation), leads to a shift of the 
absorption and fluorescence spectra to longer wavelengths (red shift) and to an 
increase in the fluorescence quantum yields. 
The lowest-lying transitions of aromatic hydrocarbons are of * type and are 
characterized by high molar absorption coefficients and fluorescence quantum yields. 
If a heteroatom is involved (for instance, in azo compounds or compounds containing 
carbonyl groups and/or nitrogen heterocycles), the lowest-lying transition may be of 
n* type. Such transitions are characterized by molar absorption coefficients that 
are, at least, 100 times smaller than those of * transitions, because these 
transitions are symmetry-forbidden (see section 3.2.). As a consequence, the radiative 
rate constant is much smaller than the non-radiative rate constant and the 
fluorescence quantum yields are low. 
 
 Substitution effects on aromatic hydrocarbons 
Generally, the presence of internal heavy atoms increase spin-orbit coupling (which 
has a Z4 dependence) and thus the probability of intersystem crossing, unless the 
fluorescence rate constant is much higher, or much smaller, than other de-excitation 
rate constants, or unless there is no triplet state energetically close to the singlet 
emitting state. 
 
 Electron-donating substituents (-OH, -OR, -NH2, -NHR1, -NR2)  
The presence of electron-donating substituents induce an increase in the molar 
absorption coefficient and the fluorescence quantum yield, as well as a bathochromic 
effect (red shift) in both absorption and fluorescence spectra, which become often 
broad and structureless, compared to the parent non-substituted compound15,16. This 
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can be explained by the significant intramolecular charge transfer due to the lone pairs 
of electrons on oxygen and/or nitrogen atoms, which are involved directly in - 
bonding with the aromatic system (that is why the * nature of the parent 
molecule transitions is not affected by the oxygen or nitrogen atom). This 
intramolecular charge transfer decreases the S0S1 energy transition, which explains 
the observed effects. If the aromatic amines or alcohols are planar, the observed 
effects are more intense than if the amino or the alcohol group is twisted out of the 
plane of the aromatic ring for steric reasons, because the degree of conjugation is 
decreased. 
Note that the absorption and fluorescence spectra of aromatic amines and alcohols 
are pH-dependent. 
 
 Electron-withdrawing substituents: carbonyl and nitro compounds 
The lone-pairs of electrons of carbonyl or nitro substituents are not directly involved in 
-bonding with the aromatic system. Thus, many aromatic compounds with carbonyl 
or nitro substituents have a low-lying n* excited state. As these transitions are 
symmetry-forbidden, such compounds are submitted to an efficient intersystem 
crossing process and exhibit low fluorescence quantum yields. 
Normally, the fluorescence of nitroaromatics is not even detectable and they are 
rather phosphorescent. In some cases, as the -NO2 group has a very strong electron-
withdrawing power, such compounds have a considerable charge-transfer character 
and the absence of fluorescence (and phosphorescence) is thus rather due to S1S0 
internal conversion than to S1 T1 intersystem crossing. 
In some cases (if the n* and * states are close in energy), aromatic carbonyl 
compounds can exhibit high fluorescence quantum yields. When the polarity and the 
hydrogen bonding power of the solvent increases, the n* state shifts to higher 
energy, whereas the * state shifts to lower energy. Therefore, intense 
fluorescence can be observed in polar solvents and weak fluorescence in non-polar 
solvents. 
Conformational changes of aromatic molecules with a carboxylic group can lead to 
different absorption and fluorescence spectra for the acidic (-COOH) and the basic       
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(-COO-) forms. Normally, the carboxylate group (-COO-) is almost perpendicular to the 
ring, so that the  aromatic system is only slightly perturbed. On the contrary, the 
carboxylic group is in a position close to the coplanarity of the ring. The resulting 
interaction induces an intramolecular charge-transfer character to the * 
transition, which leads to broad and structureless fluorescence bands. 
 
 Heterocyclic compounds 
Heterocyclic compounds have a heteroatom involved in the -system of electrons. For 
that reason, the low-lying transition is of n* type (symmetry-forbidden transition), 
which explains the low fluorescence quantum yields of such compounds.  
However, in protic solvents such as alcohols, hydrogen bonds can be formed between 
the heteroatoms and the solvent molecules. In this case, the n-orbitals are more 
stabilized than the * orbitals (the electron density on the heteroatom is reduced on 
the excited state) and there is an inversion of the n* and * states: the lowest-
lying transition becomes of * type. As a consequence, the spectra of these 
compounds exhibit a bathochromic effect and the fluorescence quantum yields are 
increased from non-polar to polar solvents. 
If the heteroatom is singly bonded to carbon atoms of the heterocycle, the transitions 
involving the non-bonding electrons have similar properties to those of * 
transitions. In fact, as the non-bonding orbital is perpendicular to the plane of the ring, 
the lone pair of electrons are involved in -bonding of the aromatic system by 
overlapping the -orbitals of the adjacent carbon atoms. 
 
5.5. Solvent and environmental effects on fluorescence emission spectra 
We saw that the principal cause of the Stokes shift is that, after absorption, the excess 
vibrational energy is rapidly lost to the solvent (section 4, scheme 4.3). Solvent polarity 
and the local environment have strong effects on the emission spectral properties of 
fluorophores and are another origin of the Stokes shift. These effects are complex and 
are due to several factors. Typically, more than one effect will simultaneously affect 
the fluorophore and it can be difficult to know which effect is dominant.  
At the simplest level, solvent-dependent emission spectra are interpreted in terms of 
the Lippert-Mataga equation (section 5.5.1.). These general solvent effects occur 
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whenever a fluorophore is dissolved in any solvent, and are independent of the 
chemical properties of the fluorophore and the solvent. However, this theory is often 
inadequate for explaining the detailed behavior of fluorophores in a variety of 
environments. For example, indole displays a structured emission spectrum in 
cyclohexane but, after addition of a small amount of the polar solvent ethanol (1 to 
5%), we note a loss of the structured emission and a spectral shift to higher 
wavelengths. As the amount of ethanol is too small to significantly change the solvent 
polarity, the observed effects are rather due to hydrogen bonding of ethanol to the 
imino nitrogen on the indole ring than to general solvent effects. In addition to such 
general and specific solvent effects (section 5.5.1.), solvent relaxation may be 
accompanied by internal rotation within the fluorophore, leading to a Twisted 
Intramolecular Charge Transfer (TICT), from which emission occurs (section 5.5.2.). 
Additionally, the quantum yield can be altered due to a conformational change in the 
fluorophore or due to a change in the rate of radiative or non-radiative decay (Sections 
5.5.3. and 5.5.4.). Finally, a fluorophore may display a large spectral shift due to 
excimer or exciplex formation (the fluorophore may be fluorescent or non-fluorescent 
in these different states, see section 5.5.5.). In summary, no single theory can be used 
for a quantitative interpretation of the effects of environment on fluorescence3. 
 
5.5.1. Effects of solvent polarity and viscosity 
The fluorescence emission spectra of many fluorophores, especially those containing 
polar substituents on the aromatic rings are sensitive to the polarity of their 
surrounding environment. As the excitation process induces the movement of an 
electron from one orbital to another, it is normally accompanied by an increase in the 
dipole moment of the fluorescent molecule. In other words, the fluorophore has a 
larger dipole moment in the excited state (μ*) than in the ground state (μ). If the 
molecule has both an electron-donating and an electron-withdrawing group, this 
increase can be quite large.  Thus, if the medium is sufficiently fluid, the solvent 
molecules rotate until the solvation shell is in equilibrium with the fluorophore (solvent 
relaxation) and a relaxed intramolecular charge transfer (ICT) state is reached. 
Normally, when we increase solvent polarity, this effect becomes larger and results in 
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Increasing polarity 
shifts (solvatochromic shifts) of the emission spectrum to longer wavelengths (red 
shifts) which are often, but not always, accompanied by decrease in the quantum yield 
of the fluorophore (Figures 4.12, 4.13 and scheme 4.5). As the emission of a 
fluorescence photon is quasi-instantaneous, the solute recovers its ground state dipole 
moment and a new relaxation process leads to the most stable initial configuration of 
the solute–solvent system in the ground state. Note that, if the medium is sufficiently 
fluid, the time required for the reorganization of solvent molecules around the solute 
is short comparatively to the excited-state lifetime and fluorescence will essentially be 
emitted from molecules in equilibrium with their solvation shell. Conversely, if the 
medium is too viscous to allow solvent molecules to reorganize, emission arises from a 
state close to the Franck–Condon state (F) (as in the case of a non-polar medium) and 
no shift of the fluorescence spectrum will be observed17.  
 
Scheme 4.5. Jablonski diagram for fluorescence with solvent relaxation
17
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13. Solvatochromic effects on fluorescence spectra. 
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One common use of solvent effects is to determine the polarity of the probe binding 
site on a macromolecule. This is accomplished by comparison of the emission spectra 
and/or quantum yields when the fluorophore is bound to the macromolecule or 
dissolved in solvents of different polarity.  
The observed shifts result from both the interactions of the dipole moment of the 
fluorophores with the reactive fields induced in the surrounding solvent (General 
Solvent Effects), and from the specific chemical interactions between the fluorophores 
and one or more solvent molecules (Specific Solvent Effects). General Solvent Effects 
(non-specific dielectric interactions) result from the refractive index (n) and the 
dielectric constant (), i.e. the physical constants which reflect the freedom of 
movement of the electrons in the solvent molecules and the dipole moment of these 
molecules. Specific solvent effects (specific interactions) refer to specific chemical 
interactions between the fluorophores and the solvent molecules, such as hydrogen 
bonding and complexation. General solvent effects are expected to always be present 
whereas specific solvent effects depend upon the chemical structures of the solvent 
and the fluorophore. Normally, general solvent effects lead to higher spectral shifts17.  
 
Polarity and solvatochromism 
Compounds are called solvatochromic when the location of their absorption (and 
emission) spectra depends on solvent polarity. A bathochromic (red) shift and a 
hypsochromic (blue) shift with increasing solvent polarity pertain to positive and 
negative solvatochromism, respectively. Such shifts of appropriate solvatochromic 
compounds in solvents of various polarities were used to construct several empirical 
polarity scales18,19. The * scale of Kamlet and Taft20 deserves special recognition 
because it has been successfully applied to the positions or intensities of maximal 
absorption in IR, NMR, ESR and UV–visible absorption and fluorescence spectra, and 
many other physical or chemical parameters (reaction rate, equilibrium constant, etc.). 
It is remarkable that the * scale has been established from the averaged spectral 
behavior of numerous solutes. It offers the distinct advantage of taking into account 
both non-specific and specific interactions3. 
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Table 4.3. Parameters of the * scale of polarity, where * is a measure of the polarity/polarizability 
effects of the solvent; the  scale is an index of solvent HBD (hydrogen bond donor) acidity and the  
scale is an index of solvent HBA (hydrogen bond acceptor) basicity
3
. 
Solvent *   
Cyclohexane  0.00 0.00 0.00 
n-Hexane, n-heptane -0.08 0.00 0.00 
Benzene  0.59 0.10 0.00 
Toluene  0.54 0.11 0.00 
Dioxane  0.55 0.00 0.37 
Tetrahydrofuran  0.58 0.00 0.55 
Acetone  0.71 0.08 0.48 
Carbon tetrachloride  0.28 0.00 0.00 
1,2-Dichloroethane  0.81 0.00 0.00 
Diethyl ether 0.27 0.00 0.47 
Ethyl acetate  0.55 0.00 0.45 
Dimethylsulfoxide  1.00 0.00 0.76 
N,N-Dimethylformamide  0.88 0.00 0.69 
Acetonitrile  0.75 0.19 0.31 
Ethanol  0.54 0.83 0.77 
Methanol  0.60 0.93 0.62 
n-Butanol  0.47 0.79 0.88 
Trifluoroethanol  0.73 1.51 0.00 
Ethylene glycol  0.92 0.90 0.52 
Water  1.09 1.17 0.18 
 
 
General Solvent Effects on fluorescence spectra: the Lippert-Mataga equation 
A variety of equations have been proposed to describe the effects of the physical 
properties of solvents on emission spectra. In these equations, the solvent is 
considered as a continuum in which the fluorophore is contained. This simplifying 
assumption limits the applicability of the equations since specific fluorophore-solvent 
interactions which can have substantial effects upon the emission spectra are not 
considered. Nevertheless, as the general solvent effects are always present, a 
quantitative prediction of these effects provides a framework within which one can 
analize the experimental data. The most widely used expression was previously 
presented by Lippert and others21-23. As the interactions between the solvent and 
fluorophore molecules affect the energy difference between the ground and the 
excited state, the Lippert-Mataga equation represents this energy difference: 
         
 
  ε 
 
 
  
  
ε   
 ε +  
 
    
   +  
 
       
  
+     s                            
Chapter 4 – Molecular Fluorescence Spectroscopy 
__________________________________________________________________________________________________________  
 
122 
 
where     and     are the wavenumbers of the absorption and emission, respectively 
(thus, the difference        represents the energy difference between the ground 
and the excited state); ε  is the vacuum permittivity; h is the Planck’s constant; c is the 
speed of light; R is the radius of the cavity in which the fluorophore resides 
(considering the fluorophore a point dipole at the center of a spherical cavity 
immersed in the homogeneous solvent); *– is the difference in the dipole moment 
of solute molecule between excited (*) and ground () states. 
The term in brackets is called the orientation polarizability ( f). Then, the Lippert-
Mataga equation can be written3 
         
 
  ε 
 
 
  
             +     s                                         
 f ranges from -0.001 in cyclohexane to 0.320 in water (Table 4.4). 
This equation is only an approximation but there is a reasonable correlation between 
the observed and calculated energy losses in nonprotic solvents (those not having 
hydroxyl groups or other groups capable of hydrogen bonding). In this case, a linear 
behaviour is observed which allows us to determine the increase in dipole moment 
 =*-, provided that a correct estimation of the cavity radius is possible. 
This sensitivity of the Stokes shift to solvent polarity is the reason why fluorescence 
emission spectra are frequently used to estimate the polarity of the environment 
surrounding the fluorophore. 
Table 4.4. Dielectric constant (at 20ºC), refractive index (at 20ºC) and orientational polarizability  f of 
some solvents
3
. 
Solvent       f 
Cyclohexane  2.023 1.4266 -0.001 
Benzene  2.284 1.5011 0.003 
Toluene  2.379 1.4961 0.013 
Dioxan  2.218 1.4224 0.021 
Chloroform  4.806 1.4459 0.149 
Diethyl ether  4.335 1.3526 0.167 
Butyl acetate  5.01 1.3941 0.171 
Dichloromethane  9.08 1.4242 0.219 
Dimethylsulfoxide  48.9 1.4770 0.265 
N,N-Dimethylformamide  37.6 1.4305 0.275 
Acetonitrile  38.8 1.3442 0.306 
Ethanol  25.07 1.3611 0.290 
Methanol  33.62 1.3288 0.309 
Water2 80.10 1.3330 0.320 
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Note that the Lippert-Mataga equation only considers the absolute magnitude of the 
charge transfer dipole moment  =*- and not the angle between the dipoles. 
Bakhshiev argued that the general solvent effects must also depend upon the angle 
between the ground and excited state dipole moments of the fluorophore and have 
presented an alternative expression to the Lippert-Mataga equation24,25. However, as 
other specific interactions between the solvent and the fluorophore result in 
substantial spectral shifts and are not conveniently accounted for within the 
framework of the existing theories, the use of the simplest conceptual model for 
general solvent effects seems justified. This simple theory is useful for interpreting 
experimental data and to evaluate the presence/importance of specific solvent effects. 
As the Lippert-Mataga equation describes the Stokes shift expected for a given 
fluorophore in media of varying polarity, it has two main applications: 
- The sensitivity of a fluorophore to solvent polarity is expected to be 
proportional to (*-)2. Once this term is constant for a given fluorophore, we 
can prepare calibration curves for (       ) versus  f. Then, if the fluorophore 
is placed in an unknown environment, the polarity of this environment can be 
estimated from (      ). An ideal polarity probe based on photoinduced 
charge transfer and solvent relaxation should (i) undergo a large change in dipole 
moment upon excitation but without change in direction; (ii) bear no permanent 
charge in order to avoid contributions from ionic interactions; (iii) be soluble in 
solvents of various polarities, from the apolar solvents to the most polar ones. 
- The sensitivity of the Stokes shift to  f can be used to estimate the change in 
dipole moment which occurs upon excitation. For that, we can trace a Lippert-
Mataga plot, which is a plot of (      ) versus the orientational polarizability, 
 f, and evaluate the change in dipole moment   assuming the molecular radius 
as the cavity radius. Fluorophores which have the largest changes in dipole 
moment upon excitation are more sensitive to solvent polarity. As an example, 
Lippert-Mataga plots for two naphtylamine derivatives are shown in Figure 4.14. 
The N-phenyl-N-methyl derivative is clearly more sensitive to solvent polarity 
than the unsubstituted derivative12. 
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Figure 4.14. Lippert-Mataga plots for N-phenyl-N-methyl-2-aminonaphthalene-6-sulfonate (ο) and 2-
aminonaphthalene-6-sulfonate (). Adapted from ref. 26.  
 
Specific Solvent Effects on fluorescence spectra 
General solvent effects are approximately described by the Lippert-Mataga equation 
and represent the collective influence of the entire set of surrounding solvent 
molecules on the fluorophore. In contrast, specific interactions are produced by one or 
a few neighboring molecules, and are determined by the specific chemical properties 
of both fluorophores and solvent27,28. Specific effects can be due, for example, to 
hydrogen bonding, acid-base equilibrium, or charge transfer interactions and they can 
lead to substantial shifts. 
Specific solvent effects can be identified by examining either emission spectra in a 
variety of solvents, or the Lippert-Mataga plots. When a substantial red shift of the 
emission spectrum of a fluorophore in a non-polar solvent is observed for the addition 
of a small percentage of a polar solvent, it can indicate that the observed shift is due to 
specific solvent effects. For example, the emission spectrum of 2-acetylanthracene (2-
AA) in hexane shifted gradually as the percentage of dioxane was increased to 100%. 
These shifts are probably a result of general solvent effects. In contrast, most of the 
shift expected for methanol, together with a loss of structured emission, was produced 
by only about 1-2% methanol. This amount of alcohol is too small to affect the 
refractive index or dielectric constant of the solvent, and hence this shift is a result of 
specific solvent effects (Figures 4.15 and 4.16)17. 
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Figure 4.15. Fluorescence spectra of 2-acetylanthracene in methanol–hexane mixtures at 20°C
17
. 
Concentrations of methanol in mol dm–3: (0) 0, (1) 0.03, (2) 0.05, (3) 0.075, (4) 0.12, (5) 0.2, and (6) 0.34.  
1 kK=1000 cm–1. 
 
 
Figure 4.16. Effect of solvent composition on the emission maximum of 2-acetylanthracene (1 kK=1000 
cm
–1
)
17
. 
 
Specific solvent–fluorophore interactions can occur in either the ground state or the 
excited state. If the interaction only occurred in the excited state, then the polar 
additive would not affect the absorption spectra. If the interaction occurs in the 
ground state, then some change in the absorption spectrum is expected.  
In the case of n-* transitions, the electronic density on a heteroatom like nitrogen 
decreases upon excitation and these transitions have a charge transfer character 
illustrated by an increase of the dipole moment with respect to the ground state dipole 
moment. It can be explained by the fact that the electron is removed from the 
heteroatom and goes to an * orbital localized half on the heteroatom, half on a 
Chapter 4 – Molecular Fluorescence Spectroscopy 
__________________________________________________________________________________________________________  
 
126 
 
carbon atom. This results in a decrease in the capability of this heteroatom to form 
hydrogen bonds. The resulting effect is a blue-shift of the absorption spectrum (the 
higher the strength of hydrogen bonding, the larger the shift). This criterion is 
convenient for assigning a n-* band and the spectral shift can be used to determine 
the energy of the hydrogen bond. The fluorescence emitted from a n-* singlet state 
will be always less sensitive to the ability of the solvent to form hydrogen bonds than 
absorption because, as n-* excitation of a heterocycle containing nitrogen (e.g. in 
solution in methanol) causes hydrogen bond breaking (e.g. N...HOCH3), the 
fluorescence spectrum will only be slightly affected by the ability of the solvent to form 
hydrogen bonds (emission arises from an n-* state without hydrogen bonds). 
In the case of -* transitions, it is often observed that the heteroatom of a 
heterocycle (e.g. N) is more basic in the excited state than in the ground state. The 
resulting excited molecule can thus be hydrogen bonded more strongly than the 
ground state. -* fluorescence is thus more sensitive to hydrogen bonding than -* 
absorption3. 
Attention must be paid to the emission spectrum of a fluorophore bound to a 
macromolecule. For example, a molecule like 2-acetylanthracene, when bound in a 
hydrophobic site on a protein, may display an emission spectrum comparable to that 
seen in water if only a single water molecule is near the carbonyl group. 
Evidence of specific solvent effects can also be seen in the Lippert-Mataga plots. For 
example, the Stokes shifts observed for methyl 8-(2-anthroyl) octanoate (a 2-AA 
derivative) in hydrogen bonding solvents (water, methanol and ethanol) are much 
larger than that observed in solvents that less readily form hydrogen bonds (Figure 
4.17). 
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Figure 4.17. Stokes shifts of methyl 8-(2-anthroyl) octanoate in organic solvents and water. The solvents 
are benzene (B), n-hexane (H), diethyl ether (DEE), ethyl acetate (EA), acetone (Ac), N,N-
dimethylformamide (DMF), chloroform (Ch), dimethyl sulfoxide (DMSO), ethanol (EA), methanol (Me), 
and water (W)
17
. 
 
The presence of specific solvent effects can be problematic because these effects can 
prevent a quantitative interpretation of the emission spectra in terms of the 
orientation polarizability of the macromolecule. On the other hand, the presence of 
specific solvent effects can be favorable because they could reveal the accessibility of 
the macromolecule-bound probe to the aqueous phase.  
An understanding of specific and general solvent effects can provide a basis for 
interpreting the emission spectra of fluorophores that are bound to macromolecules. 
For instance, the emission spectra of 2-anilinonaphthalene (2-AN) bound to 
membranes composed of dimyristoyl-L--phosphatidylcholine (DMPC) is considerably 
red shifted relative to the emission in cyclohexane, but it is blue shifted relative to 
water (Figure 4.18)17. 
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Figure 4.18. Normalized fluorescence emission spectra of 2-anilinonaphthalene in solvents and bound to 
vesicles of dimyristoyl-L-α-phosphatidylcholine (DMPC). The dashed line indicates the spectrum in 
cyclohexane (CH), which contains 3% ethanol
17
. 
 
As 2-AN is highly sensitive to small concentrations of ethanol, it seems likely that 
cyclohexane containing more than 3% ethanol is the preferable reference solvent for a 
low polarity environment (in this solvent the specific effects are saturated). With this 
adjustment in mind, one may conclude that the environment in which the 2-AN is 
localized is mostly nonpolar, but that this site is accessible to water. Without 
consideration of specific solvent effects one might conclude that the 2-AN is in a more 
polar environment. 
 
Temperature effects (solvent viscosity effects) 
At low temperatures the solvent can become more viscous, and the time for solvent 
reorientation increases. Upon excitation, the fluorophore is assumed to be initially in 
the Franck-Condon state (F). Solvent relaxation proceeds with a rate kS. If this rate is 
much slower than the decay rate (1/), then one expects to observe the emission 
spectrum of the unrelaxed F state. If solvent relaxation is much faster than the 
emission rate (kS >> 1/), then emission from the relaxed state (R) will be observed. 
At intermediate temperatures, where kS  1/, emission and relaxation will occur 
simultaneously. Under these conditions, an intermediate emission spectrum will be 
observed (Scheme 4.6). Frequently, this intermediate spectrum (– – –) is broader on 
the wavelength scale because of contributions from both the F and R states. 
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Scheme 4.6. Jablonski diagram and respective emission spectra for solvent relaxation
17
. 
 
Normally, internal rotations favor non-radiative de-excitation processes. That is the 
reason why rigid compounds are more fluorescent than similar compounds which can 
suffer internal rotations (e.g. phenolphthalein versus fluorescein). For the same 
reasons, when the temperature decreases, the environment become more rigid 
(because the solvent viscosity increases), the fluorophore suffers less internal rotations 
and, consequently, the fluorescence quantum yield increases. 
 
5.5.2. Compounds submitted to photoinduced Intramolecular Charge Transfer 
(ICT) and internal rotation 
Solvent relaxation may be accompanied by internal rotation within the fluorophore, 
leading to a Twisted Intramolecular Charge Transfer (TICT) state. Thus, highly 
conjugated planar molecules can sometimes completely loss the conjugation. In this 
case, there is a total charge separation and two bands can be observed in the 
fluorescence spectrum of the fluorophore in polar non-viscous solvents: one 
corresponding to the emission from the Franck Condon state and one to the emission 
from the TICT state (at higher wavelengths). Attention may be paid to the fact that 
internal rotation accompanying solvent relaxation or not can occur in many 
fluorophores, but dual fluorescence and right angle twist (required for full charge 
separation) are exceptional. Note that intramolecular charge transfer and internal 
rotation can also occur in non-polar and highly symmetric molecules3. 
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5.5.3. Changes in the non-radiative decay rates 
Increases in quantum yield are frequently observed when fluorophores bind to 
biomolecules. These changes are due to solvent or environmental effects, but these 
changes are not explained by the Lippert equation. It seems reasonable to suggest that 
changes in quantum yield are due to changes in the rates of non-radiative decay (kNR). 
One example for such a process is Coumarin-151. Figure 4.19 shows the Stokes shift 
and the quantum yields for Coumarin-151 in several solvents. The Stokes shift 
increases in a stepwise manner upon addition of the polar solvent dioxane, even 
though the value of  f is almost unchanged. The quantum yield is low in nonpolar 
solvents and also increases stepwise when the solvent contains a polar additive. Since 
the excitation coefficient and radiative decay rates are usually not very sensitive to 
solvent polarity, the decrease in quantum yield suggests an increase in kNR in nonpolar 
solvents17.  
 
Figure 4.19. Stokes shifts and quantum yields for Coumarin-151 in various solvents. 2-MP, 2-
methylpentane; M70D30, 70% 2-MP and 30% dioxane (D); M60EA40, 60%, 2-MP and 40% EA, ethyl acetate; 
MeOH, methanol
29
. 
 
 
This fact can be explained by a polarity-induced inversion of n-* and -* states3. A 
change in the ability of a solvent to form hydrogen bonds can affect the nature (n–* 
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vs –*) of the lowest singlet state. Some aromatic carbonyl compounds often have 
low-lying, closely spaced –* and n–* states (see section 5.4.). Inversion of these 
two states can be observed when the polarity and the hydrogen-bonding power of the 
solvent increases, because the n–* state shifts to higher energy whereas the –* 
state shifts to lower energy. This results in an increase in fluorescence quantum yield 
because radiative emission from n–* states is known to be less efficient than from –
* states. The other consequence is a red-shift of the fluorescence spectrum (Scheme 
4.7). 
 
Scheme 4.7. The effects of polarity-induced inversion of n-* and -* states
3
. 
 
 
5.5.4. Changes in the radiative decay rates 
In the previous example, the quantum yield of Coumarin-151 decreases in low polarity 
solvents. A more typical situation is an increase in quantum yield in low-polarity 
solvents. This behavior can be explained by the formation of an ICT state. In low 
polarity solvents, emission arises from the Franck-Condon -* state which is lower in 
energy. In high polarity solvents, the ICT state is stabilized by interaction with the 
solvent and thus becomes the emitting species. Thus, we can observe a redshift and, as 
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hydrogen bonds favor intersystem crossing, the radiative decay rates decrease as well 
as the fluorescence quantum yields, when the solvents polarity increases17. 
 
5.5.5. Probe-probe interactions 
In addition to interacting with solvents, fluorophores can interact with each other. One 
example is excimer formation due to an excited-state complex of two identical 
fluorophores. Excimer formation is a short-range interaction that requires molecular 
contact between the fluorophores. Excimer formation has found some utility in 
biotechnology, to detect, for example, an insertion mutation in DNA30,31: a probe DNA 
with a insertion mutant sequence can prevent a non-fluorescent compound from 
intercalating into the double helix, resulting in the formation of an excimer out of the 
double helix that exhibits fluorescence.  Another use of excimer formation is to follow 
self-assembly processes32 in which, according to the extent of the self-association, the 
fluorescence spectrum suffers spectral shifts. 
 
5.6. Resolution of Fluorescence spectra 
The width of a band in the emission (and/or the absorption) spectrum of a fluorophore 
is the result of two effects: homogeneous and inhomogeneous broadening. 
Homogeneous broadening is due to the existence of a continuous set of vibrational 
levels. Thus, at room temperature, most emission (and absorption) spectra of 
moderately large and rigid fluorophores in solution are almost structureless. 
Inhomogeneous broadening is due to the fluctuations in the structure of the solvation 
shell surrounding the fluorophore. The distribution of solute-solvent configurations 
leads to a distribution of the energies of the electronic transitions. Normally, the 
extent of inhomogeneous broadening is larger than that of homogeneous broadening, 
but there are several ways to reduce these effects like using solid matrices at low 
temperatures, or using laser excitation (whose linewidth is reduced) which allows 
exciting individual compounds in complex mixtures33,34. 
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6.  Quenching of fluorescence 
Fluorescence quenching refers to any process that decreases the fluorescence intensity 
of a sample. A variety of photophysical processes can result in quenching. Most of 
them involve interaction of an excited molecule M* with another molecule Q, as 
shown in Scheme 4.8. kM is the sum of the rate constants of the intrinsic pathways 
(radiative and non-radiative) of de-excitation and is the reciprocal of the excited-state 
lifetime   (equation 4.22); kq represents the observed rate constant for the 
bimolecular process3. 
 
Scheme 4.8. Interaction of an excited molecule M* and another molecule Q and respective rate 
constants
3
. 
 
These intermolecular photophysical processes responsible for de-excitation of 
molecules compete with the intrinsic de-excitation and affect the fluorescence 
characteristics (fluorescence intensity, decay time and/or fluorescence quantum yield) 
of M*: 
(i) After excitation by a light pulse, the excited-state M* population, and consequently 
the fluorescence intensity, decrease more rapidly than in the absence of excited-state 
interaction with Q, because quenching is an additional rate process that depopulates 
the excited state. 
(ii) For the same reasons, in the case of dynamic quenching (section 6.2.) the excited-
state lifetime is decreased. However, in the case of static quenching (see section 6.3.) 
the lifetime is not decreased because only the fluorescent molecules are observed, and 
the uncomplex fluorophores have the unquenched lifetime . 
(iii) The fluorescence quantum yield is decreased because quenching depopulates the 
excited state without fluorescence emission. The loss of fluorescence intensity is called 
fluorescence quenching whatever the nature of the competing intermolecular process 
and even if this process leads to a fluorescent species (the word quenching applies 
only to the initially excited molecule)3. 
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The processes responsible for quenching include electron transfer, energy transfer, 
excimer or exciplex formation (in these cases, we talk about dynamic quenching or 
collisional quenching), and the formation of a non-fluorescent ground-state complex 
(static quenching). Intramolecular excited-state processes (intramolecular charge 
transfer, internal rotation, intramolecular proton transfer, etc.) and photochemical de-
excitation (i.e. de-excitation resulting from organic photochemical reactions implying 
bond breaking and formation of new bonds, so that the ground state of M is not 
recovered) can also affect the fluorescence characteristics (we talked about some of 
these effects in section 5.5.). 
There are numerous applications of quenching measurements. For example, 
quenching measurements can reveal the accessibility of fluorophores to quenchers. An 
example is a fluorophore bound to a protein or in a membrane. If the protein or 
membrane is impermeable to the quencher, and the fluorophore is located in the 
interior of the macromolecule/aggregate, then neither collisional nor static quenching 
can occur. For this reason, quenching studies can be used to reveal the localization of 
fluorophores in proteins and membranes, and their permeabilities to quenchers17. 
 
6.1. Quenchers of fluorescence 
There is a large variety of substances which act as quenchers. One of the best-known 
collisional quenchers is molecular oxygen which quenches almost all known 
fluorophores. The mechanism by which oxygen quenches has been a subject of 
debate35. The most likely mechanism is that the paramagnetic oxygen causes the 
fluorophore to undergo intersystem crossing to the triplet state. Under atmospheric 
pressure, the concentration of oxygen in most solvents is 10-3–10-4 mol L-1. For that 
reason, it is frequently necessary to remove dissolved oxygen by bubbling the solutions 
with nitrogen or argon for example, in order to obtain reliable measurements of the 
fluorescence quantum yields or lifetimes.  
Aromatic and aliphatic amines are also efficient quenchers of most unsubstituted 
aromatic hydrocarbons36. Another type of quenching is due to heavy atoms such as 
iodide and bromide. Quenching by these larger halogens may be a result of 
intersystem crossing to an excited triplet state, promoted by spin–orbit coupling of the 
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excited (singlet) fluorophore and the halogen37. There is a large variety of other 
quenchers and we can identify fluorophore–quencher combinations for a desired 
purpose. It is important to note that not all fluorophores are quenched by all the 
substances identified as “quenchers”. This fact occasionally allows selective quenching 
of a given fluorophore. The occurrence of quenching depends upon the mechanism, 
which in turn depends upon the chemical properties of the individual molecules. An 
overview of some possible quenchers for typical fluorophores can be found in 
reference 17. 
 
6.2. Collisional quenching (dynamic quenching) 
Collisional quenching of fluorescence results from diffusive encounters between the 
fluorophore and quencher during the lifetime of the excited state (diffusion-controlled 
process, scheme 4.9). This is a time-dependent process because the excited 
fluorophores, M*, that are at a short distance from a quencher, Q, at the time of 
excitation react, on average, at shorter times than those that are more distant, 
because mutual approach requires a longer time before reaction occurs. 
 
 
 
 
 
Scheme 4.9. Illustration of dynamic quenching. 
 
As a first approach, the experimental quenching rate constant, kq, is assumed to be 
time-independent. In this case, collisional quenching is described by the Stern-Volmer 
equation17: 
  
 
 
  
 
  +          +                                              
 
where    and  are the fluorescence quantum yields in the absence and presence of 
quencher, respectively; I0 and I are the fluorescence intensities in the absence and 
presence of quencher, respectively; 0 is the lifetime of the fluorophore in the absence 
of quencher; [Q] is the concentration of quencher; KSV = kq0  is the Stern–Volmer 
constant. kq is the bimolecular quenching constant which reflects the efficiency of 
quenching or the accessibility of the fluorophores to the quencher. Diffusion-
M* + Q  M*Q 
M + Q 
 
h 
Non- fluorescent 
h 
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controlled quenching typically results in values of kq near 1010 M
–1 s–1. Values of kq 
smaller than the diffusion-controlled value can result from steric shielding of the 
fluorophore or a low quenching efficiency. Apparent values of kq larger than the 
diffusion-controlled limit usually indicate some type of binding interaction. 
The meaning of the bimolecular quenching constant can be understood in terms of the 
collisional frequency between freely diffusing molecules. The collisional frequency (Z) 
of a fluorophore with a quencher is given by  
Z = k0 [Q] 
where k0 is the diffusion-controlled bimolecular rate constant. This constant may be 
calculated using the Smoluchowski equation which describes the diffusive flux of a 
molecule with a diffusion coefficient D through the surface of a sphere of radius R17: 
   
    
    
    
    
    
    +       +                                    
where R is the collision radius (generally, it is assumed to be the sum of the molecular 
radii of the fluorophore Rf and quencher Rq); D is the sum of the diffusion coefficients 
of the fluorophore Df and quencher Dq; NA is Avogadro's number (the term NA/1000 
converts molarity to molecules/cm3).  
The collisional frequency is related to the bimolecular quenching constant by the 
quenching efficiency, fQ: 
kq = fQ k0                                                               (4.40) 
For example, if fQ=0.5, then 50% of the collisional encounters are effective in 
quenching and kq will be half the diffusion-controlled value, k0. Since k0 can be 
estimated with moderate precision, the observed value of kq can be used to judge the 
efficiency of quenching. Quenchers like oxygen, acrylamide, and iodide ion generally 
have efficiencies near unity, but the quenching efficiency of weak quenchers like 
succinimide depends on the solvent and/or viscosity. The efficiency of quenching can 
be calculated from the observed value of kq, if the diffusion coefficients and molecular 
radii are known. The radii can be obtained from molecular models, or from the 
molecular weights and densities of the quencher in question. Diffusion coefficients 
may be obtained from the Stokes-Einstein equation: 
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where k is Boltzmann's constant, T is the absolute temperature,   is the solvent 
viscosity, and R is the molecular radius. Frequently, the Stokes-Einstein equation 
underestimates the diffusion coefficients of small molecules (this equation describes 
the diffusion of molecules that are larger than the solvent molecules). As an alternative 
method, diffusion coefficients can be obtained from nomograms based upon the 
physical properties of the system38. Once the diffusion coefficients are known, the 
bimolecular quenching constant for fQ=1 can be predicted using Smoluchowski 
equation (equation 4.39).  
Generally, the ratio  
  
 
  is plotted against the quencher concentration (Stern–Volmer 
plot). If the variation is found to be linear, the slope gives the Stern–Volmer constant. 
Then, kq can be calculated if the excited-state lifetime in the absence of quencher is 
known. A linear Stern-Volmer plot is generally indicative of a single class of 
fluorophores, all equally accessible to quencher. If two fluorophore populations are 
present, and one class is not accessible to quencher, then the Stern-Volmer plots 
deviate from linearity toward the x-axis. As an example, when we study the interaction 
of a compound with DNA, a fraction of compound molecules can intercalate between 
DNA base pairs. In this case, the Stern-Volmer plot generally exhibits a downward 
curvature because the fraction of intercalated molecules is not accessible to the 
quencher. Then, the modified Stern-Volmer plot allows the determination of the 
fraction of compound molecules accessible to the quencher, 
  
  
   
 
  
 +  
 
        
                                                           
where I0 and I are the fluorescence intensities in the absence and in the presence of 
quencher, respectively;     = I0  I; fa is the fraction of molecules accessible to the 
quencher; KSV is the Stern-Volmer constant; and [Q] is the quencher concentration. 
Attention must be paid to the fact that the observation of a linear Stern-Volmer do not 
necessarily imply that collisional quenching of fluorescence has occurred because 
static quenching also results in linear Stern-Volmer plots17.  
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6.3. Static quenching  
Static quenching occurs as a result of the existence of a sphere of effective quenching 
or as a result of the formation of a non-fluorescent ground-state complex between the 
fluorophore and quencher.  
 
 
 Sphere of effective quenching 
In the case of viscous media or rigid matrices, M* and Q cannot change their positions 
in space relative to one another during the excited-state lifetime of M*. Perrin 
proposed a model for that cases, in which quenching of a fluorophore is assumed to be 
complete if a quencher molecule Q is located inside a sphere (sphere of effective 
quenching, active sphere or quenching sphere) of volume Vq surrounding the 
fluorophore M. If a quencher is outside the quenching sphere, it has no effect on M 
(Figure 4.20)3. 
 
Figure 4.20. Sphere of effective quenching
3
.  
 
Therefore, the fluorescence intensity of the solution is decreased by addition of Q, but 
the fluorescence decay after pulse excitation is unaffected: 
  
 
                                                                   
where I0 and I are the fluorescence intensities in the absence and presence of 
quencher, respectively; Vq is the volume of the quenching sphere;    is the Avogadro’s 
number and [Q] is the concentration of quencher. 
In contrast to the Stern–Volmer equation, the ratio  
  
 
  is not linear and shows an 
upward curvature at high quencher concentrations. At low concentrations, 
              +        , so that the concentration dependence is almost linear 
and a plot of  
  
 
 versus [Q] yields Vq. The values of VqNA are often found to be in the 
range of 1–3 Lmol-1. This corresponds to a quenching sphere radius of about 10Å, 
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which is somewhat larger than the Van der Waals contact distance between M and 
Q17. 
 
 Formation of a ground-state non-fluorescent complex 
Static quenching can also occur from the formation of non-fluorescent ground-state 
complex. When this complex absorbs light it immediately returns to the ground state 
without emission of a photon (Scheme 4.10).  
 
 
 
 
 
Scheme 4.10. Illustration of static quenching by formation of a ground-state non-fluorescent complex. 
 
The association constant for the complex formation is given by: 
   
       
      
                                                                     
where [MQ] is the concentration of the complex, [M] is the concentration of 
uncomplexed fluorophore, and [Q] is the concentration of quencher. 
As the total concentration of fluorophore, [M]0, is given by 
[M]0 = [M] + [MQ]                                                        (4.45) 
substitution into equation 4.44 leads to  
   
        
      
 
    
      
 
 
   
                                                   
The fraction of uncomplexed fluorophores is thus 
   
    
 
 
 +      
                                                                
Considering that the fluorescence intensities are proportional to the concentrations 
(which is valid only in dilute solutions), this relationship can be rewritten as 
  
 
  +                                                                        
Note that this relation is linear, as in the case of the Stern-Volmer plot for dynamic 
quenching, except that the quenching constant is now the association constant. 
 
 
(MQ)* 
M + Q  MQ 
 
h 
Non  fluorescent 
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6.4. How to distinguish between dynamic and static quenching 
The value of KS can sometimes be used to demonstrate that dynamic quenching 
cannot account for the decrease in intensity. However, the measurement of 
fluorescence lifetimes is the most definitive method to distinguish static and dynamic 
quenching. Static quenching removes a fraction of the fluorophores from observation. 
The complexed fluorophores are nonfluorescent, and the only observed fluorescence 
is from the uncomplexed fluorophores. The uncomplexed fraction, and thus, the 
lifetime 0 are unperturbed. Therefore, for static quenching 
  
 
 = 1 whereas for dynamic 
quenching  
  
 
 
  
 
 . 
Static and dynamic quenching can also be distinguished by their differing dependence 
on temperature and viscosity. Higher temperatures result in faster diffusion and in the 
dissociation of weakly bound complexes. Consequently, there are larger amounts of 
collisional quenching and smaller amounts of static quenching. 
One additional method to distinguish between static and dynamic quenching is by 
careful examination of the absorption spectra of the fluorophore. Collisional 
quenching only affects the excited states of the fluorophores, and thus no changes in 
the absorption spectra are expected. In contrast, static quenching as a result of the 
formation of a ground-state non-fluorescent complex will frequently result in 
perturbation of the absorption spectrum of the fluorophore. Attention must be paid to 
the fact that, at low concentrations, the absence of changes on the absorption 
spectrum and a linear variation of 
  
 
 can lead to confusion between dynamic 
quenching and static quenching as a result of the existence of a quenching sphere 
(Figure 4.21)17. 
 
 
 
 
 
 
 
 
Figure 4.21. Comparison between dynamic and static quenching (adapted from ref. 17). 
  
No changes on absorption spectrum   Changes on absorption spectrum 
       (for complex formation) 
Collisional quenching             Static quenching 
Slope=KSV = kq0   
Slope=VqNA  for quenching 
sphere 
 at low cocentration   
Slope=KS for complex formation 
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6.5. Simultaneous dynamic and static quenching 
In many cases, the fluorophore can be quenched both by collisions and by complex 
formation or by a quenching sphere, with the same quencher. The characteristic 
feature of the Stern-Volmer plots in such circumstances is an upward curvature, 
concave towards the y-axis.  
Let us consider first the case of static quenching by formation of a non-fluorescent 
complex. The ratio  
  
 
  obtained for dynamic quenching must be multiplied by the 
fraction of fluorescent molecules (i.e. uncomplexed)17: 
 
  
  
 
  
 
   
  
   
    
                                                        
Replacing  
 
  
 
   
 by 
 
        
 (from the Stern-Volmer equation, equation 4.38) and 
   
    
  
by 
 
       
 (static quenching by formation of a non-fluorescent complex, equation 
4.47):  
  
 
   +          +                                                        
This modified form of the Stern-Volmer equation is second order in [Q], which 
accounts for the upward curvature observed when both static and dynamic quenching 
occur for the same fluorophore (Figure 4.22, left). 
 
 
 
 
 
 
 
 
Figure 4.22. Simultaneous dynamic and static quenching by formation of a non-fluorescent complex
17
. 
 
The dynamic portion of the observed quenching can be determined by lifetime 
measurements. That is, 
  
 
  +        (the dashed line in Figure 4.22, left). If 
lifetime measurements are not available, then the last equation can be modified to 
allow a graphical separation of KS and KSV. Multiplication of the terms in parentheses 
yields 
 
KSV + KS 
Slope = KSV KS 
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  +     +       +         
   
  
 
  +         
         
  
 
   
 
   
     +    +                                      
The apparent quenching constant is calculated at each quencher concentration. A plot 
of  
  
 
   
 
   
      versus [Q] yields a straight line with an intercept of KSV + KS and 
a slope of KSVKS  (Figure 4.22, right). The individual values can also be obtained from 
the two solutions of the quadratic equation below.  
In the case of the sphere of effective quenching model, the ratio  
  
 
  obtained for 
dynamic quenching must be multiplied by the ratio  
  
 
  obtained for static quenching by 
a quenching sphere17: 
 
  
  
 
  
 
   
   
 
  
 
    
                                                      
Replacing  
 
  
 
   
 by 
 
        
 (from the Stern-Volmer equation, equation 4.38) and 
 
 
  
 
    
 by                for high concentrations or by 1 +          for low 
concentrations (static quenching by a quenching sphere, equation 4.43) we obtain  
  
 
   +                                                                  
for high concentrations (upward curvature)  
or            
  
 
   +           +                                                        
for low concentrations (upward curvature) 
But if we plot 
  
 
   versus [Q] we obtain a straight line with an intercept of                 
KSV +      and a slope of KSV    . 
 
6.6. Some applications of quenching 
The extent of quenching can be affected by steric shielding and charge. Thus, 
protection against quenching is frequently observed for probes bound to 
macromolecules39,40 and even cyclodextrins41. Furthermore, charge effects are 
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generally present with charged quenchers such as iodide, and absent with neutral 
quenchers like oxygen and acrylamide. 
The most dramatic effects of charge and shielding on quenching have been observed 
for fluorophores bound to DNA. The extent of quenching is decreased by intercalation 
of probes into the DNA double helix. For instance, ethidium bromide (EB) bound to 
DNA was found to be protected from oxygen quenching by a factor of 30 as compared 
to EB in solution42. Given the high negative charge density of DNA, one can expect the 
quenching to be sensitive to the charge of the quencher, the ionic strength of the 
solution, and the rate of quencher diffusion near the DNA helix43,44.  
The extent of quenching can also be affected by the charge on the quenchers. For 
instance, Hoechst 33258 is readily quenched by iodide when free in solution, but is not 
quenched when bound to DNA. Apparently, the negative charges on DNA prevent 
iodide from coming into contact with Hoechst 33258 when bound to DNA45.  
As the occurrence of intercalation with DNA is one of the fundamental steps for 
antitumoral activity46, fluorescent quenching experiments with external quenchers are 
of major importance, in order to determine the DNA binding modes47 of new potential 
antitumoral compounds.  
 
6.7. Experimental considerations in quenching 
When performing quenching experiments, several problems can appear: 
 We should examine emission spectra under conditions of maximum quenching. 
In these conditions (low fluorescence intensity), the contribution from 
background fluorescence may begin to be significant. 
 Quenchers are often used at high concentrations, and the quenchers 
themselves may contain fluorescent impurities. 
 The intensity of the Raman and Rayleigh scattering peaks from solvent is 
independent of quencher concentration. Hence, the relative contribution of 
scattered light always increases with quenching. 
 The absorption spectra of the quenchers must be taken into consideration. For 
example, iodide and acrylamide absorb light below 290 nm. In this case, the 
inner filter effect due to absorption can decrease the apparent fluorescence 
intensity, causing distortion on the quenching data48. Thus, if inner filter effects 
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are present, the observed fluorescence intensities must be corrected, except 
for lifetime measurements which are relatively independent of total intensity. 
 When using iodide or other ionic quenchers, it is important to maintain a 
constant ionic strength. This is usually accomplished by addition of KCl. It is also 
important to use freshly prepared solutions or to add a reducing agent, such as 
Na2S2O3 (otherwise, I2 may be formed)
3,17. 
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7.  Fluorescence anisotropy 
As we saw at the beginning of section 4, light is an electromagnetic wave consisting of 
an electric field E and a magnetic field H perpendicular to each other and to the 
direction of propagation, and oscillating in phase (vd. Figure 4.1). These fields have no 
preferred orientation for natural light but they oscillate along a given direction when 
the light is linearly polarized (the intermediate case corresponds to light which is 
partially polarized, Figure 4.23)3. 
 
Figure 4.23. Natural, linearly polarized and partially polarized light
3
. 
 
When excited with polarized light, those fluorophores that have their absorption 
transition moments,   
            , oriented along the electric vector of the incident light are 
preferentially excited. Indeed, if the incident light is linearly polarized, the probability 
of excitation of a chromophore is proportional to the square of the scalar product 
  
  .E, and therefore to cos2 A, A being the angle between the electric vector     of 
the incident light and the absorption transition moment   
            ,  (Figure 4.24). This 
probability is maximum when     is parallel to   
            ,  of the molecule; it is zero when the 
electric vector is perpendicular (photoselection)3. 
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Figure 4.24. Transition moments and photoselection
3
. 
 
Upon excitation with polarized light, the emission from many samples is also polarized. 
The extent of polarization of the emission is described in terms of the anisotropy (r). 
Samples exhibiting nonzero anisotropies are said to display polarized emission. Any 
change in direction of the transition moment during the lifetime of the excited state 
will cause this anisotropy to decrease, i.e. will induce a partial (or total) depolarization 
of fluorescence. The emission can become depolarized by a number of factors: 
 Noncollinear absorption and emission transition moments17; 
 Torsional vibrations; 
 Light scattering, reabsorption and misalignment of the polarizers; 
 Transfer of the excitation energy to another molecule with different orientation; 
 Brownian motion (molecular rotation occurring between fluorophore excitation 
and emission). 
 
Anisotropy measurements reveal the average angular displacement of the fluorophore 
that occurs between absorption and subsequent emission of a photon. This angular 
displacement is dependent upon the motions of the fluorophore. Therefore, the 
viscosity of the solvent and the size and shape of the molecule are important factors 
that affect anisotropy. For example, small fluorophores in low-viscosity solutions move 
very fast comparatively to the rate of emission. Under these conditions, the emission is 
depolarized and the anisotropy is close to zero. The dependence of fluorescence 
anisotropy upon fluorophore motions has resulted in numerous applications of this 
technique in biochemical research, as it provides useful information on molecular 
mobility, size, shape and flexibility of molecules, fluidity of a medium, and order 
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parameters (e.g. in a lipid bilayer). For example, the anisotropies of membrane-bound 
fluorophores have been used to estimate the internal viscosities of membranes and 
the effects of lipid composition upon the membrane phase-transition temperature17. 
 
7.1. Polarization ratio and emission anisotropy 
For most experiments of fluorescence anisotropy, the sample is excited with vertically 
polarized light. The electric vector of the excitation light is oriented parallel to the 
vertical or z-axis. The intensity of the emission is measured through a polarizer. When 
the emission polarizer is oriented parallel to the direction of the polarized excitation 
the observed intensity is called IVV. Likewise, when the polarizer is perpendicular to the 
excitation, the intensity is called IVH (Figure 4.25)
17. 
 
 
 
 
 
 
 
 
Figure 4.25. Schematic diagram for measurement of fluorescence anisotropies
17
. 
 
Fluorescence can be considered as the result of three independent sources of light 
polarized along three perpendicular axis Ox, Oy, Oz without any phase relation 
between them. Ix, Iy, Iz are the intensities of these sources, and the total intensity is   
                                IT = Ix + Iy + Iz                                                          (4.55) 
For vertically polarized incident light, Iz= IVV and Ix =Iy =IVH and thus the total intensity 
is  
IT = IVV + 2 IVH                                                           (4.56) 
 The polarization state of fluorescence is characterized either by 
 the polarization ratio, p, defined as the fraction of light that is linearly polarized:  
  
       
   +    
                                                                     
When IVV or IVH is 0, the polarization ratio will have values of -1 or 1, respectively. This 
represents the full range of polarization ratio values possible with a value of 1, 
 
IVV 
IVH 
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indicating a perfect alignment of emission dipoles with the orientation of the light 
source electric field; a value of -1 indicates an orthogonal orientation49.  
 or the emission anisotropy, r, which represents the ratio of the polarized 
component to the total intensity (IT) : 
  
       
   +     
                                                                  
When IVV or IVH is 0, the emission anisotropy will have values of –0.5 or 1, respectively. 
This represents the full range of anisotropy values possible; a value of 1 indicates a 
perfect alignment of emission dipoles with the orientation of the light source and a 
value of -0.5 indicates an orthogonal orientation of emission dipoles49. 
The anisotropy is a dimensionless quantity that is independent of the total intensity of 
the sample. This is because the difference (IVV – IVH) is normalized by the total intensity            
(IT=IVV+2IVH), whereas in the expression of the polarization ratio, the denominator 
represents the fluorescence intensity in the direction of observation.  For that reason, 
the use of anisotropy leads to simpler equations and is preferred to the use of 
polarization, except in a few situations (e.g. the study of radiative transfer). 
When the sample contains a mixture of fluorophores, each has its own emission 
anisotropy3, ri: 
   
         
    +      
 
         
   
                                                 
and each contributes to the total fluorescence intensity with a fraction  
   
   
  
                                             (4.60) 
Thus, the total emission anisotropy is the weighted sum of the individual anisotropies: 
       
 
                                                                     
The polarization and anisotropy values can be interchanged using 
  
  
 +  
                                                                        
and                                                           
  
  
   
                                                                          
If the light observed through the emission polarizer is completely polarized along the 
transmission direction of the polarizer, then IVH = 0 and p = r = 1.0. Completely 
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polarized emission can be observed for oriented samples, but not for homogeneous 
unoriented samples: in this case, the measured values are smaller due to the angular 
dependence of photoselection.  
If the light observed through the emission polarizer is completely depolarized, then   
IVH = IVV and p = r = 0. It is important to note that p and r are not equal for 
intermediate values.  
For the moment, we have assumed that these intensities could be measured without 
interference due to the polarizing properties of the optical components, especially the 
emission monochromator. However, an additional factor must be introduced in order 
to correct this effect: in most cases, the sample is excited with vertically polarized light, 
and the emission is observed through a monochromator. The monochromator will 
usually have different transmission efficiencies for vertically and horizontally polarized 
light. Consequently, rotation of the emission polarizer changes the measured 
intensities even if the sample emits unpolarized light. The measured intensities are not 
the desired parallel and perpendicular intensities, but rather intensities that are also 
proportional to the transmission efficiencies of the monochromator for each polarized 
component. The objective is to measure these actual intensities, IVV and IVH, unbiased 
by the detection system17.  
The measured intensity ratio IVV/IVH is different from the true value by a factor G, 
which is the ratio of the sensitivities of the detection system for vertically and 
horizontally polarized light (SV and SH, respectively). The G factor is easily measured 
using horizontally polarized excitation: 
  
  
  
 
   
   
                                                                 
When the G factor is known, the polarization ratio and the anisotropy are respectively 
given by: 
  
        
   +     
                                                              
 
and                                              
  
        
   +      
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7.2. Relation between anisotropy and the absorption and emission dipoles 
orientation 
 7.2.1. Parallel absorption and emission transition moments 
We will consider a population of N molecules randomly oriented and excited at time 0 
by an infinitely short pulse of light polarized along Oz. At time t, the emission 
transition moments,   
            , of the excited molecules have a certain angular distribution. 
Here we assume that the absorption and emission transition moments are parallel. 
The orientation of these transition moments is characterized by , the angle with 
respect to the Oz axis, and by , the angle between the projection of the  transition 
moments in the xy plane and the Ox axis (Figure 4.26)3. 
 
Figure 4.26. System of coordinates for characterizing the emission dipole orientation of one molecule 
(adapted from ref. 3). 
 
Figure 4.26 shows IVV and IVH being proportional to the projection of the emission 
transition moment of one molecule onto the axes. This is true because the projection 
of the transition moment is the same as the projection of the electric field created by 
the fluorophore. Hence the projection of the field onto the z-axis is proportional to 
cosθ and the intensity is proportional to cos2θ. Similarly, the field along the y-axis is 
proportional to sinθsin and the intensity is proportional to sin2θsin2: 
IVV  cos2                                                              (4.67) 
and                    IVH   sin2θsin2                                                     (4.68) 
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If we consider now randomly oriented fluorophores, the anisotropy is calculated by 
performing the appropriate averaged intensities based on excitation photoselection. 
For excitation polarized along the z-axis, the population of excited molecules is 
oriented with values of  from 0 to 2  with equal probability. Hence we can eliminate 
the  dependence (equation 4.68) by calculating the average value of sin2 with the 
general definition of an averaged quantity17: 
 s      
 s      
  
 
   
  
 
 
 
 
                                                       
Therefore, 
IVV  cos2                                                              (4.70) 
 and                IVH  
 
 
sin2θ                                                            (4.71) 
If we assume we are observing a collection of fluorophores that are oriented relative 
to the z-axis with a probability f(θ), the measured fluorescence intensities for this 
collection of molecules are 
       θ   s
 θ θ      s θ  
 
 
 
                                         
and                                   
 
 
   θ s   θ
   
 
 θ  
 
 
 s   θ                                       
 
where f(θ)dθ is the probability that a fluorophore is oriented between θ and θ + dθ, 
and k is an instrumental constant. 
Thus, using the identity  
sin2=1-cos2                                                         (4.74) 
we can write 
  
       
   +     
 
    s θ    
 
                                              
 
This equation shows that, for a single fluorophore oriented along the z-axis with 
collinear transitions (=0), r=1.0. However, it is not possible to obtain a perfectly 
oriented excited-state population with optical excitation of homogeneous solutions. 
Hence the anisotropies are always less than 1.0. Complete loss of anisotropy is 
equivalent to θ=54.7. This does not mean that each fluorophore is oriented at 54.7, 
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or that they have rotated through 54.7. Rather, it means that the average value of 
cos2θ is 1/3.  
In this expression, we assumed that the absorption and the emission transition 
moments are collinear. However, for almost all fluorophores, they rarely are. In 
addition, these anisotropies values are not taking into account the effects of 
photoselection17.  
When a sample is illuminated with polarized light, those molecules with absorption 
transitions aligned parallel to the electric vector of the polarized excitation have the 
highest probability of excitation (photoselection) and this probability is proportional to 
cos2. For the random ground state distribution, which must exist in a disordered 
solution, the number of molecules at an angle between θ and θ + dθ is proportional to 
sin θ dθ. This quantity is proportional to the surface area on a sphere within the angles 
θ and θ + dθ. 
Hence, the probability distribution of molecules excited by vertically polarized light is 
given by: 
f()d = cos2sind                                                  (4.76) 
This probability determines the maximum photoselection that can be obtained using 
one-photon excitation (more highly oriented populations can be obtained using 
multiphoton excitation). 
For collinear absorption and emission transition moments, the value of <cos2> is 
given by: 
   s θ   
   s θ  θ  θ
   
 
   θ  θ
   
 
 
 
 
                                             
The emission anisotropy can thus be written as 
   
    s θ    
 
 
 
 
                                                  
r0 is called the fundamental anisotropy, i.e. the theoretical anisotropy that is observed 
when the absorption and emission dipoles are collinear, and when there are no 
processes which result in depolarization (in practice, rotational motions can be 
hindered in a rigid medium). Under these conditions, the excited-state population is 
preferentially oriented along the z-axis and the value of IVH is one-third the value of IVV 
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(IVV = 3 IVH). This value of 0.4 is considerably smaller than that possible for a single 
fluorophore oriented along the z-axis (r = 1.0).  
The experimental value, called the limiting anisotropy, is always slightly smaller than 
the theoretical value (normally it ranges from 0.32 to 0.39). This difference is mainly 
due to torsional vibrations of the fluorophores about their equilibrium orientation50. 
Consequently, a temperature dependence of the limiting anisotropy is noted51,52: at 
low temperature (i.e. when the medium is frozen), r0 may be considered as a constant 
quantity, whereas at high temperature it decreases linearly with the temperature. 
It is important to remember that there are other possible origins for polarized light. 
These include reflections and light scattered by the sample that can interfere with 
anisotropy measurements: in the case of one-photon excitation, if the measured 
anisotropy for a randomly-oriented sample is greater than 0.4, we can infer the 
presence of scattered light in addition to fluorescence (for multiphoton excitation, 
anisotropy values can exceed 0.4)17. 
 
7.2.2. Non-parallel absorption and emission transition moments 
The situation of non-parallel absorption and emission transition moments occurs when 
excitation brings the fluorophores to an excited state other than the first singlet state 
from which fluorescence is emitted. In this case, the absorption and emission 
transition moments are displaced by an angle β relative to each other. We saw 
previously that displacement of the emission dipole by an angle θ from the z-axis 
resulted in a decrease in the anisotropy by a factor (3cos2θ – 1)/2. Similarly, the 
displacement of the absorption and emission dipoles by an angle β results in a further 
loss of anisotropy. The observed anisotropy in a vitrified dilute solution is a product of 
the loss of anisotropy due to photoselection (2/5), and that due to the angular 
displacement of the dipoles. The fundamental anisotropy of a fluorophore is then 
given by  
   
 
 
 
    s β    
 
                                                           
where β is the angle between the absorption and emission transition moments3. 
The fundamental anisotropy value is zero when β = 54.7. When β exceeds 54.7 the 
anisotropy becomes negative. The maximum negative value (-0.20) is found for 
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β=90. In other words, for any fluorophore randomly distributed in solution, with one-
photon excitation, the value of r0 must be within the range from -0.20 to 0.40. The 
values for both r0 and p0 are summarized in Table 4.5. 
 
Table 4.5. Relationship between the angular displacement of transition moments (β) and the 
fundamental anisotropy (r0) or polarization (p0)
17
. 
 (deg) r0 p0 
0 0.40 0.50=1/2 
45 0.10 0.143=1/7 
54.7 0.00 0.000 
90 -0.20 -0.333=-1/3 
 
Negative values generally correspond to S0S2 transitions. A value close to -0.2 is 
indeed observed in the case of some aromatic molecules excited to the second singlet 
state whose transition moment is perpendicular to that of the first singlet state, from 
which fluorescence is emitted (e.g. perylene).  
The measurement of the fundamental anisotropy requires special conditions. In order 
to avoid rotational diffusion, the probes are usually examined in solvents that form a 
clear glass at low temperature, such as propylene glycol or glycerol. Additionally, the 
solutions must be optically dilute to avoid depolarization due to radiative reabsorption 
and emission, or due to resonance energy transfer. One commonly used solvent for 
measuring fundamental anisotropies is propylene glycol at -60 to -70 C. Under these 
conditions, the fluorophores remain immobile during the lifetime of the excited state. 
Glycerol also forms a rigid glass at low temperature. However, glycerol typically 
displays more autofluorescence than propylene glycol. At similar temperatures, 
phosphorescence from the fluorophores seems to be more common in glycerol than in 
propylene glycol. The anisotropy values (r0) determined in these rigid solutions provide 
a measure of the angle between the absorption and emission dipoles17. 
 
7.3. Causes of depolarization 
There are several causes of depolarization. One of them is non-collinear absorption 
and emission transition moments, as we discussed in section 7.2.2. Another cause of 
depolarization can be torsional vibrations of the fluorophores about their equilibrium 
orientation50 (section 7.2.1.). The two principal causes of depolarization are Resonance 
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Energy Transfer (RET) and rotational Brownian motion, which will be discussed in 
sections 7.3.1. and 7.3.2., respectively. Light scattering, reabsorption and misalignment 
of the polarizers represent three experimental causes of depolarization and will be 
examined in section 7.3.3. 
 
7.3.1. Resonance Energy Transfer (RET) 
Radiationless energy transfer in solution occurs only in concentrated solutions, where 
the average distance between the fluorophore molecules is comparable to a 
characteristic distance R0, which is typically near 40 Å. Millimolar fluorophore 
concentrations are required to obtain this average distance. This concentration is 
considerably larger than the usual concentrations required for fluorescence 
measurements, which are about 10–6 M. Hence, radiationless energy transfer is easily 
avoided by the use of dilute solutions. The solutions also need to be adequately diluted 
so that radiative transfer does not occur3. 
The effect of RET on the anisotropy is illustrated by the excitation anisotropy spectrum 
of fluorescein in dilute and concentrated solution53. Fluorescein is subject to radiative 
(emission and reabsorption) and non-radiative energy transfer because of the small 
Stokes shift. In this experiment (Figure 4.27), radiative transfer was avoided by using 
thin samples, and rotational diffusion was eliminated by using a vitrified sample. Under 
these experimental conditions, RET is the only mechanism that can decrease the 
anisotropy. In dilute solution, fluorescein displays its characteristic anisotropy 
spectrum, with high anisotropy for excitation above 380 nm. At high concentration, 
the anisotropy is decreased, due to the occurrence of RET between fluorescein 
molecules. In random solution, it is known that a single non-radiative transfer step 
reduces the anisotropy to 4% of the initial value54-57. Hence, RET is an effective 
mechanism of depolarization. The presence or absence of RET can usually be predicted 
from the concentration of the sample and the spectral properties of the probes. 
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Figure 4.27. Excitation polarization spectra of fluorescein in propylene glycol at -50°C. Radiative transfer 
was avoided by using thin samples, 30 to 50 microns thick. Adapted from ref. 53. 
 
7.3.2. Rotational Brownian motion: the Perrin equation 
If excited molecules can rotate during the excited-state lifetime, the emitted 
fluorescence is partially (or totally) depolarized. Rotational diffusion of fluorophores is 
a dominant cause of fluorescence depolarization, and most applications depend on 
changes in the rate of rotation. From the extent of fluorescence depolarization, we can 
obtain information on the molecular motions, which depend on the size and the shape 
of molecules, and on the fluidity of their microenvironment. A distinction should be 
made between free rotation and hindered rotation. In the case of free rotation, after a 
-pulse excitation, the emission anisotropy decays from r0 to 0, because the rotational 
motions of the molecules lead to a random orientation at long times. In the case of 
hindered rotations (not considered here), the molecules cannot become randomly 
oriented at long times, and the emission anisotropy does not decay to zero, but to a 
steady value17. 
Depolarization by rotational diffusion of spherical rotors (isotropic rotations) is 
described by the Perrin equation58-60: 
  
 
  +
 
θ
  +                                                         
where  is the fluorescence lifetime, θ is the rotational correlation time, and D is the 
rotational diffusion coefficient. If the correlation time is much larger than the lifetime 
(θ >> ), then the measured anisotropy (r) is equal to the fundamental anisotropy 
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(r0). If the correlation time is much shorter than the lifetime (θ << ), then the 
anisotropy tends to zero. 
The rotational correlation time of the fluorophore () is related to the rotational 
diffusion coefficient by θ=(6D)–1 and is given by the Stokes-Einstein relation: 
θ  
  
  
                                                                     
where   is the viscosity of the medium, T is the absolute temperature, R is the gas 
constant, and V is the volume of the rotating unit. The Stokes-Einstein relation is valid 
only when the microviscosity around the molecule is equal to the total viscosity of the 
sample. 
A different version of the Perrin equation (equivalent, except for the use of 
polarization instead of anisotropy) is often found in literature 
 
 
 
 
 
 
 
   
 
  
 
 
 
   +
   
  
   
 
  
 
 
 
   +                                 
 
Using the Perrin equation, it is possible to calculate the anisotropy expected for 
fluorophores in solvents or for labelled macromolecules, assuming the molecules are 
spherical. For example, perylene has a lifetime of 6 ns and r0=0.36. In ethanol, 
rotational diffusion is expected to decrease the anisotropy to 0.005. 
The Perrin equation also allows calculating the apparent volume of a protein. 
Substitution of equation 4.81 into equation 4.80 yields a modified form of the Perrin 
equation: 
 
 
 
 
  
+
   
    
                                                                  
 
Normally, the protein is covalently labeled with an extrinsic fluorophore, which is 
chosen on the basis of its fluorescence lifetime. This lifetime should be comparable to 
the expected rotational correlation time of the protein (this way, the anisotropy will be 
sensitive to changes in the correlation time)17.  
In most cases, fluorescent molecules undergo anisotropic rotations because of their 
asymmetry (non-spherical rotors). A totally asymmetric rotor has three different 
rotational diffusion coefficients. Steady-state anisotropy measurements are then 
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insufficient for fully characterizing rotational motions and time-resolved experiments 
are required. 
 
7.3.3. Experimental causes of depolarization 
Light scattering, reabsorption and misalignment of the polarizers are three 
experimental problems on anisotropy measurements that depend only on the optical 
conditions of the experiment, and do not provide useful information on the molecular 
properties of the sample. 
Biological samples, such as aqueous suspensions of membranes, are frequently turbid. 
This turbidity can cause scattering of both the incident light and the emitted photons. 
The scattered incident light can result in excitation, and the emitted photons can be 
scattered prior to observation. The observed anisotropy is expected to decrease 
linearly with the optical density due to turbidity. It is therefore advisable to investigate 
the effect of turbidity for any sample which displays visible turbidity. This can be 
accomplished by either actual dilution of the sample or using a cuvette with smaller 
dimensions. If dilution does not change the anisotropy value, then there is unlikely to 
be significant depolarization due to scattering.  
A more serious effect of scattering is the possibility that scattered light reaches the 
detector. This is particularly true for dilute solutions where the intensity is low and 
scattering from the optics and sample can be significant. Since the scattered light will 
be highly polarized (r=1.0), a small percentage of scattered light can result in 
significant changes in the anisotropy (normally, the measured anisotropy increases 
relative to its true value). 
Reabsorption of emitted photons (radiative transfer) is another cause of depolarization 
that occurs with fluorophores with large spectral overlap (e.g. fluorescein). It is difficult 
to eliminate this effect since it occurs at lower concentrations than RET. Radiative 
transfer is more efficient in depolarization than RET since a single radiative transfer 
step results in an anisotropy loss of 28%, whereas a single RET step results in an 
anisotropy loss for 4%17. 
Inefficiency of the polarizers can also result in a loss of anisotropy: for example, film 
polarizers become less ideal at short wavelengths. Misalignment of the polarizers can 
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also reduce the anisotropy, but the alignment can be easily checked and adjusted using 
a dilute suspension of glycogen or colloidal silica in water (it is essential to use dilute 
suspensions of the scatterer; otherwise multiple scattering events lead to decreased 
values of polarization). The scattered light is 100% polarized, that is, r=1.0. To 
accomplish alignment, the excitation polarizer is rotated to the approximate vertical 
position. Precise vertical alignment is not necessary since the scattered light is 
vertically polarized. The angular alignment of the emission polarizer is adjusted so that 
the minimum intensity is observed. This is the horizontal position. Rotation of the 
emission polarizer should now yield the maximum and minimum intensities when the 
polarizer is at the vertical and horizontal stops, respectively. These adjustments should 
be performed with the emission monochromator removed, or its wavelength chosen 
for approximate equal transmission efficiencies for vertically and horizontally polarized 
light. Otherwise, the polarizing properties of the emission monochromator could 
interfere with the alignment. The wavelength selection for equal transmission 
efficiencies can be accomplished using either horizontally polarized excitation, to 
obtain IVV=IVH, or a sample whose emission is not polarized. Examples of such 
solutions are 9-cyanoanthracene in the fluid solvent ethanol or [Ru(bpy)3]
2+ in water61. 
Alignment of the excitation polarizer is performed in a similar manner17. 
Finally, one should always examine a blank sample that scatters approximately the 
same light as the sample. Background signals can be especially problematic for 
anisotropy measurements. The background signal may be polarized if due to scattered 
light, or unpolarized if due to low-molecular-weight impurities. Hence, background 
signals can either increase or decrease the anisotropy. In order to correct for 
background, it is necessary to measure the four individual intensities from the blank 
sample, and subtract them from each respective intensity value. 
 
7.4. Applications of fluorescence polarization 
There are several fields concerned with the applications of fluorescence polarization. 
For example, the study of DNA-fluorophore interactions in the field of molecular 
biology; the determination of fluidity and order parameters; the determination of the 
phase-transition temperature and the effect of additives such as cholesterol, in the 
field of biological membranes3,17. In this work, steady-state fluorescence anisotropy 
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measurements were performed in order to evaluate the location and the behavior of 
several new potential antitumoral fluorophores into lipid membranes (Chapter 5, 
sections 5.1., 5.2., and 5.4.). 
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ABSTRACT 
In this work we were able to obtain the benzothieno[3,2-b]quinoline 1 and benzothieno[2,3-
c]quinoline 2 using a new one pot procedure from the reaction of the commercial available 3-
bromobenzo[b]thiophene-2-carbaldehyde with 2-aminophenylpinacolborane under Suzuki 
coupling conditions using a stereochemically hindered ligand, 2-
(cyclohexylphosphane)biphenyl and Ba(OH)2.8H2O as the base.  
Fluorescence properties of the benzothieno[3,2-b]quinoline 1 and the benzothieno[2,3-
c]quinoline 2 were studied in solvents of different polarity. Both compounds exhibit a solvent 
sensitive emission, compound 1 being less fluorescent (F < 0.05) than compound 2 (0.04 ≤ 
F ≤ 0.10). 
The interaction of these compounds with salmon sperm DNA and synthetic double-stranded 
heteropolynucleotides, poly(dA–dT)·(dA–dT) and poly(dG–dC)·(dG–dC), was studied using 
spectroscopic methods, allowing the determination of the intrinsic binding constants and 
binding site sizes. The interaction of both compounds is stronger with adenine-thymine (A-T) 
base pairs. Compound 1 is the most intercalative in salmon sperm DNA (47%) and 
polynucleotides (46%-49% of intercalated molecules), while for compound 2, 41% is 
intercalated in salmon sperm DNA and only 8% in poly(dG–dC)·(dG–dC). Overall, these 
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results point to a predominant interaction of both compounds to nucleic acids by groove 
binding. 
 
 
KEYWORDS: Benzothieno[3,2-b]quinoline, Benzothieno[2,3-c]quinoline, DNA interaction, 
polynucleotides, binding constants. 
 
 
1. INTRODUCTION 
The investigation of the nature and dynamics of the binding of small molecules to 
biomacromolecules is actually an active area of research [1,2]. DNA interaction studies are 
important to understand the mechanism of action of antitumor and antiviral drugs and to 
design new DNA-targeted drugs [3,4]. Three different modes of binding to DNA have been 
described: intercalation into the base pairs, in the major or minorgrooves, and outside the 
double helix by electrostatic interactions. Small molecules are stabilized on groove binding 
and intercalationwith DNA through a series of associative interactions such as π-stacking, 
hydrogen bonding, attractive van der Waals and hydrophobic interactions [4]. DNA 
intercalation seems to be an essential, but not sufficient, step for antitumoral activity [3]. 
Benzothieno[3,2-b]quinoline 1 [5] and benzothieno[2,3-c]quinoline 2 [6] are known for 
their anti-plasmodic and anti-infectious activities, acting mainly through intercalation between 
DNA base pairs when used in their salt form. Earlier synthesized by separated reactions and 
in several steps [5,6], in this work we were able to obtain the two compounds in a one pot 
procedure.  
The interactions of the biologically active compounds with nucleic acids have been 
studied using a variety of techniques [7-11], including absorption and fluorescence 
spectroscopies. The binding of the fluorescent polycyclic molecules to DNA can be 
conveniently investigated by these methods, because their absorption and emission properties 
significantly change on complex formation [7,12,13]. Fluorescence quenching experiments 
using external quenchers have been used to establish the DNA-binding modes, since 
intercalated fluorophores are less accessible to anionic quenchers, due to electrostatic 
repulsion with the negatively charged DNA backbone [13-15]. 
In this work, the interaction of the synthesized benzothienoquinolines 1 and 2 with 
natural double-stranded salmon sperm DNA and with synthetic ds-polyheteronucleotides was 
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investigated by fluorescence emission measurements. These studies are important due to the 
biological relevance of both compounds as potential antitumorals.  
 
 
2. EXPERIMENTAL 
2.1. Synthesis 
General remarks 
Melting points (oC) were determined in a SMP3 Stuart apparatus and are uncorrected. 1H and 
13C NMR spectra were recorded on a Varian Unity Plus at 300 and 75.4 MHz, respectively. 
Heteronuclear correlations, 1H-13C, HMQC or HMBC were performed to attribute some 
signals. HRMS data were recorded using a method of direct injection by EI by the mass 
spectrometry service of the University of Vigo, Spain. The reactions were monitored by thin 
layer chromathography (TLC) in aluminium plates covered with a layer of silica gel 60 
(Macherey-Nagel) of 0.2 mm, with UV254 fluorescence indicator. Column chromatography 
was performed using silica-gel 230-400 mesh. Petroleum ether refers to the 40-60 ºC boiling 
range fraction. 
 
One pot synthesis of  benzotieno[3,2-b]quinoline 1 and benzotieno[2,3-c]quinoline 2: To a 
solution of 3-bromobenzo[b]thiophene-2-carbaldehyde (150 mg, 0.600 mmol) in dioxane (5 
mL) Pd(AcO)2 (5 mol%), 2-(cyclohexylphosphane)biphenyl (20 mol%), Ba(OH)2.8H2O (3 
equiv.) and 2-aniline pinacolborane (170 mg, 0.780 mmol). The mixture was heated at 100 ºC 
for 5h. After cooling, H2O and AcOEt were added and the phases were separated. The organic 
phase was dried (MgSO4), filtered and the removal of the solvent gave an oil which was 
submitted to column chromatography using solvent gradient from neat petroleum ether to  
20% ether/petroleum ether and the two products were separated.  
Compound 1 was the major product and was isolated using 10% ether/petroleum ether (45.0 
mg, 30 %), p.f. 173-175 ºC [5]. 1H NMR (CDCl3, 300 MHz): δ 7.55-7.67 (3H, m, Ar-H), 
7.74-7.81 (1H, m, Ar-H), 7.84-7.94 (2H, m, Ar-H), 8.31 (1H, d, J = 8.4 Hz, Ar-H), 8.59 (1H, 
s, 11-H), 8,66-8,71 (1H, m, Ar-H) ppm. 13C NMR (CDCl3, 75.4 MHz): δ 123.04 (CH), 124.01 
(CH), 125.08 (CH), 126.19 (CH), 126.60 (C), 127.08 (CH), 128.89 (11-CH), 129.06 (CH), 
129.42 (CH), 129.90 (CH), 130.61 (C), 134.14 (C), 141.17 (C), 146.44 (C), 153.96 (C). MS 
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(EI): m/z (%) 235 (M+, 100). HRMS M+: Calculated for C15H9NS: 235.0456; Found: 
235.0449.  
Compound  2 was isolated  using 20% ether/petroleum ether (28.0 mg, 20 %), p.f. 123-125 ºC 
[6]. 1H NMR (CDCl3, 300 MHz): δ 7.61-7.70 (2H, m, Ar-H), 7.74-7.82 (2H, m, Ar-H), 8.05-
8.11 (1H, m, Ar-H), 8.30-8.36 (1H, m, Ar-H), 8.84-8.94 (2H, m, Ar-H), 9.37 (1H, s, 6-H) 
ppm. 13C NMR (CDCl3, 75.4 MHz): δ 122.92 (CH), 123.77 (CH), 125.39 (CH+C), 126.04 
(CH), 127.49 (CH), 127.51 (CH), 127.76 (CH), 130.81 (CH), 133.37 (C), 135.15 (C), 135.37 
(C), 141.35 (C), 145.56 (C), 145.65 (6-CH) [6b]. MS (EI): m/z (%) 235 (M+, 100). HRMS 
M+: Calculated for C15H9NS: 235.0456; Found: 235.0457. 
The data for both compounds are identical to those presented in earlier works [5,6]. 
2.2. Spectroscopic measurements 
Absorption spectra were recorded in a Shimadzu UV-3101PC UV-Vis-NIR 
spectrophotometer. Fluorescence measurements were performed using a Fluorolog 3 
spectrofluorimeter, equipped with double monochromators in both excitation and emission 
and a temperature-controlled cuvette holder. For fluorescence quantum yield determination, 
the solutions were previously bubbled for 30 minutes with ultrapure nitrogen. Fluorescence 
spectra were corrected for the instrumental response of the system.  
The fluorescence quantum yields (s) were determined using the standard method 
(equation 1) [16,17] and 9,10-diphenylanthracene in ethanol as reference, r = 0.95 at 25 ºC 
[18]. 
 
     r2rrs2ssrs  nFAnFA     (1) 
where A is the absorbance at the excitation wavelength, F the integrated emission area and n 
the index of refraction of the solvents used. Subscripts refer to the reference (r) or sample (s) 
compound.  
All solutions were prepared using spectroscopic grade solvents and Milli-Q grade water. 
Natural double-stranded salmon sperm DNA was obtained from Invitrogen, while synthetic 
double-stranded heteropolynucleotides, poly(dA–dT)·(dA–dT) and poly(dG–dC)·(dG–dC), 
were obtained from Sigma-Aldrich. Salmon sperm DNA, polynucleotides and compounds 
stock solutions were prepared in 10-2 M Tris-HCl buffer (pH=7.2), with 10-3 M EDTA. The 
purity of DNA was checked by monitoring the absorption spectrum and the ratio of the 
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absorbance at 260 and 280 nm, A260/A280=1.95 (good-quality DNA has an A260/A280 ratio 
higher than 1.8) [19]. The DNA and polynucleotide concentrations in number of bases (or 
phosphate groups) were determined from the molar absorption coefficients [12], ε=6600      
M-1 cm-1 at 260 nm for DNA, ε=8400 M-1 cm-1 at 254 nm for poly(dG–dC)·(dG–dC) and 
ε=6600 M-1 cm-1 at 260 nm for poly(dA–dT)·(dA–dT). 
The absorption and emission spectra of several solutions with different [nucleic 
acid]/[compound] ratios using the same compound concentration (210-6 M) were recorded. 
The solutions were left 24 h to stabilize. The absorbance at excitation wavelengths was 
always less than 0.1, in order to avoid inner filter effects. All measurements were performed 
at room temperature (25.00.5 ºC). Binding analysis of the experimental data was performed 
according to McGhee and von Hippel model [20] to determine the intrinsic binding constants 
and the binding site sizes. 
 
3. RESULTS AND DISCUSSION 
3.1. Synthesis 
The reaction of the commercial available 3-bromobenzo[b]thiophene-2-carbaldehyde 
with 2-aminophenylpinacolborane under Suzuki coupling conditions using a stereochemically 
hindered ligand as 2-(cyclohexylphosphane)biphenyl [21] and Ba(OH)2.8H2O as the base, 
gave in a one pot procedure compounds 1 and 2 which were separated by column 
chromatography (Scheme 1). 
 
Scheme 1. One pot synthesis of benzothieno[3,2-b]quinoline 1 and benzothieno[2,3-c]quinoline 2. 
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Although these compounds have already been synthesized by other authors in several 
steps, we were able to prepare them in a one pot procedure which is very advantageous to 
save reagents and time. 
The synthesis of the benzothieno[3,2-b]quinoline 1 was unexpected using these reaction 
conditions. It seems that it is the result of a Pd-catalyzed C-N coupling followed by an 
intramolecular cyclization that may perhaps occur by nucleophilic attack of the activated 
ortho position of the diarylamine intermediate on the carbonyl of the aldehyde, after 
deboronation. In the synthesis of the expected compound 2, a Suzuki cross-coupling and a 
nucleophilic attack of the amino group on the aldehyde occurred.  
 
3.2. Fluorescence studies in several solvents 
The absorption and fluorescence properties of compounds 1 and 2 were studied in several 
solvents of different polarity. The maximum absorption (abs) and emission wavelengths (em) 
and fluorescence quantum yields (F) of both compounds in several solvents are presented in 
Table 1. The normalized fluorescence spectra are shown in Figures 2 and 3 (examples of 
absorption spectra are also shown as insets).  
Compounds 1 and 2 exhibit fluorescence emission in several polar and non-polar media, 
including water. Fluorescence quantum yield values are generally low, varying from 2% to 
10% (Table 1), the benzothieno[2,3-c]quinoline 2 being the more fluorescent compound. A 
red-shift and loss of vibrational structure is observed for the emission in polar solvents, this 
effect being more pronounced for compound 1 (red shifts between cyclohexane and water are 
48 nm for compound 1 and 28 nm for compound 2). As in the absorption spectra the red shifts 
are negligible (Table 1), this behavior indicates that solvent relaxation after photoexcitation 
plays an important role, especially for the benzothieno[3,2-b]quinoline 1. This predicts a 
higher ICT character of the excited state for the latter compound. 
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Figure 2. Normalized fluorescence spectra of solutions (3×10-6 M) of compound 1 (λexc=335 nm) in 
several solvents. Inset: absorption spectra of 2×10-5 M solutions of compound 1 in cyclohexane and 
ethanol, as examples.  
 
 
 
Figure 3. Normalized fluorescence spectra of solutions (3×10-6 M) of compound 2 (λexc=325 nm) in 
several solvents. Inset: Absorption spectra of 10-5 M solutions of compound 2 in cyclohexane and 
ethanol, as examples.  
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Table1. Maximum absorption (λabs) and emission wavelengths (λem) and fluorescence quantum yields (F) of 
compounds 1 and 2 in several solvents.  
Solvent λabs(nm) λem (nm) Fa 
1 2 1 2 1 2 
Cyclohexane 372, 354, 334, 272, 243 359, 342, 319, 307, 256 378 364 0.02 0.07 
Dioxane 372, 354, 335, 272, 242 359, 343, 320, 308, 257 392 367 0.03 0.10 
Ethylacetateb 371, 353, 334, 271 358, 342, 318, 307 393 365 0.02 0.08 
Dichloromethane 372, 354, 336, 273, 243 360, 344, 321, 309, 257 392 370 0.02 0.06 
Chloroformb 374, 356, 337, 274 361, 345, 322, 310, 258 394 372 0.02 0.04 
Acetonitrile 371, 353, 334, 270, 241 358, 342, 319, 307, 255 394 369 0.02 0.05 
N,N-Dimethylformamideb 372, 355, 335 360, 344, 320, 309 395 384 0.04 0.08 
Dimethylsulfoxideb 373, 356, 337 360, 344, 322, 310 403 374 0.03 0.08 
Ethanol 372, 336, 272, 241 361, 347, 321, 310, 256 401 374 0.03 0.09 
Methanol 371, 336, 271, 240 361, 346, 321, 310, 256 406 375 0.02 0.07 
Water 372, 336, 271, 240 362, 349, 321, 311, 255 426 392 0.01 0.06 
aRelative to 9,10-diphenylanthracene in ethanol (R =0.95) [18]. Error about 10%. 
bSolvents cut-off: Chloroform: 250 nm; Ethyl acetate: 265 nm; N,N-dimethylformamide: 280 nm.  
Dimethylsulfoxide: 275 nm. 
 
 
 
The fluorescence quantum yields in protic solvents tend to decrease with increasing 
solvent hydrogen bonding capability (ФF in ethanol > ФF in methanol > ФF in water), may be 
due to an increase of ST intersystem crossing efficiency through H-bond formation 
between these quinoline derivatives and protic solvents, probably by protonation of the N 
atom of the pyridine moiety. A similar behaviour has been observed previously for other 
compounds synthesized by us and containing a pyridine ring, namely several thieno[3,2-
b]pyridine derivatives [22-24]. The formation of hydrogen bonds between chloroform and 
these proton acceptor quinoline derivatives can also explain the lower fluorescence quantum 
yield values in this solvent [25,26]. 
 
3.3. Interaction with salmon sperm DNA and with synthetic double-stranded 
polynucleotides 
The interaction of compounds 1 and 2 with natural double-stranded salmon sperm DNA 
was studied by fluorescence. Changes in absorption spectra upon DNA interaction are 
negligible, as previously observed for other neutral aromatic compounds already studied by 
some of us, namely tetracyclic lactams [27] and thieno[3,2-b]pyridine derivatives [24]. 
Figures 4 and 5 show the emission spectra of the benzothienoquinolines 1 and 2 with 
increasing [DNA]/[compound] ratio, where [DNA] is expressed in number of bases or 
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phosphate groups. For both quinoline derivatives, spectral invariance with increasing DNA 
concentration occurs for the ratio [DNA]/[compound]=100, indicating that total compound 
binding is achieved at this [DNA]/[compound] ratio (spectra corresponding to ratio 100 and 
120 are overlapped). 
 
Figure 4. Fluorescence spectra of the benzothienoquinoline 1 (210-6 M) in 10 mM Tris-HCl buffer     
(pH = 7.2), with increasing DNA content.  
 
 
 
Figure 5. Fluorescence spectra of the benzothienoquinoline 2 (210-6 M) in 10 mM Tris-HCl buffer     
(pH = 7.2), with increasing DNA content.  
 
An enhancement in emission intensity with increasing DNA concentration is observed for 
compound 1, while the opposite occurs for compound 2 (figure 6). This may indicate a 
232 
 
different type of interaction of the two benzothienoquinolines with DNA bases, as already 
observed for other tetracyclic compounds [24,27]. The high [DNA]/[compound] ratio needed 
for total binding, together with the negligible changes observed in absorption spectra (not 
shown), point to a weak interaction of these molecules with the nucleic acid, which is also a 
common behavior with tetracyclic thienopyridine derivatives [24]. 
 
Figure 6. Fluorescence intensities ratio in the presence (I) and absence (I0) of DNA for compounds 1 
and 2 at several [DNA]/[compound] molar ratios. 
 
To clarify the different behavior of the two quinolines, the base sequence binding 
preference was also investigated, using synthetic ds-heteropolynucleotides, poly(dA-dT)·(dA-
dT) and poly(dG-dC)·(dG-dC). Figure 7 displays the ratio of maximum emission intensities in 
the presence (I) and absence (I0) of ds-heteropolynucleotides for several [nucleic 
acid]/[compound] ratios, for compounds 1 and 2, respectively. The behaviour in 
heteropolynucleotides is similar to that in salmon sperm DNA, with a rise in fluorescence 
intensity with increasing polynucleotide concentration for compound 1 and a decrease for 
compound 2. However, the stabilization in emission intensity, indicative of full binding, is 
attained at a significantly lower molar ratio for poly(dA-dT)·(dA-dT) 
([nucleotide]/[compound]=60 and 80, respectively for compound 1 and 2). For poly(dG-
dC)·(dG-dC), the stabilization is attained at a molar ratio of 100 for both quinolines, similarly 
to the behavior observed with salmon sperm DNA. 
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Figure 7. Fluorescence intensities ratio in the presence (I) and absence (I0) of heteropolynucleotides 
for the benzothienoquinolines 1 and 2 at several [nucleotide]/[compound] molar ratios.  
A: Poly(dA-dT)∙poly(dA-dT); B: poly(dG-dC)∙poly(dG-dC). 
 
The binding constants and binding site sizes were determined by the modified Scatchard 
equation, given by McGhee and von Hippel [20] 
       1i
f
)1(111  nrnnrnrK
c
r
     (2) 
where Ki is the intrinsic binding constant, n is the binding site size in base pairs, r is the ratio 
cb/nucleic acid, cb and cf are the concentrations of bound and free compound, respectively, 
calculated by 
   total
bF,F,0
FF,0
b cII
II
c 


     ;     bftotal ccc     (3) 
being IF,0 the fluorescence intensity of the free compound and IF,b the fluorescence intensity of 
the bound compound at total binding. 
The fluorescence measurements results were fitted by least squares methods to obtain the 
values of the binding constants (Ki) and the number of base pairs between consecutive 
intercalated compound molecules (n). The results are presented in Table 2. 
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Table 2. Values of binding constants (Ki) and binding site sizes (n) for benzothienoquinolines interaction with 
DNA and synthetic heteropolynucleotides. 
 Nucleic acid Ki (M
-1) n 
Compound 1 
salmon sperm DNA (2.6  0.3)105 14  5 
poly(dA-dT)·(dA-dT)  (3.0  0.4)105 13  5 
poly(dG-dC)·(dG-dC)  (5.9  0.6)104 35 ± 9  
Compound 2 
salmon sperm DNA (2.9  0.3)105 16 ± 6 
poly(dA-dT)·(dA-dT)  (3.1  0.4)105 14  5 
poly(dG-dC)·(dG-dC)  (4.5  0.5)104 25 ± 9  
 
It has already been reported that small variations in the structure of tetracyclic 
compounds, as differences only in the substituent groups, influence strongly the interaction 
with nucleic acids [13,24,27], either by changes in the main mechanism and/or by affecting 
the magnitude of interaction (binding constant and binding site size). As both compounds 
exhibit a stronger interaction with poly(dA-dT)∙poly(dA-dT) than with poly(dG-dC)∙(dG-dC) 
(higher binding constants and lower binding site sizes in the former), it can be concluded that 
the main interaction in DNA is established with A-T base pairs. The mechanism of 
photoinduced electron transfer between compounds and DNA bases is not expected to occur, 
as this kind of interaction depends strongly on the bases structure [28,29]. A more likely 
mechanism for the intercalation of these compounds in nucleic acids is the π-stacking.  
Fluorescence quenching experiments with iodide ion were also performed for compounds 
1 and 2 in the presence of DNA and heteropolynucleotides. The quenching data were first 
plotted according to the Stern-Volmer relation (equation 4) [30], 
 Q1 SV
0 K
I
I
       (4) 
where I0 and I are, respectively, the fluorescence intensities in the absence and in the presence 
of quencher (I-), KSV is the Stern-Volmer constant and Q is the quencher concentration.  
In all cases, Stern-Volmer plots are non-linear (figure 8, as an example), with a 
downward curvature. This means that not all the fluorescent molecules are accessible to the 
quencher. In this case, the system contains heterogeneously emitting sites, in which some 
compound molecules are accessible to the quencher and other molecules are not accessible. 
Thus, the Stern-Volmer equation must be modified [31] as (5): 
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                        (5) 
where III  0 , fa is the accessibility to quencher. From the plots of II 0  vs. 1/[Q], it is 
possible to obtain the accessibilities to the anionic quencher. The results are summarized on 
Table 3. 
 
 
Table 3. Values of the accessibilities (fa) to the quencher (I
-) and Stern-Volmer constants 
for compounds 1 and 2 bound to DNA and heteropolynucleotides. 
 Nucleic acid KSV (M
-1) fa 
Compound 1 
Salmon sperm DNA 4.65 0.53 
poly(dA-dT)·(dA-dT) 9.33 0.54 
poly(dG-dC)·(dG-dC) 11.1 0.51 
Compound 2 
Salmon sperm DNA 8.61 0.59 
poly(dA-dT)·(dA-dT) 9.54 0.63 
poly(dG-dC)·(dG-dC) 6.1 0.92 
 
 
Anionic quenchers can be used to distinguish between DNA binding modes [14,15,31]. 
Intercalated chromophores are less accessible to quenching by iodide ion due to electrostatic 
repulsion between the negatively charged DNA and iodide anion [15]. Compounds which are 
bound at the DNA surface (groove binding or electrostatic binding) are more accessible and, 
therefore, emission from these molecules can be quenched more efficiently. As these 
benzothienoquinolines are neutral molecules, electrostatic binding to nucleic acids is not 
anticipated. Therefore, the fraction of compound molecules accessible to the external 
quencher (fa) should correspond to bound molecules at the grooves. 
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Figure 8. A: Stern-Volmer plots for quenching with iodide ion (I-) for compounds 1 and 2 with 
salmon sperm DNA. B: Corresponding modified Stern-Volmer plots.  
 
The fraction of intercalated molecules into salmon sperm DNA and 
heteropolynucleotides is higher for the benzothienoquinoline 1 (46% to 49%). On the 
contrary, compound 2 presents a very small fraction of intercalated molecules (8%) in 
poly(dG-dC)(dG-dC), while in poly(dA-dT)(dA-dT) the percentage is similar to the 
observed in natural DNA (around 40%). As both compounds are neutral molecules, the 
relatively high value for fa for compounds 1 and 2 may indicate that the main type of binding 
of these quinoline derivatives to DNA must be the groove binding [24,27] (electrostatic 
interaction is not expected), being compound 1 the more intercalative one. 
 
 
CONCLUSIONS 
A new one pot method was achieved for the synthesis of benzothieno[3,2-b]quinoline 1 and 
benzothieno[2,3-c]quinoline 2 by the reaction from the reaction of the commercial available 
3-bromobenzo[b]thiophene-2-carbaldehyde with 2-aminophenylpinacolborane under Suzuki 
coupling conditions using a stereochemically hindered ligand, 2-
(cyclohexylphosphane)biphenyl and Ba(OH)2.8H2O as the base. Although the compounds 
have already been synthesized earlier by other authors using several steps, our methodology is 
advantageous saving reagents and time. Both compounds are fluorescent and present a solvent 
sensitive emission, despite the low fluorescence quantum yields (below 10%). 
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The benzothieno[3,2-b]quinoline 1 is the most intercalative compound in DNA and synthetic 
heteropolynucleotides. Both compounds exhibit a stronger interaction with A-T than with G-
C base pairs, exhibiting higher binding constants and smaller binding site sizes. Fluorescence 
quenching measurements allowed concluding that the main mechanism of interaction of these 
quinoline derivatives is the binding in the DNA grooves. 
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As outlined in the Abstract the spectroscopic properties of several classes of potential 
antitumoral heterocyclic compounds, derivatives of indoles, benzo[b]thiophenes and 
thieno[3,2-b]pyridines, synthesized in our research group, were studied in different 
environments, like solvents of different polarity, liposomes and in the presence of 
nucleic acids.  
All compounds exhibited a solvent sensitive emission, with red-shifts in polar solvents.  
For the planar tetracyclic compounds, either derivatives of thieno[3,2-b]pyridines or of 
benzo[b]thiophenes, the interaction with nucleic acids, which may be important for 
the antitumoral activity, was also evaluated by fluorescence. Experiments of 
fluorescence quenching using iodide anion indicated that the groove binding is the 
main type of interaction, some of the compounds exhibiting also a significant 
intercalation.  
The intrinsic fluorescence of the compounds was used to monitor the location and 
behaviour in nanoliposomes of neat lipids and lipid mixtures of different formulations, 
keeping in mind drug delivery applications using these systems as carriers. 
Future work is envisaged, considering applications of the most promising compounds 
as antitumoral drugs: 
- Evaluation of the interaction and internalization of the nanoliposomes with 
incorporated compounds, with human tumor cell lines. 
- Development of nanoliposomes labeled with folate or transferrin in order to 
enhance the interaction with the tumor cells. 
- Development of magnetoliposomes (liposomes entrapping magnetic 
nanoparticles) with incorporated antitumoral compounds. These systems allow 
the exact location in the therapeutic site of interest, through the use of an 
external magnetic field.  
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